[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "vicuna-13b_response": "Acrokeratosis paraneoplastica is a medical condition characterized by the development of thick, scaly patches on the skin of the hands and feet. The condition is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.\nOne synonym for acrokeratosis paraneoplastica is \"acrokeratotic hyperplasia.\" This term refers to the thick, scaly patches that develop on the skin, as well as the increased cell growth that occurs in the affected areas.\nOther synonyms for acrokeratosis paraneoplastica include \"paraneoplastic acrokeratitis,\" \"acrokeratosis associated with malignancy,\" and \"neoplastic acrokeratosis.\" These terms all refer to the connection between the development of acrokeratosis paraneoplastica and the presence of cancer in the body.\nIt is important to note that while acrokeratosis paraneoplastica is often seen in individuals with cancer, it is not necessarily a direct result of the cancer itself. Rather, it is thought to be caused by a reaction to the cancer or its treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Acrokeratosis paraneoplastica is a medical condition characterized by thick, scaly patches on the skin of the hands and feet.\n2. Acrokeratosis paraneoplastica is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.\n3. One synonym for acrokeratosis paraneoplastica is \"acrokeratotic hyperplasia.\"\n4. Other synonyms for acrokeratosis paraneoplastica include \"paraneoplastic acrokeratitis,\" \"acrokeratosis associated with malignancy,\" and \"neoplastic acrokeratosis.\"\n5. The cause of acrokeratosis paraneoplastica is thought to be a reaction to cancer or its treatment.",
    "vicuna-13b_fact": [
      "Acrokeratosis paraneoplastica is a medical condition characterized by thick, scaly patches on the skin of the hands and feet.",
      "Acrokeratosis paraneoplastica is often seen in individuals with cancer, particularly those with lung, breast, or ovarian cancer.",
      "One synonym for acrokeratosis paraneoplastica is \"acrokeratotic hyperplasia.\"",
      "Other synonyms for acrokeratosis paraneoplastica include \"paraneoplastic acrokeratitis,\" \"acrokeratosis associated with malignancy,\" and \"neoplastic acrokeratosis.\"",
      "The cause of acrokeratosis paraneoplastica is thought to be a reaction to cancer or its treatment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: One synonym for acrokeratosis paraneoplastica is \"Bazex syndrome.\"\n4. FALSE [correction]: Other synonyms for acrokeratosis paraneoplastica include \"Bazex's syndrome,\" \"acrokeratosis neoplastica,\" and \"Bazex syndrome.\"\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "vicuna-13b_response": "Weaver syndrome and Sotos syndrome are both genetic disorders that can affect a person's physical development and growth. However, they are different conditions with different characteristics.\nWeaver syndrome, also known as mesomelic dwarfism with normal intelligence, is a rare genetic disorder that affects bone growth and development. People with Weaver syndrome typically have short stature, with an average height of around 4 feet, and normal intelligence. They may also have other features such as a broad chest, short arms and legs, and a large head.\nSotos syndrome, on the other hand, is a genetic disorder that affects growth and development in several areas of the body. People with Sotos syndrome tend to be tall, with an average height of around 6 feet, and they may have a high degree of intelligence. However, they may also have other features such as a broad forehead, long arms and legs, and a large hands and feet.\nWhile both Weaver syndrome and Sotos syndrome can affect a person's physical development and growth, they are distinct conditions with different characteristics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Weaver syndrome and Sotos syndrome are both genetic disorders that can affect a person's physical development and growth.\n2. Weaver syndrome, also known as mesomelic dwarfism with normal intelligence, is a rare genetic disorder that affects bone growth and development.\n3. People with Weaver syndrome typically have short stature, with an average height of around 4 feet, and normal intelligence. \n4. Sotos syndrome is a genetic disorder that affects growth and development in several areas of the body.\n5. People with Sotos syndrome tend to be tall, with an average height of around 6 feet, and they may have a high degree of intelligence.",
    "vicuna-13b_fact": [
      "Weaver syndrome and Sotos syndrome are both genetic disorders that can affect a person's physical development and growth.",
      "Weaver syndrome, also known as mesomelic dwarfism with normal intelligence, is a rare genetic disorder that affects bone growth and development.",
      "People with Weaver syndrome typically have short stature, with an average height of around 4 feet, and normal intelligence.",
      "Sotos syndrome is a genetic disorder that affects growth and development in several areas of the body.",
      "People with Sotos syndrome tend to be tall, with an average height of around 6 feet, and they may have a high degree of intelligence."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Weaver syndrome is not also known as mesomelic dwarfism with normal intelligence, it is a rare genetic disorder that can cause rapid growth.\n3. FALSE [correction]: People with Weaver syndrome typically have accelerated growth, leading to a large physique, not a short stature.\n4. TRUE\n5. FALSE [correction]: People with Sotos syndrome often do grow to be tall, however, they typically face learning disabilities or have intellectual impairment and do not usually have a high degree of intelligence.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "vicuna-13b_response": "The JASPAR database is a repository of transcription factor (TF) binding profiles calculated using a variety of bioinformatics tools. Here is a list of the major releases of the JASPAR database:\n1. JASPAR 2014: This was the first official release of the JASPAR database, which included TF binding profiles for 1288 transcription factors and 6288 genomic regions.\n2. JASPAR 2016: This release expanded the database to include TF binding profiles for 1779 transcription factors and 10,507 genomic regions. It also introduced new features such as improved data quality control and visualization tools.\n3. JASPAR 2020: This release expanded the database to include TF binding profiles for 2129 transcription factors and 17,445 genomic regions. It also introduced new features such as improved data integration and analysis tools.\n4. JASPAR 2021: This is the latest release of the JASPAR database as of my knowledge cutoff (September 2021). It includes TF binding profiles for 2247 transcription factors and 20,891 genomic regions, and introduces new features such as improved data visualization and analysis tools.\nIt's worth noting that there may be additional, smaller releases of the JASPAR database between these major releases. However, these are the main releases that have been announced by the JASPAR team.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. JASPAR 2014 was the first official release of the JASPAR database, which included TF binding profiles for 1288 transcription factors and 6288 genomic regions.\n2. JASPAR 2016 expanded the database to include TF binding profiles for 1779 transcription factors and 10,507 genomic regions, and introduced new features such as improved data quality control and visualization tools.\n3. JASPAR 2020 further expanded the database to include TF binding profiles for 2129 transcription factors and 17,445 genomic regions, and introduced new features such as improved data integration and analysis tools.\n4. JASPAR 2021 includes TF binding profiles for 2247 transcription factors and 20,891 genomic regions, and introduced new features such as improved data visualization and analysis tools.\n5. There may be additional, smaller releases of the JASPAR database between these major releases.",
    "vicuna-13b_fact": [
      "JASPAR 2014 was the first official release of the JASPAR database, which included TF binding profiles for 1288 transcription factors and 6288 genomic regions.",
      "JASPAR 2016 expanded the database to include TF binding profiles for 1779 transcription factors and 10,507 genomic regions, and introduced new features such as improved data quality control and visualization tools.",
      "JASPAR 2020 further expanded the database to include TF binding profiles for 2129 transcription factors and 17,445 genomic regions, and introduced new features such as improved data integration and analysis tools.",
      "JASPAR 2021 includes TF binding profiles for 2247 transcription factors and 20,891 genomic regions, and introduced new features such as improved data visualization and analysis tools.",
      "There may be additional, smaller releases of the JASPAR database between these major releases."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "vicuna-13b_response": "The KP4 protein is a viral protein that is produced by the KP strain of the bacteriophage ΦKP1. The KP4 protein is a structural protein that is involved in the assembly and stability of the virion, which is the infectious particle of the bacteriophage.\nThe KP4 protein is a major component of the virion and is thought to play a role in the recognition and binding of the virion to the host cell. The KP4 protein is also involved in the stability and resistance of the virion to host cell defenses and to environmental stresses.\nIn addition to its role in the virion, the KP4 protein has been shown to have antioxidant and anti-inflammatory properties, and it may play a role in protecting the host cell from oxidative stress and inflammation.\nOverall, the function of the KP4 protein is to support the assembly and stability of the virion, and to protect the virion from host cell defenses and environmental stresses. Additionally, the KP4 protein may have beneficial effects on the host cell by providing antioxidant and anti-inflammatory protection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The KP4 protein is produced by the KP strain of the bacteriophage ΦKP1.\n2. The KP4 protein is a structural protein that is involved in the assembly and stability of the virion.\n3. The KP4 protein plays a role in the recognition and binding of the virion to the host cell.\n4. The KP4 protein is involved in the stability and resistance of the virion to host cell defenses and environmental stresses.\n5. The KP4 protein has shown to have antioxidant and anti-inflammatory properties.",
    "vicuna-13b_fact": [
      "The KP4 protein is produced by the KP strain of the bacteriophage ΦKP1.",
      "The KP4 protein is a structural protein that is involved in the assembly and stability of the virion.",
      "The KP4 protein plays a role in the recognition and binding of the virion to the host cell.",
      "The KP4 protein is involved in the stability and resistance of the virion to host cell defenses and environmental stresses.",
      "The KP4 protein has shown to have antioxidant and anti-inflammatory properties."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "vicuna-13b_response": "Yes, DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog that has been used in experimental and clinical studies. It is a synthetic form of the thyroid hormone triiodothyronine (T3), which is one of the two major hormones produced by the thyroid gland. DITPA is similar in structure to T3, but it has some differences in its chemical properties and biological effects.\nDITPA has been used in research to study the effects of T3 on various physiological processes, such as metabolism and growth. It has also been used as a tracer in imaging studies to assess thyroid function and to identify abnormalities in thyroid hormone metabolism. In addition, DITPA has been investigated as a potential treatment for various conditions, such as hypothyroidism and obesity, although its use in clinical settings is limited.\nOverall, DITPA is an important tool in the study of thyroid physiology and pathology, and it has contributed to our understanding of the role of T3 in various biological processes. However, more research is needed to fully understand its potential therapeutic uses and to determine its safety and efficacy in clinical settings.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog. \n2. DITPA is a synthetic form of the thyroid hormone triiodothyronine (T3).\n3. T3 is one of the two major hormones produced by the thyroid gland.\n4. DITPA has been utilized in research to study the effects of T3 on metabolism and growth.\n5. DITPA has been used as a tracer in imaging studies to assess thyroid function and identify abnormalities in thyroid hormone metabolism.",
    "vicuna-13b_fact": [
      "DITPA (3,5-diiodothyropropionic acid) is a thyroid hormone analog.",
      "DITPA is a synthetic form of the thyroid hormone triiodothyronine (T3).",
      "T3 is one of the two major hormones produced by the thyroid gland.",
      "DITPA has been utilized in research to study the effects of T3 on metabolism and growth.",
      "DITPA has been used as a tracer in imaging studies to assess thyroid function and identify abnormalities in thyroid hormone metabolism."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "vicuna-13b_response": "COUGER is an open-source tool that is used for testing and evaluating the security of web applications. It is designed to identify vulnerabilities in web applications by exploiting known vulnerabilities and weaknesses. COUGER is a command-line tool that can be used to perform various tests, including SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI) tests.\nCOUGER is a useful tool for security professionals, developers, and researchers who are interested in testing the security of web applications. It can be used to identify vulnerabilities and weaknesses in web applications, which can then be fixed to improve the overall security of the application. COUGER can also be used to test the effectiveness of security controls and to evaluate the security posture of a web application.\nOverall, COUGER is a powerful and useful tool for anyone who is interested in testing the security of web applications. It is easy to use and can provide valuable information about the security of a web application.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. COUGER is an open-source tool used for testing and evaluating the security of web applications.\n2. The tool is designed to identify vulnerabilities in web applications.\n3. COUGER can be used to perform various tests, including SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI) tests.\n4. COUGER is used by security professionals, developers, and researchers.\n5. COUGER can be used to test the effectiveness of security controls and to evaluate the security posture of a web application.",
    "vicuna-13b_fact": [
      "COUGER is an open-source tool used for testing and evaluating the security of web applications.",
      "The tool is designed to identify vulnerabilities in web applications.",
      "COUGER can be used to perform various tests, including SQL injection, cross-site scripting (XSS), and remote file inclusion (RFI) tests.",
      "COUGER is used by security professionals, developers, and researchers.",
      "COUGER can be used to test the effectiveness of security controls and to evaluate the security posture of a web application."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "vicuna-13b_response": "Yes, there are drugs for Tick-borne Encephalitis (TBE). TBE is a viral infection that is spread through the bite of infected ticks, and can cause symptoms such as fever, headache, and muscle weakness.\nThe most common treatment for TBE is the use of antiviral medications, such as oseltamivir (Tamiflu) and zanamivir (Relenza). These drugs can help reduce the severity and duration of the illness, and may be prescribed by a doctor if the patient is experiencing severe symptoms.\nIt is important to note that antiviral medications work best when started early in the course of the illness, so it is important to seek medical attention if you suspect that you may have TBE. In addition to antiviral medications, supportive care such as rest, hydration, and pain management may also be provided to help manage symptoms.\nIt is also important to take measures to prevent tick bites, such as using tick repellents, wearing protective clothing, and tucking pants into socks. If you find a tick attached to your skin, remove it promptly using a tick removal tool or by using a pair of tweezers to grasp the tick as close to the skin as possible and pulling it out.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tick-borne Encephalitis (TBE) is a viral infection that is spread through the bite of infected ticks.\n2. Antiviral medications, like oseltamivir (Tamiflu) and zanamivir (Relenza), are commonly used treatments for TBE.\n3. These antiviral drugs can help reduce the severity and duration of TBE.\n4. Antiviral medications for TBE work best when started early in the course of the illness.\n5. Prevention of TBE includes measures such as using tick repellents, wearing protective clothing, and removing attached ticks promptly.",
    "vicuna-13b_fact": [
      "Tick-borne Encephalitis (TBE) is a viral infection that is spread through the bite of infected ticks.",
      "Antiviral medications, like oseltamivir (Tamiflu) and zanamivir (Relenza), are commonly used treatments for TBE.",
      "These antiviral drugs can help reduce the severity and duration of TBE.",
      "Antiviral medications for TBE work best when started early in the course of the illness.",
      "Prevention of TBE includes measures such as using tick repellents, wearing protective clothing, and removing attached ticks promptly."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: There are no specific antiviral treatments for TBE. Supportive care is usually provided for those infected.\n3. FALSE [correction]: There are no specific antiviral medications proven to reduce the severity and duration of TBE.\n4. FALSE [correction]: There is no specific antiviral treatment for TBE, but early management with supportive care can help alleviate symptoms.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "vicuna-13b_response": "There are several genome browser databases available for DNA shape annotations, including:\n1. Ensembl: Ensembl is a comprehensive genome browser that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n2. UCSC Genome Browser: The UCSC Genome Browser is a widely used genome browser that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n3. Genome Data Viewer: The Genome Data Viewer is a genome browser developed by the Broad Institute that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n4. Integrative Genomics Viewer (IGV): IGV is a genome browser developed by the University of California, Santa Cruz that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\n5. JBrowse: JBrowse is a genome browser developed by the European Bioinformatics Institute that provides a variety of DNA shape annotations, such as chromosome views, gene views, and regulatory region views.\nThese are just a few examples of the many genome browser databases available for DNA shape annotations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ensembl is a genome browser that provides a variety of DNA shape annotations.\n2. The UCSC Genome Browser is a widely used genome browser that provides a variety of DNA shape annotations.\n3. The Genome Data Viewer is a genome browser developed by the Broad Institute.\n4. Integrative Genomics Viewer (IGV) is a genome browser developed by the University of California, Santa Cruz.\n5. JBrowse is a genome browser developed by the European Bioinformatics Institute.",
    "vicuna-13b_fact": [
      "Ensembl is a genome browser that provides a variety of DNA shape annotations.",
      "The UCSC Genome Browser is a widely used genome browser that provides a variety of DNA shape annotations.",
      "The Genome Data Viewer is a genome browser developed by the Broad Institute.",
      "Integrative Genomics Viewer (IGV) is a genome browser developed by the University of California, Santa Cruz.",
      "JBrowse is a genome browser developed by the European Bioinformatics Institute."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Genome Data Viewer is a genome browser developed by the National Center for Biotechnology Information (NCBI).\n4. FALSE [correction]: Integrative Genomics Viewer (IGV) is a genome browser developed by the Broad Institute.\n5. FALSE [correction]: JBrowse is a genome browser developed by the Genome Informatics group of the University of Cambridge.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "vicuna-13b_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Beckwith-Wiedemann syndrome: a genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor, hepatoblastoma, and rhabdomyosarcoma.\n2. Wiedemann-Beckwith syndrome: a condition that is similar to Beckwith-Wiedemann syndrome, but with less severe symptoms.\n3. Weaver syndrome: a rare genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor and hepatoblastoma.\n4. Sotos syndrome: a genetic disorder characterized by an overgrowth of certain parts of the body, such as an enlarged tongue (macroglossia), an overactive thyroid gland (hyperthyroidism), and an increased risk of developing certain tumors, such as Wilms tumor and rhabdomyosarcoma.\nIt's important to note that these syndromes are rare and the association between EZH2 mutations and these syndromes is still being researched and understood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mutations in the EZH2 gene have been associated with Beckwith-Wiedemann syndrome.\n2. Beckwith-Wiedemann syndrome is characterized by overgrowth in body parts and risk of developing specific tumors.\n3. Wiedemann-Beckwith syndrome, similar to Beckwith-Wiedemann syndrome but with less severe symptoms, is associated with EZH2 gene mutations.\n4. Mutations in the EZH2 gene have been associated with Weaver syndrome.\n5. Sotos syndrome, associated with EZH2 gene mutations, is characterized by overgrowth in body parts and risk of developing specific tumors.",
    "vicuna-13b_fact": [
      "Mutations in the EZH2 gene have been associated with Beckwith-Wiedemann syndrome.",
      "Beckwith-Wiedemann syndrome is characterized by overgrowth in body parts and risk of developing specific tumors.",
      "Wiedemann-Beckwith syndrome, similar to Beckwith-Wiedemann syndrome but with less severe symptoms, is associated with EZH2 gene mutations.",
      "Mutations in the EZH2 gene have been associated with Weaver syndrome.",
      "Sotos syndrome, associated with EZH2 gene mutations, is characterized by overgrowth in body parts and risk of developing specific tumors."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mutations in the CDKN1C gene, not the EZH2 gene, have been associated with Beckwith-Wiedemann syndrome.\n2. TRUE\n3. FALSE [correction]: Wiedemann-Beckwith syndrome is another name for Beckwith-Wiedemann syndrome, not a different condition with less severe symptoms. Both are associated with mutations in several genes, including the CDKN1C gene, not the EZH2 gene.\n4. TRUE\n5. FALSE [correction]: Sotos syndrome is associated with mutations in the NSD1 gene, not the EZH2 gene. It is characterized by overgrowth in body parts and risk of developing specific tumors.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "vicuna-13b_response": "A dimer-to-tetramer transition refers to a change in the oligomerization state of a protein from a dimer (a protein consisting of two identical or similar subunits) to a tetramer (a protein consisting of four identical or similar subunits).\nThere are several human proteins that are subject to a dimer-to-tetramer transition, including:\n1. Hemoglobin: Hemoglobin is a protein found in red blood cells that is responsible for carrying oxygen from the lungs to the body's tissues and for carrying carbon dioxide from the tissues to the lungs. Hemoglobin is composed of two alpha and two beta chains, and it undergoes a dimer-to-tetramer transition as it binds to oxygen.\n2. Myoglobin: Myoglobin is a protein found in muscle cells that functions as an oxygen storage protein. Like hemoglobin, myoglobin is composed of two alpha and two beta chains, and it undergoes a dimer-to-tetramer transition as it binds to oxygen.\n3. Cytochrome c: Cytochrome c is a protein found in the mitochondria of cells that plays a role in cellular respiration. Cytochrome c is composed of three polypeptide chains, and it undergoes a dimer-to-tetramer transition as it participates in electron transport.\n4. Apolipoprotein A-1: Apolipoprotein A-1 is a protein found in lipoproteins that plays a role in the transport of cholesterol and other lipids in the blood. Apolipoprotein A-1 is composed of two identical subunits, and it undergoes a dimer-to-tetramer transition as it binds to lipids.\n5. Hemopexin: Hemopexin is a protein found in the blood that plays a role in the regulation of iron homeostasis. Hemopexin is composed of two identical subunits, and it undergoes a dimer-to-tetramer transition as it binds to iron.\nThese are just a few examples of human proteins that undergo a dimer-to-tetram",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hemoglobin is a human protein that undergoes a dimer-to-tetramer transition as it binds to oxygen.\n2. Myoglobin is found in muscle cells and it also undergoes a dimer-to-tetramer transition as it binds to oxygen.\n3. Cytochrome c, a protein found in the mitochondria of cells that participates in cellular respiration, undergoes a dimer-to-tetramer transition as it participates in electron transport.\n4. Apolipoprotein A-1, a protein found in lipoproteins, undergoes a dimer-to-tetramer transition as it binds to lipids.\n5. Hemopexin, a protein found in the blood, undergoes a dimer-to-tetramer transition as it binds to iron.",
    "vicuna-13b_fact": [
      "Hemoglobin is a human protein that undergoes a dimer-to-tetramer transition as it binds to oxygen.",
      "Myoglobin is found in muscle cells and it also undergoes a dimer-to-tetramer transition as it binds to oxygen.",
      "Cytochrome c, a protein found in the mitochondria of cells that participates in cellular respiration, undergoes a dimer-to-tetramer transition as it participates in electron transport.",
      "Apolipoprotein A-1, a protein found in lipoproteins, undergoes a dimer-to-tetramer transition as it binds to lipids.",
      "Hemopexin, a protein found in the blood, undergoes a dimer-to-tetramer transition as it binds to iron."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Hemoglobin is a protein in red blood cells that undergoes a transition from a relaxed state (R state) to a tense state (T state) upon binding to oxygen, but not from a dimer to a tetramer. Hemoglobin is already a tetrameric protein, consisting of two alpha and two beta subunits.\n2. FALSE [correction]: Myoglobin, found in muscle cells, is a monomeric protein that binds to oxygen. It does not undergo a dimer-to-tetramer transition when it binds to oxygen.\n3. FALSE [correction]: Cytochrome c does not undergo a dimer-to-tetramer transition. It is a monomeric protein involved in the electron transport chain during cellular respiration.\n4. UNKNOWN\n5. FALSE [correction]: Hemopexin, a plasma protein, binds free heme released during hemoglobin degradation. There is no known dimer-to-tetramer transition as it binds to iron or heme.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "vicuna-13b_response": "One protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is the protein known as \"Bcl-2\".\nBcl-2 is a member of the Bcl-2 protein family, which plays a critical role in regulating programmed cell death, or apoptosis. Bcl-2 is an anti-apoptotic protein, meaning that it helps to prevent cell death. Bcl-2 has been found to interact with phospholamban (PLN) through its N-terminal domain, which is involved in the regulation of its anti-apoptotic function.\nThe interaction between Bcl-2 and phospholamban (PLN) has been shown to be important in regulating the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA), which is an enzyme that pumps calcium ions into the sarcoplasmic reticulum (SR) of heart muscle cells. The interaction between Bcl-2 and PLN has been shown to modulate the activity of SERCA, and this can have important implications for the regulation of heart function and the prevention of cell death in heart muscle cells.\nOverall, the interaction between Bcl-2 and phospholamban (PLN) is an important regulatory mechanism that helps to maintain the proper function of heart muscle cells and prevent cell death.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Bcl-2 is a protein that interacts with phospholamban (PLN) and is also an anti-apoptotic protein.\n2. Bcl-2 is a member of the Bcl-2 protein family, which plays a critical role in regulating programmed cell death or apoptosis.\n3. Bcl-2 interacts with phospholamban (PLN) through its N-terminal domain.\n4. The interaction between Bcl-2 and phospholamban (PLN) regulates the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA).\n5. The interaction between Bcl-2 and phospholamban (PLN) is an important regulatory mechanism that helps to maintain the proper function of heart muscle cells and prevent cell death.",
    "vicuna-13b_fact": [
      "Bcl-2 is a protein that interacts with phospholamban (PLN) and is also an anti-apoptotic protein.",
      "Bcl-2 is a member of the Bcl-2 protein family, which plays a critical role in regulating programmed cell death or apoptosis.",
      "Bcl-2 interacts with phospholamban (PLN) through its N-terminal domain.",
      "The interaction between Bcl-2 and phospholamban (PLN) regulates the activity of the cardiac sarcoendoplasmic reticulum Ca2+-ATPase (SERCA).",
      "The interaction between Bcl-2 and phospholamban (PLN) is an important regulatory mechanism that helps to maintain the proper function of heart muscle cells and prevent cell death."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "vicuna-13b_response": "Yes, vitamin D has been shown to reduce the incidence of falls in older people in clinical trials. Several studies have found that vitamin D supplementation can improve balance and reduce the risk of falls in older adults.\nOne randomized controlled trial published in the Journal of the American Geriatrics Society found that older adults who took vitamin D supplements had a 20% lower risk of falling compared to those who did not take vitamin D supplements. Another study published in the Journal of Clinical Endocrinology & Metabolism found that vitamin D supplementation reduced the risk of falls in postmenopausal women by 30%.\nOther studies have also found that vitamin D supplementation can improve muscle strength, balance, and cognitive function, all of which can help reduce the risk of falls in older adults.\nIt's important to note that while vitamin D supplementation can be beneficial for reducing the risk of falls, it is not a guarantee and should not be the sole intervention for fall prevention. A comprehensive fall prevention program should include a combination of strategies such as exercise, home safety assessments, and medication management.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vitamin D has been shown to reduce the incidence of falls in older people in clinical trials.\n2. A randomized controlled trial published in the Journal of the American Geriatrics Society found a 20% reduced risk of falling in older adults who took vitamin D supplements.\n3. Another study in the Journal of Clinical Endocrinology & Metabolism found that vitamin D reduced the risk of falls in postmenopausal women by 30%.\n4. Studies suggest that vitamin D supplementation can improve muscle strength, balance, and cognitive function.\n5. Vitamin D supplementation is not a guarantee for fall prevention and should be complemented with other strategies such as exercise, home safety assessments, and medication management.",
    "vicuna-13b_fact": [
      "Vitamin D has been shown to reduce the incidence of falls in older people in clinical trials.",
      "A randomized controlled trial published in the Journal of the American Geriatrics Society found a 20% reduced risk of falling in older adults who took vitamin D supplements.",
      "Another study in the Journal of Clinical Endocrinology & Metabolism found that vitamin D reduced the risk of falls in postmenopausal women by 30%.",
      "Studies suggest that vitamin D supplementation can improve muscle strength, balance, and cognitive function.",
      "Vitamin D supplementation is not a guarantee for fall prevention and should be complemented with other strategies such as exercise, home safety assessments, and medication management."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "vicuna-13b_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells.\nJarid2 is a transcriptional repressor that has been shown to play a role in regulating the differentiation and function of T helper 17 (Th17) cells, which are a subset of T cells that play a critical role in regulating the immune response.\nmiR-155 is a microRNA that has been shown to be involved in the regulation of Th17 cell differentiation and function. Specifically, miR-155 has been shown to target the Jarid2 gene, leading to the repression of Jarid2 expression and the promotion of Th17 cell differentiation.\nIn addition, miR-155 has been shown to be involved in the regulation of other aspects of Th17 cell biology, including their survival, proliferation, and cytokine production.\nOverall, the association between Jarid2 and miR-155 in Th17 cells is important for the regulation of Th17 cell differentiation and function, and dysregulation of this pathway has been implicated in the pathogenesis of a variety of autoimmune diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Jarid2 is a transcriptional repressor that plays a role in regulating the differentiation and function of T helper 17 (Th17) cells.\n2. Th17 cells are a subset of T cells that play a critical role in regulating the immune response.\n3. miR-155 is a microRNA that is involved in the regulation of Th17 cell differentiation and function.\n4. miR-155 has been shown to target the Jarid2 gene, leading to the repression of Jarid2 expression and the promotion of Th17 cell differentiation.\n5. Dysregulation of the pathway between Jarid2 and miR-155 in Th17 cells has been implicated in the pathogenesis of a variety of autoimmune diseases.",
    "vicuna-13b_fact": [
      "Jarid2 is a transcriptional repressor that plays a role in regulating the differentiation and function of T helper 17 (Th17) cells.",
      "Th17 cells are a subset of T cells that play a critical role in regulating the immune response.",
      "miR-155 is a microRNA that is involved in the regulation of Th17 cell differentiation and function.",
      "miR-155 has been shown to target the Jarid2 gene, leading to the repression of Jarid2 expression and the promotion of Th17 cell differentiation.",
      "Dysregulation of the pathway between Jarid2 and miR-155 in Th17 cells has been implicated in the pathogenesis of a variety of autoimmune diseases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "vicuna-13b_response": "The human hoxD cluster contains 39 genes. The hoxD cluster is a group of genes that are involved in the development of the body plan of an organism, and is located on chromosome 13. These genes play a crucial role in the process of embryonic development, and are responsible for the proper formation and differentiation of various body parts. The hoxD cluster is one of the largest clusters of genes in the human genome, and is thought to have evolved through a process of gene duplication and diversification.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The human hoxD cluster contains 39 genes.\n2. The hoxD cluster is involved in the development of the body plan of an organism.\n3. The hoxD cluster is located on chromosome 13.\n4. Genes in the hoxD cluster are responsible for the proper formation and differentiation of various body parts.\n5. The hoxD cluster is one of the largest clusters of genes in the human genome.",
    "vicuna-13b_fact": [
      "The human hoxD cluster contains 39 genes.",
      "The hoxD cluster is involved in the development of the body plan of an organism.",
      "The hoxD cluster is located on chromosome 13.",
      "Genes in the hoxD cluster are responsible for the proper formation and differentiation of various body parts.",
      "The hoxD cluster is one of the largest clusters of genes in the human genome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The human hoxD cluster contains 9 genes.\n2. TRUE\n3. FALSE [correction]: The hoxD cluster is located on chromosome 2.\n4. TRUE\n5. FALSE [correction]: The hoxD cluster is not one of the largest clusters of genes in the human genome.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "vicuna-13b_response": "Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases that play important roles in various cellular processes, such as cell cycle progression, differentiation, and apoptosis. The phosphorylation consensus motifs for CK1 are as follows:\n1. S/T-X-R/K-X-S/T\n2. S/T-P-S/T-P-S/T-P\n3. S/T-P-S/T-P-S/T-P-P\n4. S/T-P-S/T-P-S/T-P-P-P\n5. S/T-P-S/T-P-S/T-P-P-P-P\nThese consensus motifs are based on the sequence analysis of known CK1 substrates and are not exhaustive. Additionally, CK1 can also phosphorylate other amino acids such as tyrosine and histidine in some cases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases.\n2. CK1 plays a role in cellular processes such as cell cycle progression, differentiation, and apoptosis.\n3. The phosphorylation consensus motifs for CK1 include S/T-X-R/K-X-S/T, S/T-P-S/T-P-S/T-P, S/T-P-S/T-P-S/T-P-P, S/T-P-S/T-P-S/T-P-P-P, and S/T-P-S/T-P-S/T-P-P-P-P.\n4. These consensus motifs are based on the sequence analysis of known CK1 substrates.\n5. CK1 can phosphorylate other amino acids such as tyrosine and histidine in some cases.",
    "vicuna-13b_fact": [
      "Casein Kinase 1 (CK1) is a family of serine/threonine protein kinases.",
      "CK1 plays a role in cellular processes such as cell cycle progression, differentiation, and apoptosis.",
      "The phosphorylation consensus motifs for CK1 include S/T-X-R/K-X-S/T, S/T-P-S/T-P-S/T-P, S/T-P-S/T-P-S/T-P-P, S/T-P-S/T-P-S/T-P-P-P, and S/T-P-S/T-P-S/T-P-P-P-P.",
      "These consensus motifs are based on the sequence analysis of known CK1 substrates.",
      "CK1 can phosphorylate other amino acids such as tyrosine and histidine in some cases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: CK1 cannot phosphorylate other amino acids such as tyrosine and histidine, it mainly phosphorylates serine and threonine residues.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "vicuna-13b_response": "The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme, which is involved in the metabolism of certain amino acids. There are several different proteins/isoforms that can be encoded by the ASPH gene, including:\n1. Aspartate beta-hydroxylase 1 (ABH1)\n2. Aspartate beta-hydroxylase 2 (ABH2)\n3. Aspartate beta-hydroxylase 3 (ABH3)\nEach of these isoforms of the enzyme has slightly different properties and functions, and they may be expressed in different tissues and under different conditions. For example, ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme.\n2. The aspartate beta-hydroxylase enzyme is involved in the metabolism of certain amino acids.\n3. The ASPH gene can encode different proteins/isoforms: Aspartate beta-hydroxylase 1 (ABH1), Aspartate beta-hydroxylase 2 (ABH2), and Aspartate beta-hydroxylase 3 (ABH3).\n4. Each isoform of the enzyme has different properties and functions, and they may be expressed in different tissues and under different conditions.\n5. ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis.",
    "vicuna-13b_fact": [
      "The ASPH gene in humans encodes for the aspartate beta-hydroxylase enzyme.",
      "The aspartate beta-hydroxylase enzyme is involved in the metabolism of certain amino acids.",
      "The ASPH gene can encode different proteins/isoforms: Aspartate beta-hydroxylase 1 (ABH1), Aspartate beta-hydroxylase 2 (ABH2), and Aspartate beta-hydroxylase 3 (ABH3).",
      "Each isoform of the enzyme has different properties and functions, and they may be expressed in different tissues and under different conditions.",
      "ABH1 is expressed in the liver and kidneys, while ABH2 is expressed in the brain and testis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "vicuna-13b_response": "Empagliflozin is a medication used to treat type 2 diabetes. It was approved by the U.S. Food and Drug Administration (FDA) in 2014. The FDA approved empagliflozin under the brand name Jardiance, which is manufactured by Boehringer Ingelheim and Eli Lilly and Company. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which helps the body remove excess glucose through the urine. It is taken orally and is used in combination with diet and exercise to improve blood sugar control in people with type 2 diabetes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Empagliflozin is a medication used to treat type 2 diabetes.\n2. The FDA approved empagliflozin in 2014.\n3. Empagliflozin's brand name is Jardiance, manufactured by Boehringer Ingelheim and Eli Lilly and Company.\n4. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.\n5. Empagliflozin is taken orally and is used in combination with diet and exercise to improve blood sugar control in people with type 2 diabetes.",
    "vicuna-13b_fact": [
      "Empagliflozin is a medication used to treat type 2 diabetes.",
      "The FDA approved empagliflozin in 2014.",
      "Empagliflozin's brand name is Jardiance, manufactured by Boehringer Ingelheim and Eli Lilly and Company.",
      "Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.",
      "Empagliflozin is taken orally and is used in combination with diet and exercise to improve blood sugar control in people with type 2 diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "vicuna-13b_response": "Loss of the protein Lon1 in the plant Arabidopsis has been shown to have a number of effects on plant growth and development. Some of the results of Lon1 loss in Arabidopsis include:\n1. Increased sensitivity to oxidative stress: Lon1 is involved in the degradation of proteins that are damaged by oxidative stress, and loss of Lon1 leads to an accumulation of these damaged proteins. This accumulation can make the plant more sensitive to oxidative stress, which can lead to decreased growth and development.\n2. Impaired chlorophyll synthesis: Lon1 is involved in the degradation of proteins that are involved in chlorophyll synthesis, and loss of Lon1 can lead to decreased chlorophyll content and a decrease in the ability of the plant to photosynthesize. This can lead to decreased growth and development.\n3. Altered plant growth and development: Loss of Lon1 can lead to altered growth and development in Arabidopsis, including decreased plant height, smaller leaves, and a delay in flowering.\n4. Increased susceptibility to disease: Loss of Lon1 can lead to increased susceptibility to disease in Arabidopsis, as the accumulation of damaged proteins can make the plant more vulnerable to pathogens.\nOverall, the loss of Lon1 in Arabidopsis can have a significant impact on plant growth and development, and further research is needed to fully understand the mechanisms underlying these effects.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Loss of the protein Lon1 in the plant Arabidopsis increases sensitivity to oxidative stress.\n2. Lon1 in Arabidopsis is involved in the degradation of proteins damaged by oxidative stress.\n3. Loss of Lon1 in Arabidopsis can impair chlorophyll synthesis, leading to decreased chlorophyll content and less efficient photosynthesis.\n4. The absence of Lon1 can lead to altered growth and development in Arabidopsis, including decreased plant height, smaller leaves, and a delay in flowering.\n5. Loss of Lon1 can lead to increased susceptibility to disease in Arabidopsis due to accumulation of damaged proteins.",
    "vicuna-13b_fact": [
      "Loss of the protein Lon1 in the plant Arabidopsis increases sensitivity to oxidative stress.",
      "Lon1 in Arabidopsis is involved in the degradation of proteins damaged by oxidative stress.",
      "Loss of Lon1 in Arabidopsis can impair chlorophyll synthesis, leading to decreased chlorophyll content and less efficient photosynthesis.",
      "The absence of Lon1 can lead to altered growth and development in Arabidopsis, including decreased plant height, smaller leaves, and a delay in flowering.",
      "Loss of Lon1 can lead to increased susceptibility to disease in Arabidopsis due to accumulation of damaged proteins."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "vicuna-13b_response": "Yes, linker histones are present in the yeast genome. Linker histones are a type of non-coding RNA that play a role in regulating gene expression by binding to chromatin and modifying chromatin structure. In yeast, linker histones are essential for the proper organization of chromatin and the regulation of gene expression.\nThere are several types of linker histones in yeast, including H1, H2A, H2B, and H3. These linker histones are involved in the formation of a variety of chromatin structures, including chromosome condensation, chromatin compaction, and the regulation of access to the chromatin.\nIn addition to their role in chromatin regulation, linker histones also play a role in the regulation of transcription and the maintenance of chromosome stability. Overall, linker histones are essential for the proper functioning of the yeast genome and are an important component of the chromatin regulatory network.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Linker histones exist in the yeast genome.\n2. Linker histones are a type of non-coding RNA.\n3. In yeast, linker histones are essential for the proper organization of chromatin and the regulation of gene expression.\n4. Types of linker histones in yeast include H1, H2A, H2B, and H3.\n5. Linker histones play a role in the regulation of transcription and the maintenance of chromosome stability.",
    "vicuna-13b_fact": [
      "Linker histones exist in the yeast genome.",
      "Linker histones are a type of non-coding RNA.",
      "In yeast, linker histones are essential for the proper organization of chromatin and the regulation of gene expression.",
      "Types of linker histones in yeast include H1, H2A, H2B, and H3.",
      "Linker histones play a role in the regulation of transcription and the maintenance of chromosome stability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Linker histones are a type of protein, not non-coding RNA.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "vicuna-13b_response": "There is some evidence that drinking tomato juice may help to lower cholesterol levels. Tomatoes are a good source of a compound called lycopene, which has been shown to have cholesterol-lowering properties. Studies have found that consuming tomato products, such as tomato juice, can increase the levels of lycopene in the blood, which may help to lower cholesterol levels.\nOne study published in the Journal of the American College of Nutrition found that participants who drank 1.4 liters of tomato juice per week for 12 weeks had a significant decrease in total cholesterol and LDL (bad) cholesterol levels compared to a control group that did not drink tomato juice.\nAnother study published in the Journal of Nutrition found that consuming tomato products as part of a low-fat, low-cholesterol diet may help to further lower cholesterol levels.\nHowever, it's important to note that more research is needed to fully understand the effects of tomato juice on cholesterol levels, and it should not be relied upon as the sole means of managing cholesterol levels. It's always best to consult with a healthcare professional before making any changes to your diet or cholesterol-lowering regimen.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Tomatoes are a source of a compound called lycopene, which has been shown to have cholesterol-lowering properties.\n2. Consuming tomato products can increase the levels of lycopene in the blood.\n3. A study published in the Journal of the American College of Nutrition found a decrease in total cholesterol and LDL (bad) cholesterol levels in participants who drank 1.4 liters of tomato juice per week for 12 weeks.\n4. Another study published in the Journal of Nutrition reported that consuming tomato products as part of a low-fat, low-cholesterol diet may help to further lower cholesterol levels.\n5. It's suggested to consult with a healthcare professional before making any changes to your diet or cholesterol-lowering regimen.",
    "vicuna-13b_fact": [
      "Tomatoes are a source of a compound called lycopene, which has been shown to have cholesterol-lowering properties.",
      "Consuming tomato products can increase the levels of lycopene in the blood.",
      "A study published in the Journal of the American College of Nutrition found a decrease in total cholesterol and LDL (bad) cholesterol levels in participants who drank 1.4 liters of tomato juice per week for 12 weeks.",
      "Another study published in the Journal of Nutrition reported that consuming tomato products as part of a low-fat, low-cholesterol diet may help to further lower cholesterol levels.",
      "It's suggested to consult with a healthcare professional before making any changes to your diet or cholesterol-lowering regimen."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "vicuna-13b_response": "Hsp70 and Hsp110 are two different types of heat shock proteins (HSPs) that play important roles in the regulation of protein folding and mRNA stability.\nHsp70 proteins are molecular chaperones that help to fold and transport proteins to their correct locations within the cell. They also help to refold denatured proteins and prevent protein aggregation. Hsp70 proteins are involved in the regulation of mRNA stability by binding to and stabilizing mRNAs that are targeted for degradation. This binding prevents the degradation of these mRNAs and allows them to be translated into proteins.\nHsp110 proteins are also involved in the regulation of mRNA stability. They are capable of binding to and destabilizing mRNAs that are targeted for degradation, leading to their degradation and inhibition of protein translation. Hsp110 proteins also play a role in the regulation of protein folding and transport.\nIn conclusion, Hsp70 and Hsp110 play important roles in the regulation of mRNA stability by binding to and stabilizing or destabilizing mRNAs, respectively. These proteins help to ensure that the proper balance of protein synthesis and degradation is maintained in the cell, and they play a critical role in the response of cells to stress.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hsp70 and Hsp110 are types of heat shock proteins (HSPs) that play roles in the regulation of protein folding and mRNA stability.\n2. Hsp70 proteins are molecular chaperones that help to fold and transport proteins within the cell.\n3. Hsp70 proteins help regulate mRNA stability by binding to and stabilizing mRNAs that are targeted for degradation.\n4. Hsp110 proteins can bind to and destabilize mRNAs that are targeted for degradation.\n5. Hsp70 and Hsp110 play significant roles in maintaining the proper balance of protein synthesis and degradation in the cell.",
    "vicuna-13b_fact": [
      "Hsp70 and Hsp110 are types of heat shock proteins (HSPs) that play roles in the regulation of protein folding and mRNA stability.",
      "Hsp70 proteins are molecular chaperones that help to fold and transport proteins within the cell.",
      "Hsp70 proteins help regulate mRNA stability by binding to and stabilizing mRNAs that are targeted for degradation.",
      "Hsp110 proteins can bind to and destabilize mRNAs that are targeted for degradation.",
      "Hsp70 and Hsp110 play significant roles in maintaining the proper balance of protein synthesis and degradation in the cell."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "vicuna-13b_response": "There are two main types of deiodinases present in skeletal muscle: deiodinase 1 (D1) and deiodinase 2 (D2).\nD1 is the main enzyme responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue. D1 is expressed at high levels in skeletal muscle, and its activity is regulated by a number of factors, including muscle contraction, exercise, and changes in the levels of other hormones such as glucocorticoids.\nD2, on the other hand, is responsible for converting T4 to T3, but it has a much lower activity than D1. D2 is also expressed in skeletal muscle, but at much lower levels than D1.\nBoth D1 and D2 are important for the proper functioning of thyroid hormone in skeletal muscle. D1 is critical for the conversion of T4 to T3, which is necessary for the regulation of muscle metabolism and protein synthesis. D2, on the other hand, plays a role in the regulation of T3 levels in the body, and may be involved in the feedback regulation of thyroid hormone synthesis and secretion by the thyroid gland.\nOverall, the balance between D1 and D2 activity is important for maintaining proper thyroid hormone levels in skeletal muscle, and dysregulation of these enzymes can have significant effects on muscle function and metabolism.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Deiodinase 1 (D1) and deiodinase 2 (D2) are present in skeletal muscle.\n2. D1 is responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue.\n3. The activity of D1 is regulated by a number of factors, including muscle contraction, exercise, and changes in the levels of other hormones such as glucocorticoids.\n4. D2 is also responsible for converting T4 to T3, but it has a much lower activity than D1.\n5. The balance between D1 and D2 activity is important for maintaining proper thyroid hormone levels in skeletal muscle.",
    "vicuna-13b_fact": [
      "Deiodinase 1 (D1) and deiodinase 2 (D2) are present in skeletal muscle.",
      "D1 is responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue.",
      "The activity of D1 is regulated by a number of factors, including muscle contraction, exercise, and changes in the levels of other hormones such as glucocorticoids.",
      "D2 is also responsible for converting T4 to T3, but it has a much lower activity than D1.",
      "The balance between D1 and D2 activity is important for maintaining proper thyroid hormone levels in skeletal muscle."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: D2, not D1, is primarily responsible for converting the inactive form of thyroid hormone (T4) to the active form (T3) in skeletal muscle tissue.\n3. TRUE\n4. FALSE [correction]: D2 has a much higher activity than D1, not lower.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "vicuna-13b_response": "Caspases are a family of cysteine proteases that play a crucial role in cellular apoptosis (programmed cell death). There are several types of caspases, including inflammatory caspases. Inflammatory caspases are a subset of caspases that are involved in the inflammatory response. Here are some of the inflammatory caspases:\n1. Caspase-1: Caspase-1 is an inflammatory caspase that is activated by the inflammasome, a complex that plays a crucial role in the innate immune response. Caspase-1 cleaves and activates pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), which play important roles in the immune response.\n2. Caspase-4: Caspase-4 is another inflammatory caspase that is activated by the inflammasome. It cleaves and activates pro-inflammatory cytokines such as IL-1β and IL-18.\n3. Caspase-5: Caspase-5 is an inflammatory caspase that is activated by the inflammasome. It cleaves and activates the pro-inflammatory cytokine gasdermin D, which plays a role in the immune response.\n4. Caspase-12: Caspase-12 is an inflammatory caspase that is activated by the inflammasome. It cleaves and activates the pro-inflammatory cytokine IL-18.\nOverall, inflammatory caspases play a crucial role in the inflammatory response and the immune system. Dysregulation of inflammatory caspases has been implicated in a variety of diseases, including autoimmune diseases and chronic inflammation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Caspases are a family of cysteine proteases that play a role in cellular apoptosis.\n2. There is a type of caspases called inflammatory caspases, which are involved in the inflammatory response.\n3. Caspase-1, caspase-4, caspase-5, and caspase-12 are examples of inflammatory caspases. \n4. Inflammatory caspases such as Caspase-1, Caspase-4, and Caspase-5 are activated by the inflammasome and they cleave and activate pro-inflammatory cytokines.\n5. Dysregulation of inflammatory caspases has been implicated in diseases like autoimmune diseases and chronic inflammation.",
    "vicuna-13b_fact": [
      "Caspases are a family of cysteine proteases that play a role in cellular apoptosis.",
      "There is a type of caspases called inflammatory caspases, which are involved in the inflammatory response.",
      "Caspase-1, caspase-4, caspase-5, and caspase-12 are examples of inflammatory caspases.",
      "Inflammatory caspases such as Caspase-1, Caspase-4, and Caspase-5 are activated by the inflammasome and they cleave and activate pro-inflammatory cytokines.",
      "Dysregulation of inflammatory caspases has been implicated in diseases like autoimmune diseases and chronic inflammation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "vicuna-13b_response": "Yes, there is a link between the Aurora B kinase and the Polycomb protein Ring1B. Aurora B is a key regulator of mitosis, and it is involved in the formation of the mitotic spindle and the proper segregation of chromosomes during cell division. Ring1B is a member of the Polycomb group of proteins, which are involved in the regulation of gene expression and the maintenance of the cell's developmental state.\nStudies have shown that Ring1B interacts with and is phosphorylated by Aurora B. This interaction is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division. Ring1B also plays a role in the regulation of the Aurora B kinase, and it is thought to do so by modifying the activity of the protein or by controlling its localization.\nIn conclusion, there is a link between the Aurora B kinase and the Polycomb protein Ring1B, and their interaction is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Aurora B is a key regulator of mitosis and is involved in the formation of the mitotic spindle and the proper segregation of chromosomes during cell division.\n2. Ring1B is a member of the Polycomb group of proteins, which are involved in the regulation of gene expression and the maintenance of the cell's developmental state.\n3. Ring1B interacts with and is phosphorylated by Aurora B.\n4. The interaction between Ring1B and Aurora B is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division.\n5. Ring1B also plays a role in the regulation of the Aurora B kinase.",
    "vicuna-13b_fact": [
      "Aurora B is a key regulator of mitosis and is involved in the formation of the mitotic spindle and the proper segregation of chromosomes during cell division.",
      "Ring1B is a member of the Polycomb group of proteins, which are involved in the regulation of gene expression and the maintenance of the cell's developmental state.",
      "Ring1B interacts with and is phosphorylated by Aurora B.",
      "The interaction between Ring1B and Aurora B is important for the proper functioning of the mitotic spindle and the proper segregation of chromosomes during cell division.",
      "Ring1B also plays a role in the regulation of the Aurora B kinase."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "vicuna-13b_response": "Non-canonical sequence motifs are sequence patterns that deviate from the typical splice site consensus sequence. In vertebrates, the most frequent non-canonical sequence motifs at the donor and acceptor splice sites are as follows:\nAt the donor splice site:\n1. The presence of a purine at the -3 position, immediately upstream of the splice site.\n2. The presence of a pyrimidine at the +1 position, immediately downstream of the splice site.\n3. The presence of a guanine at the +2 position, immediately downstream of the splice site.\nAt the acceptor splice site:\n1. The presence of a pyrimidine at the -3 position, immediately upstream of the splice site.\n2. The presence of a purine at the +1 position, immediately downstream of the splice site.\n3. The presence of a guanine at the +2 position, immediately downstream of the splice site.\nIt is important to note that these non-canonical sequence motifs are not exclusive to vertebrates, but are also observed in other organisms. Additionally, the presence of these motifs does not guarantee that a particular sequence will be included in the final mRNA transcript, as other factors such as the presence of regulatory elements and RNA-binding proteins can also influence the splicing process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Non-canonical sequence motifs are sequence patterns that deviate from the typical splice site consensus sequence. \n2. The most frequent non-canonical sequence motifs at the donor splice site in vertebrates include the presence of a purine at the -3 position, a pyrimidine at the +1 position, and a guanine at the +2 position.\n3. The most frequent non-canonical sequence motifs at the acceptor splice site in vertebrates include the presence of a pyrimidine at the -3 position, a purine at the +1 position, and a guanine at the +2 position.\n4. The non-canonical sequence motifs are not exclusive to vertebrates.\n5. The presence of these motifs does not guarantee that a particular sequence will be included in the final mRNA transcript.",
    "vicuna-13b_fact": [
      "Non-canonical sequence motifs are sequence patterns that deviate from the typical splice site consensus sequence.",
      "The most frequent non-canonical sequence motifs at the donor splice site in vertebrates include the presence of a purine at the -3 position, a pyrimidine at the +1 position, and a guanine at the +2 position.",
      "The most frequent non-canonical sequence motifs at the acceptor splice site in vertebrates include the presence of a pyrimidine at the -3 position, a purine at the +1 position, and a guanine at the +2 position.",
      "The non-canonical sequence motifs are not exclusive to vertebrates.",
      "The presence of these motifs does not guarantee that a particular sequence will be included in the final mRNA transcript."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "vicuna-13b_response": "The event that results in the acetylation of S6K1 is the activation of the S6K1 kinase by the upstream kinase, such as mTOR. This leads to the phosphorylation of S6K1, which in turn results in its acetylation by acetyltransferase enzymes, such as CREB-binding protein (CBP) and p300. The acetylation of S6K1 modulates its activity and plays a role in regulating cellular metabolism and growth.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The activation of the S6K1 kinase by the upstream kinase, such as mTOR, results in the acetylation of S6K1.\n2. The process leads to the phosphorylation of S6K1.\n3. The acetylation of S6K1 is carried out by acetyltransferase enzymes, such as CREB-binding protein (CBP) and p300.\n4. Acetylation of S6K1 modulates its activity.\n5. The acetylation of S6K1 plays a role in regulating cellular metabolism and growth.",
    "vicuna-13b_fact": [
      "The activation of the S6K1 kinase by the upstream kinase, such as mTOR, results in the acetylation of S6K1.",
      "The process leads to the phosphorylation of S6K1.",
      "The acetylation of S6K1 is carried out by acetyltransferase enzymes, such as CREB-binding protein (CBP) and p300.",
      "Acetylation of S6K1 modulates its activity.",
      "The acetylation of S6K1 plays a role in regulating cellular metabolism and growth."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "vicuna-13b_response": "Episodic ataxia type 6 (EA6) is a rare, inherited disorder that affects the nervous system and causes episodes of ataxia, which is a lack of coordination and balance. The cause of EA6 is a mutation in the CACNA1A gene, which provides instructions for making a protein called a voltage-gated calcium channel.\nThese channels play a critical role in the normal functioning of nerve cells, including the transmission of electrical signals that are important for movement and coordination. The mutation in the CACNA1A gene that causes EA6 leads to the production of an abnormal version of the protein, which disrupts the normal functioning of the voltage-gated calcium channels and can cause episodes of ataxia.\nEA6 is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Episodic ataxia type 6 (EA6) is a rare, inherited disorder.\n2. EA6 affects the nervous system and can cause a lack of coordination and balance.\n3. The cause of EA6 is a mutation in the CACNA1A gene.\n4. The CACNA1A gene provides instructions for making a protein called a voltage-gated calcium channel.\n5. EA6 is inherited in an autosomal recessive pattern, which means an individual must inherit two copies of the mutated gene to develop the condition.",
    "vicuna-13b_fact": [
      "Episodic ataxia type 6 (EA6) is a rare, inherited disorder.",
      "EA6 affects the nervous system and can cause a lack of coordination and balance.",
      "The cause of EA6 is a mutation in the CACNA1A gene.",
      "The CACNA1A gene provides instructions for making a protein called a voltage-gated calcium channel.",
      "EA6 is inherited in an autosomal recessive pattern, which means an individual must inherit two copies of the mutated gene to develop the condition."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The cause of EA6 is currently unknown.\n4. TRUE\n5. FALSE [correction]: Episodic ataxia is typically inherited in an autosomal dominant pattern, which means an individual must inherit only one copy of the mutated gene to develop the condition.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "vicuna-13b_response": "Chromomethylases are enzymes that add methyl groups to the DNA molecule, leading to the formation of 5-methylcytosine, a modified form of cytosine. These enzymes are present in certain bacteria and archaea, but their presence in animal genomes is less clear.\nSome studies have suggested that chromomethylases may be present in certain animal species, such as mice and rats. However, other studies have found no evidence of these enzymes in the genomes of other animal species, including humans.\nOverall, the presence of chromomethylases in animal genomes is still an area of active research and the exact extent of their presence in animal species is not yet fully understood.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Chromomethylases are enzymes that add methyl groups to the DNA molecule.\n2. They lead to the formation of 5-methylcytosine, a modified form of cytosine.\n3. These enzymes are present in certain bacteria and archaea.\n4. Some studies suggest that chromomethylases may be present in mice and rats.\n5. Some studies have found no evidence of these enzymes in the genomes of other animal species, including humans.",
    "vicuna-13b_fact": [
      "Chromomethylases are enzymes that add methyl groups to the DNA molecule.",
      "They lead to the formation of 5-methylcytosine, a modified form of cytosine.",
      "These enzymes are present in certain bacteria and archaea.",
      "Some studies suggest that chromomethylases may be present in mice and rats.",
      "Some studies have found no evidence of these enzymes in the genomes of other animal species, including humans."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "vicuna-13b_response": "There are several packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis. Some of the most popular ones are:\n1. BioMart: BioMart is a comprehensive database of genomic data that provides access to a wide range of functional genomics data, including ChIP-seq and DNase-seq data for transcription factors. BioMart can be used to identify TFBS in the genome using ChIP-seq data.\n2. ChIPseeker: ChIPseeker is a tool for identifying transcription factor binding sites in ChIP-seq data. It uses a motif-based approach to identify TFBS and can be used with a variety of transcription factors.\n3. HOMER: HOMER is a package for modeling gene expression data, including ChIP-seq data, to identify TFBS in the genome. It uses a Bayesian approach to model gene expression and can identify TFBS using a variety of models.\n4. JASPAR: JASPAR is a database of transcription factor binding profiles that can be used to identify TFBS in the genome. It provides a collection of experimentally determined transcription factor binding profiles for a variety of transcription factors.\n5. TFBS: TFBS is a package for identifying transcription factor binding sites in ChIP-seq data. It uses a motif-based approach and can be used with a variety of transcription factors.\nThese are just a few examples of the packages available for TFBS analysis in R/Bioconductor. There are many other packages available, each with its own strengths and weaknesses, so it's important to choose the right tool for the job based on the specific needs of the experiment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BioMart, ChIPseeker, HOMER, JASPAR, and TFBS are packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis.\n2. BioMart is a database of genomic data that provides access to a wide range of functional genomics data.\n3. ChIPseeker and TFBS both use a motif-based approach to identify TFBS in ChIP-seq data.\n4. HOMER is a package that models gene expression data to identify TFBS in the genome, and uses a Bayesian approach.\n5. JASPAR is a database of transcription factor binding profiles and provides a collection of experimentally determined binding profiles for various transcription factors.",
    "vicuna-13b_fact": [
      "BioMart, ChIPseeker, HOMER, JASPAR, and TFBS are packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis.",
      "BioMart is a database of genomic data that provides access to a wide range of functional genomics data.",
      "ChIPseeker and TFBS both use a motif-based approach to identify TFBS in ChIP-seq data.",
      "HOMER is a package that models gene expression data to identify TFBS in the genome, and uses a Bayesian approach.",
      "JASPAR is a database of transcription factor binding profiles and provides a collection of experimentally determined binding profiles for various transcription factors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: HOMER is a suite of tools for Motif Discovery and ChIP-Seq analysis, not specifically for modeling gene expression data.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "vicuna-13b_response": "Sarcopenia is the loss of muscle mass and strength that can occur with aging. Clinical trials are research studies that involve people, and they are designed to determine whether a treatment is safe and effective. Here are some examples of clinical trials that are focused on the prevention of sarcopenia:\n1. The Sarcopenia and Obesity: Rehabilitation, Exercise, and Nutrition (SOREAN) Study: This is a randomized controlled trial that is investigating the effectiveness of a comprehensive rehabilitation program, including exercise and nutrition counseling, in preventing or reversing sarcopenia in older adults.\n2. The Sarcopenia Prevention and Treatment Trial (SPOTT): This is a randomized controlled trial that is investigating the effectiveness of resistance training and nutritional supplementation in preventing or treating sarcopenia in older adults.\n3. The Sarcopenia in Older Adults: Prevention and Treatment (SOPHIA) Study: This is a randomized controlled trial that is investigating the effectiveness of a combination of exercise and nutritional supplementation in preventing or treating sarcopenia in older adults.\n4. The Effect of Exercise and Nutrition on Sarcopenia in Older Adults (ENSCO) Study: This is a randomized controlled trial that is investigating the effectiveness of a comprehensive exercise and nutrition program in preventing or treating sarcopenia in older adults.\nThese are just a few examples of clinical trials that are focused on the prevention of sarcopenia. It is important to note that these trials are still in progress, and it will be some time before the results are available. If you are interested in participating in a clinical trial, it is important to speak with your doctor or a research coordinator to determine whether you are eligible and to get more information about the trial.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Sarcopenia is the loss of muscle mass and strength that can occur with aging. \n2. The SOREAN Study is a randomized controlled trial focused on preventing or reversing sarcopenia in older adults using a comprehensive rehabilitation program, including exercise and nutrition counseling.\n3. The SPOTT is another randomized controlled trial studying the effectiveness of resistance training and nutritional supplementation in preventing or treating sarcopenia in older adults.\n4. The SOPHIA Study is a randomized controlled trial investigating the combination of exercise and nutritional supplementation in preventing or treating sarcopenia in older adults.\n5. The ENSCO Study is examining the effectiveness of a comprehensive exercise and nutrition program in preventing or treating sarcopenia in older adults through a randomized controlled trial.",
    "vicuna-13b_fact": [
      "Sarcopenia is the loss of muscle mass and strength that can occur with aging.",
      "The SOREAN Study is a randomized controlled trial focused on preventing or reversing sarcopenia in older adults using a comprehensive rehabilitation program, including exercise and nutrition counseling.",
      "The SPOTT is another randomized controlled trial studying the effectiveness of resistance training and nutritional supplementation in preventing or treating sarcopenia in older adults.",
      "The SOPHIA Study is a randomized controlled trial investigating the combination of exercise and nutritional supplementation in preventing or treating sarcopenia in older adults.",
      "The ENSCO Study is examining the effectiveness of a comprehensive exercise and nutrition program in preventing or treating sarcopenia in older adults through a randomized controlled trial."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "vicuna-13b_response": "There are several databases that contain information on molecular recognition features in membrane proteins. Some of the most well-known databases include:\n1. The Membrane Protein Data Bank (MPDB): This database contains a large collection of three-dimensional structures of membrane proteins, along with information on the molecular recognition features that are important for their function.\n2. The Protein Data Bank (PDB): This database contains a wide range of protein structures, including membrane proteins, and can be searched using various criteria, including molecular recognition features.\n3. The Comparative Membrane Protein Structure Database (COMPASS): This database provides a comprehensive collection of membrane protein structures and associated information, including details on molecular recognition features.\n4. The Molecular Recognition Database (MoRD): This database contains a large collection of molecular recognition data, including information on the interactions between proteins and small molecules, which can be used to study membrane protein function.\n5. The Membrane Protein Interaction Database (MPIDB): This database contains information on the interactions between membrane proteins and other proteins, lipids, and small molecules, including details on the molecular recognition features involved in these interactions.\nThese databases can be useful resources for researchers studying membrane protein function and molecular recognition.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Membrane Protein Data Bank (MPDB) contains a large collection of three-dimensional structures of membrane proteins.\n2. The Protein Data Bank (PDB) includes a wide range of protein structures, which can be searched using various criteria.\n3. The Comparative Membrane Protein Structure Database (COMPASS) provides a comprehensive collection of membrane protein structures.\n4. The Molecular Recognition Database (MoRD) contains a large collection of molecular recognition data.\n5. The Membrane Protein Interaction Database (MPIDB) includes information on the interactions between membrane proteins and other proteins, lipids, and small molecules.",
    "vicuna-13b_fact": [
      "The Membrane Protein Data Bank (MPDB) contains a large collection of three-dimensional structures of membrane proteins.",
      "The Protein Data Bank (PDB) includes a wide range of protein structures, which can be searched using various criteria.",
      "The Comparative Membrane Protein Structure Database (COMPASS) provides a comprehensive collection of membrane protein structures.",
      "The Molecular Recognition Database (MoRD) contains a large collection of molecular recognition data.",
      "The Membrane Protein Interaction Database (MPIDB) includes information on the interactions between membrane proteins and other proteins, lipids, and small molecules."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "vicuna-13b_response": "Yes, rivaroxaban is metabolized in the kidneys. Rivaroxaban is an oral anticoagulant medication that is used to prevent blood clots from forming in the body. It is a direct factor Xa inhibitor and works by inhibiting the activity of factor Xa, which is an enzyme that plays a role in the coagulation cascade.\nRivaroxaban is metabolized in the liver and kidneys by enzymes such as CYP3A4 and CYP2J2. The metabolism of rivaroxaban results in the formation of several active and inactive metabolites. The active metabolites of rivaroxaban have similar anticoagulant activity as the parent compound, while the inactive metabolites are eliminated from the body in the urine.\nIt is important to note that the metabolism of rivaroxaban can be affected by other medications that a patient is taking, as well as by certain genetic factors. Therefore, the dosage and monitoring of rivaroxaban therapy should be individualized based on the patient's specific medical condition and other factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Rivaroxaban is metabolized in the kidneys.\n2. Rivaroxaban is an oral anticoagulant medication that is used to prevent blood clots.\n3. It works by inhibiting the activity of factor Xa, an enzyme involved in the coagulation cascade.\n4. Rivaroxaban is metabolized by enzymes such as CYP3A4 and CYP2J2 in the liver and kidneys.\n5. The inactive metabolites of rivaroxaban are eliminated from the body in the urine.",
    "vicuna-13b_fact": [
      "Rivaroxaban is metabolized in the kidneys.",
      "Rivaroxaban is an oral anticoagulant medication that is used to prevent blood clots.",
      "It works by inhibiting the activity of factor Xa, an enzyme involved in the coagulation cascade.",
      "Rivaroxaban is metabolized by enzymes such as CYP3A4 and CYP2J2 in the liver and kidneys.",
      "The inactive metabolites of rivaroxaban are eliminated from the body in the urine."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Rivaroxaban is metabolized in the liver.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "vicuna-13b_response": "TRα2 (also known as TR2) is a transcription factor that plays a role in the regulation of several genes involved in cardiac development and function. Some of the genes that have been shown to be regulated by TRα2 in the heart include:\n1. Ankyrin-2: TRα2 has been shown to regulate the expression of Ankyrin-2, a protein that is important for the formation of cardiac sarcomeres and the maintenance of cardiac muscle integrity.\n2. Beta-myosin heavy chain: TRα2 has been shown to regulate the expression of Beta-myosin heavy chain, a protein that is important for the contraction of cardiac muscle.\n3. Cardiac troponin I: TRα2 has been shown to regulate the expression of Cardiac troponin I, a protein that is important for the regulation of muscle contraction in the heart.\n4. Nkx2-5: TRα2 has been shown to regulate the expression of Nkx2-5, a transcription factor that is important for the development and differentiation of cardiac muscle cells.\n5. GATA4: TRα2 has been shown to regulate the expression of GATA4, a transcription factor that is important for the development and function of the heart.\nThese are just a few examples of the genes that have been shown to be regulated by TRα2 in the heart. It is important to note that the specific genes regulated by TRα2 can vary depending on the context and the stage of development or disease being studied.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TRα2 is a transcription factor that regulates several genes involved in cardiac development and function.\n2. TRα2 regulates the expression of Ankyrin-2, a protein important for the formation of cardiac sarcomeres and the maintenance of cardiac muscle integrity.\n3. TRα2 regulates the expression of Beta-myosin heavy chain, which is important for the contraction of cardiac muscle.\n4. TRα2 regulates the expression of Cardiac troponin I, a protein that is vital for the regulation of muscle contraction in the heart.\n5. TRα2 also regulates the expression of Nkx2-5, a transcription factor essential for the development and differentiation of cardiac muscle cells.\n6. Finally, TRα2 has been found to regulate the expression of GATA4, another transcription factor crucial for the development and function of the heart.",
    "vicuna-13b_fact": [
      "TRα2 is a transcription factor that regulates several genes involved in cardiac development and function.",
      "TRα2 regulates the expression of Ankyrin-2, a protein important for the formation of cardiac sarcomeres and the maintenance of cardiac muscle integrity.",
      "TRα2 regulates the expression of Beta-myosin heavy chain, which is important for the contraction of cardiac muscle.",
      "TRα2 regulates the expression of Cardiac troponin I, a protein that is vital for the regulation of muscle contraction in the heart.",
      "TRα2 also regulates the expression of Nkx2-5, a transcription factor essential for the development and differentiation of cardiac muscle cells.",
      "Finally, TRα2 has been found to regulate the expression of GATA4, another transcription factor crucial for the development and function of the heart."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n6. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "vicuna-13b_response": "There are several biomedical question answering systems available, including:\n1. BM25: A statistical model that uses a combination of term frequency and inverse document frequency to rank the relevance of documents to a given query.\n2. MedSpacy: A biomedical text mining library built on top of the Spacy library that provides tools for text preprocessing, entity recognition, and relation extraction.\n3. BERT: A pre-trained language model that can be fine-tuned for biomedical question answering tasks using a variety of neural network architectures.\n4. Unified Medical Language System (UMLS): A set of integrated biomedical terminologies and ontologies that can be used for question answering, information retrieval, and other biomedical text processing tasks.\n5. Neural Information Processing System (NIPS): A collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks.\n6. PubMed Query Language (PubMedQL): A natural language processing tool that can be used to search the PubMed database of biomedical literature using a variety of query types.\n7. BioASQ: A biomedical question answering challenge that provides a large dataset of biomedical questions and answers for researchers to develop and evaluate their question answering systems.\nThese are just a few examples of the many biomedical question answering systems that are available.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BM25 is a statistical model that uses a combination of term frequency and inverse document frequency to rank the relevance of documents to a query.\n2. MedSpacy is a biomedical text mining library built on top of the Spacy library.\n3. BERT is a pre-trained language model that can be fine-tuned for biomedical question answering tasks using various neural network architectures.\n4. The Unified Medical Language System (UMLS) is a set of integrated biomedical terminologies and ontologies used for question answering, information retrieval, and other biomedical text processing tasks.\n5. The Neural Information Processing System (NIPS) is a collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks.",
    "vicuna-13b_fact": [
      "BM25 is a statistical model that uses a combination of term frequency and inverse document frequency to rank the relevance of documents to a query.",
      "MedSpacy is a biomedical text mining library built on top of the Spacy library.",
      "BERT is a pre-trained language model that can be fine-tuned for biomedical question answering tasks using various neural network architectures.",
      "The Unified Medical Language System (UMLS) is a set of integrated biomedical terminologies and ontologies used for question answering, information retrieval, and other biomedical text processing tasks.",
      "The Neural Information Processing System (NIPS) is a collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Neural Information Processing System (NIPS) is a conference on machine learning and computational neuroscience, not a collection of biomedical datasets and tools for training and evaluating machine learning models for question answering tasks.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "vicuna-13b_response": "The transcription factor that activates the betalain pathway is called \"Betalain-responsive transcription factor 1\" (BTF1). BTF1 is a transcription factor that regulates the expression of genes involved in the betalain pathway, which is responsible for the production of the pigments that give red and yellow color to some fruits and vegetables, such as beets and carrots. BTF1 is a key regulator of the betalain pathway, and it is activated in response to environmental stress, such as high temperatures, drought, and disease. The activation of BTF1 leads to the upregulation of genes involved in the betalain pathway, which results in the production of the pigments that give red and yellow color to some fruits and vegetables.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The transcription factor that activates the betalain pathway is Betalain-responsive transcription factor 1 (BTF1).\n2. BTF1 regulates the expression of genes involved in the betalain pathway.\n3. The betalain pathway is responsible for the production of pigments that give red and yellow color to some fruits and vegetables.\n4. BTF1 is activated in response to environmental stress such as high temperatures, drought, and disease.\n5. The activation of BTF1 leads to the upregulation of genes involved in the betalain pathway.",
    "vicuna-13b_fact": [
      "The transcription factor that activates the betalain pathway is Betalain-responsive transcription factor 1 (BTF1).",
      "BTF1 regulates the expression of genes involved in the betalain pathway.",
      "The betalain pathway is responsible for the production of pigments that give red and yellow color to some fruits and vegetables.",
      "BTF1 is activated in response to environmental stress such as high temperatures, drought, and disease.",
      "The activation of BTF1 leads to the upregulation of genes involved in the betalain pathway."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "vicuna-13b_response": "There are several technologies that can be used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses. The choice of technology depends on various factors, such as the sample type, the number of phosphorylation sites, the dynamic range of phosphorylation levels, and the sensitivity required. Here are some of the preferred technologies for the enrichment of phosphorylated peptides:\n1. Ion Mobility Mass Spectrometry (IM-MS): IM-MS is a powerful tool for the enrichment and identification of phosphorylated peptides. IM-MS separates ions based on their mobility in a strong electric field, which allows for the separation of ions based on their mass-to-charge ratio and shape. IM-MS can be used for the enrichment of phosphorylated peptides by trapping ions based on their mobility and charge state.\n2. Phospho-specific antibodies: Phospho-specific antibodies can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes. This method is widely used in proteomics and has been used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses.\n3. Phosphate affinity chromatography: Phosphate affinity chromatography is a method that uses a phosphate-based ligand to bind to phosphorylated peptides. This method can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes.\n4. TiO2: TiO2 is a material that can be used for the enrichment of phosphorylated peptides by immobilizing phosphorylated peptides on its surface. This method is based on the interaction between phosphate groups and TiO2, which can be used to enrich for phosphorylated peptides.\n5. HPLC: High-performance liquid chromatography (HPLC) can be used for the enrichment of phosphorylated peptides by separating peptides based on their hydrophobicity, size",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ion Mobility Mass Spectrometry (IM-MS) separates ions based on their mobility in a strong electric field.\n2. IM-MS can be used for the enrichment of phosphorylated peptides by trapping ions based on their mobility and charge state.\n3. Phospho-specific antibodies can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes.\n4. Phosphate affinity chromatography is a method that uses a phosphate-based ligand to bind to phosphorylated peptides.\n5. TiO2 can be used for the enrichment of phosphorylated peptides by immobilizing phosphorylated peptides on its surface.",
    "vicuna-13b_fact": [
      "Ion Mobility Mass Spectrometry (IM-MS) separates ions based on their mobility in a strong electric field.",
      "IM-MS can be used for the enrichment of phosphorylated peptides by trapping ions based on their mobility and charge state.",
      "Phospho-specific antibodies can be used to enrich for phosphorylated peptides by binding specifically to phosphorylated epitopes.",
      "Phosphate affinity chromatography is a method that uses a phosphate-based ligand to bind to phosphorylated peptides.",
      "TiO2 can be used for the enrichment of phosphorylated peptides by immobilizing phosphorylated peptides on its surface."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "vicuna-13b_response": "The Palmini classification is a system for classifying different types of depression. It was developed by Italian psychiatrist Giovanni Palmini and his colleagues in the 1980s. The Palmini classification system is based on a combination of clinical and psychological factors, and it is used to help diagnose and treat depression.\nThe Palmini classification system includes four main types of depression:\n1. Endogenous depression: This type of depression is thought to be caused by biological factors, such as genetics or hormonal imbalances. It is characterized by a tendency to feel sad or hopeless for no apparent reason, and it often improves with antidepressant medication.\n2. Neurotic depression: This type of depression is thought to be caused by psychological factors, such as stress or anxiety. It is characterized by feelings of sadness or anxiety that are related to specific life events or situations. It may improve with therapy or counseling.\n3. Atypical depression: This type of depression is characterized by symptoms that do not fit into the other two categories. It may include symptoms such as excessive sleeping, increased appetite, and a lack of energy. It may respond to a combination of medication and therapy.\n4. Melancholic depression: This type of depression is characterized by a loss of interest in activities, a lack of energy, and feelings of hopelessness or pessimism. It may respond well to antidepressant medication, but it often requires a higher dose than other types of depression.\nIt's important to note that the Palmini classification system is not universally accepted and some experts may use different classification systems to diagnose and treat depression. It's always best to consult with a qualified mental health professional for a proper diagnosis and treatment plan.",
    "vicuna-13b_fact_raw": "1. The Palmini classification is a system for classifying different types of depression. \n2. The Palmini classification was developed by Italian psychiatrist Giovanni Palmini and his colleagues in the 1980s.\n3. The Palmini classification system includes four main types of depression: Endogenous, Neurotic, Atypical, and Melancholic depression.\n4. The Palmini classification system is based on clinical and psychological factors.\n5. The Palmini classification system is not universally accepted and some experts may use different classification systems to diagnose and treat depression.",
    "vicuna-13b_fact": [
      "The Palmini classification is a system for classifying different types of depression.",
      "The Palmini classification was developed by Italian psychiatrist Giovanni Palmini and his colleagues in the 1980s.",
      "The Palmini classification system includes four main types of depression: Endogenous, Neurotic, Atypical, and Melancholic depression.",
      "The Palmini classification system is based on clinical and psychological factors.",
      "The Palmini classification system is not universally accepted and some experts may use different classification systems to diagnose and treat depression."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Palmini classification is not a recognized system for classifying depression. The most widely used classification systems are the DSM (Diagnostic and Statistical Manual of Mental Disorders) and the ICD (International Classification of Diseases).\n2. FALSE [correction]: Since the Palmini classification is not a recognized system, it was not developed by Italian psychiatrist Giovanni Palmini or any other individual.\n3. FALSE [correction]: The DSM and ICD include different types of depression classifications, but not necessarily the categories mentioned in the statement.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "vicuna-13b_response": "Human subacute thyroiditis is a type of inflammatory thyroid disease that is characterized by inflammation and swelling of the thyroid gland. The exact cause of subacute thyroiditis is not fully understood, but it is thought to be triggered by a viral infection in some cases.\nThere is evidence to suggest that certain viruses, such as the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV), may play a role in the development of subacute thyroiditis. These viruses are known to cause inflammation and swelling of the thyroid gland, leading to the symptoms of subacute thyroiditis.\nHowever, it is important to note that not all cases of subacute thyroiditis are caused by viral infections. In some cases, the condition may be caused by other factors, such as a reaction to certain medications or an autoimmune disorder.\nIf you are experiencing symptoms of subacute thyroiditis, it is important to speak with a healthcare provider for proper diagnosis and treatment. They will be able to determine the underlying cause of your condition and recommend the appropriate course of treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Human subacute thyroiditis is a type of inflammatory thyroid disease characterized by inflammation and swelling of the thyroid gland.\n2. Subacute thyroiditis is thought to be triggered by a viral infection in some cases.\n3. Evidence suggests that the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV) might play a role in the development of subacute thyroiditis.\n4. Not all cases of subacute thyroiditis are caused by viral infections; it can also be caused by a reaction to certain medications or an autoimmune disorder.\n5. Symptoms of subacute thyroiditis require consultation with a healthcare provider for proper diagnosis and treatment.",
    "vicuna-13b_fact": [
      "Human subacute thyroiditis is a type of inflammatory thyroid disease characterized by inflammation and swelling of the thyroid gland.",
      "Subacute thyroiditis is thought to be triggered by a viral infection in some cases.",
      "Evidence suggests that the Epstein-Barr virus (EBV) and the cytomegalovirus (CMV) might play a role in the development of subacute thyroiditis.",
      "Not all cases of subacute thyroiditis are caused by viral infections; it can also be caused by a reaction to certain medications or an autoimmune disorder.",
      "Symptoms of subacute thyroiditis require consultation with a healthcare provider for proper diagnosis and treatment."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "vicuna-13b_response": "Yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy. EIF2AK2, also known as PKR-like endoplasmic reticulum (ER) kinase (PERK), is a protein kinase that plays a critical role in the regulation of protein synthesis and the unfolded protein response (UPR) in the ER. STAT3, on the other hand, is a transcription factor that is involved in a variety of cellular processes, including cell proliferation, differentiation, and survival.\nSeveral studies have shown that EIF2AK2 can phosphorylate and activate STAT3, leading to the suppression of autophagy. When EIF2AK2 is activated by ER stress, it phosphorylates and activates PERK, which then phosphorylates and activates STAT3. This activation of STAT3 then leads to the suppression of autophagy by inhibiting the expression of autophagy-related genes.\nIn conclusion, EIF2AK2-dependent suppression of autophagy is mediated, in part, by the activation of STAT3. The activation of STAT3 by EIF2AK2 in response to ER stress inhibits autophagy, which helps to maintain protein synthesis and prevent cell death.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. STAT3 is involved in EIF2AK2-dependent suppression of autophagy.\n2. EIF2AK2, also known as PKR-like endoplasmic reticulum (ER) kinase (PERK), is a protein kinase.\n3. EIF2AK2 plays a critical role in the regulation of protein synthesis and the unfolded protein response (UPR) in the ER.\n4. STAT3 is a transcription factor involved in cellular processes, including cell proliferation, differentiation, and survival.\n5. When EIF2AK2 is activated by ER stress, it phosphorylates and activates STAT3, leading to the suppression of autophagy.",
    "vicuna-13b_fact": [
      "STAT3 is involved in EIF2AK2-dependent suppression of autophagy.",
      "EIF2AK2, also known as PKR-like endoplasmic reticulum (ER) kinase (PERK), is a protein kinase.",
      "EIF2AK2 plays a critical role in the regulation of protein synthesis and the unfolded protein response (UPR) in the ER.",
      "STAT3 is a transcription factor involved in cellular processes, including cell proliferation, differentiation, and survival.",
      "When EIF2AK2 is activated by ER stress, it phosphorylates and activates STAT3, leading to the suppression of autophagy."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: EIF2AK2, also known as Protein kinase R (PKR), is a protein kinase. PERK is another kinase called EIF2AK3.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "vicuna-13b_response": "Theatre is a software tool that is used for genomic analysis. It is designed to help researchers and scientists analyze large amounts of genomic data, such as DNA sequencing data, in a more efficient and effective way.\nTheatre allows users to easily visualize and explore their genomic data, using a variety of different visualization and analysis tools. This can help researchers to identify patterns and trends in their data, and to gain insights into the underlying biology of their samples.\nSome of the key features of Theatre include:\n* Support for a wide range of different file formats, including FASTQ, BAM, and VCF\n* A powerful query and filtering system, which allows users to quickly narrow down their data to specific subsets\n* A range of different visualization tools, including track viewers, heatmaps, and gene expression plots\n* Integration with other popular genomic analysis tools, such as GATK and bcftools\nOverall, Theatre is a valuable tool for anyone who needs to analyze large amounts of genomic data, and it is widely used in a variety of different research and clinical settings.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Theatre is a software tool used for genomic analysis.\n2. Theatre is designed to help analyze large amounts of genomic data such as DNA sequencing data. \n3. Theatre supports a wide range of different file formats, including FASTQ, BAM, and VCF.\n4. Theatre has a powerful query and filtering system that allows users to narrow down their data to specific subsets.\n5. Theatre integrates with other popular genomic analysis tools, such as GATK and bcftools.",
    "vicuna-13b_fact": [
      "Theatre is a software tool used for genomic analysis.",
      "Theatre is designed to help analyze large amounts of genomic data such as DNA sequencing data.",
      "Theatre supports a wide range of different file formats, including FASTQ, BAM, and VCF.",
      "Theatre has a powerful query and filtering system that allows users to narrow down their data to specific subsets.",
      "Theatre integrates with other popular genomic analysis tools, such as GATK and bcftools."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "vicuna-13b_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences depends on several factors, including:\n1. Length of the sequences: The longer the sequences, the more computational time is required for the alignment.\n2. Number of gaps in the sequences: The more gaps in the sequences, the more computational time is required for the alignment.\n3. Number of mismatches allowed: The more mismatches allowed in the alignment, the more computational time is required for the alignment.\n4. The scoring matrix used: The scoring matrix used in the Smith-Waterman algorithm can affect the computational time. For example, using a diagonal matrix as the scoring matrix can reduce the computational time, but it may not provide the best alignment.\nIn general, the Smith-Waterman algorithm has a time complexity of O(n \\* m \\* log(n \\* m)), where n and m are the lengths of the sequences. This makes it an efficient algorithm for aligning large sequences. However, the actual execution time can be much longer than this, depending on the factors mentioned above.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The execution time or complexity of the Smith-Waterman algorithm depends on the length of the sequences.\n2. The execution time or complexity of the Smith-Waterman algorithm depends on the number of gaps in the sequences.\n3. The execution time or complexity of the Smith-Waterman algorithm depends on the number of mismatches allowed in the alignment.\n4. The scoring matrix used in the Smith-Waterman algorithm can affect the computational time.\n5. The Smith-Waterman algorithm has a time complexity of O(n*m*log(n*m)), where n and m are the lengths of the sequences.",
    "vicuna-13b_fact": [
      "The execution time or complexity of the Smith-Waterman algorithm depends on the length of the sequences.",
      "The execution time or complexity of the Smith-Waterman algorithm depends on the number of gaps in the sequences.",
      "The execution time or complexity of the Smith-Waterman algorithm depends on the number of mismatches allowed in the alignment.",
      "The scoring matrix used in the Smith-Waterman algorithm can affect the computational time.",
      "The Smith-Waterman algorithm has a time complexity of O(n*m*log(n*m)), where n and m are the lengths of the sequences."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The execution time or complexity of the Smith-Waterman algorithm does not directly depend on the number of gaps in the sequences, but on the lengths of the sequences.\n3. FALSE [correction]: The execution time or complexity of the Smith-Waterman algorithm does not directly depend on the number of mismatches allowed in the alignment, but on the lengths of the sequences.\n4. TRUE\n5. FALSE [correction]: The Smith-Waterman algorithm has a time complexity of O(n*m), where n and m are the lengths of the sequences.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "vicuna-13b_response": "FLVCR1 (Follicular Dendritic Cell Sarcoma Recurrence 1) is a member of the SLC (Solute Carrier) family of proteins. SLC proteins are a diverse family of transmembrane proteins that play important roles in the transport of solutes across cell membranes. FLVCR1 is a type I transmembrane protein that functions as a folate transporter and is involved in the uptake of folate, a B vitamin essential for cellular metabolism, into cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. FLVCR1 is a member of the SLC family of proteins.\n2. SLC proteins are a family of transmembrane proteins.\n3. SLC proteins play important roles in the transport of solutes across cell membranes.\n4. FLVCR1 is a type I transmembrane protein.\n5. FLVCR1 functions as a folate transporter and is involved in the uptake of folate into cells.",
    "vicuna-13b_fact": [
      "FLVCR1 is a member of the SLC family of proteins.",
      "SLC proteins are a family of transmembrane proteins.",
      "SLC proteins play important roles in the transport of solutes across cell membranes.",
      "FLVCR1 is a type I transmembrane protein.",
      "FLVCR1 functions as a folate transporter and is involved in the uptake of folate into cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: FLVCR1 functions as a heme transporter and is involved in the efflux of heme from cells.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "vicuna-13b_response": "GATA-1 is a transcription factor that plays a crucial role in the development and differentiation of hematopoietic cells. Several studies have identified GATA-1 interacting partners using the biotinylation tagging approach. Here are some of the known GATA-1 interacting partners:\n1. TFIIB: GATA-1 was shown to interact with TFIIB, a transcription factor that plays a role in the initiation of transcription.\n2. TBP: GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.\n3. RFX: GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.\n4. NF-E2: GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.\n5. GATA-2: GATA-1 was shown to interact with GATA-2, another GATA transcription factor that is involved in the development of hematopoietic cells.\n6. PU.1: GATA-1 was found to interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells.\nThese are just a few examples of GATA-1 interacting partners that have been identified using the biotinylation tagging approach. Further studies are needed to fully understand the role of these interactions in the regulation of hematopoietic cell development and function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GATA-1 is a transcription factor that plays a role in the development and differentiation of hematopoietic cells.\n2. GATA-1 was shown to interact with TFIIB, a transcription factor involved in the initiation of transcription.\n3. GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.\n4. GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.\n5. GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.\n5. GATA-1 was shown to interact with GATA-2, another GATA transcription factor involved in the development of hematopoietic cells.\n6. GATA-1 was found to interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells.",
    "vicuna-13b_fact": [
      "GATA-1 is a transcription factor that plays a role in the development and differentiation of hematopoietic cells.",
      "GATA-1 was shown to interact with TFIIB, a transcription factor involved in the initiation of transcription.",
      "GATA-1 was found to interact with TBP, a component of the transcriptional preinitiation complex.",
      "GATA-1 was shown to interact with RFX, a transcription factor involved in the regulation of immune cell development.",
      "GATA-1 was found to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythropoiesis.",
      "GATA-1 was shown to interact with GATA-2, another GATA transcription factor involved in the development of hematopoietic cells.",
      "GATA-1 was found to interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE\n6. TRUE\n7. FALSE [correction]: GATA-1 was found to repress, not interact with PU.1, a transcription factor that plays a role in the differentiation of myeloid cells.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "vicuna-13b_response": "TAF10 is a transcription factor that plays a role in the regulation of gene expression in many organisms, including humans. GATA1 is another transcription factor that is involved in the regulation of gene expression, particularly in the development and function of hematopoietic cells.\nThe outcome of TAF10 interacting with the GATA1 transcription factor can vary depending on the specific context and the target genes being regulated. However, in general, the interaction of TAF10 with GATA1 can enhance the transcriptional activity of GATA1, leading to the upregulation of target genes involved in hematopoiesis and other processes.\nFor example, TAF10 has been shown to interact with GATA1 and enhance its transcriptional activity in the regulation of the erythroid differentiation pathway in hematopoietic cells. In addition, TAF10 has been shown to interact with GATA1 and regulate the expression of genes involved in the immune response and inflammation.\nOverall, the interaction of TAF10 with GATA1 can play an important role in the regulation of gene expression and cellular processes, and further research is needed to fully understand the mechanisms and outcomes of this interaction.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TAF10 is a transcription factor that plays a role in the regulation of gene expression in many organisms.\n2. GATA1 is a transcription factor implicated in the regulation of gene expression, particularly in hematopoietic cells.\n3. The interaction of TAF10 with GATA1 can enhance the transcriptional activity of GATA1, leading to the upregulation of target genes.\n4. TAF10 has been shown to interact with GATA1 and enhance its transcriptional activity in the regulation of the erythroid differentiation pathway in hematopoietic cells.\n5. TAF10 has been shown to interact with GATA1 and regulate the expression of genes involved in the immune response and inflammation.",
    "vicuna-13b_fact": [
      "TAF10 is a transcription factor that plays a role in the regulation of gene expression in many organisms.",
      "GATA1 is a transcription factor implicated in the regulation of gene expression, particularly in hematopoietic cells.",
      "The interaction of TAF10 with GATA1 can enhance the transcriptional activity of GATA1, leading to the upregulation of target genes.",
      "TAF10 has been shown to interact with GATA1 and enhance its transcriptional activity in the regulation of the erythroid differentiation pathway in hematopoietic cells.",
      "TAF10 has been shown to interact with GATA1 and regulate the expression of genes involved in the immune response and inflammation."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "vicuna-13b_response": "Yes, there are decision support systems for chronic pain management. These systems are designed to help healthcare professionals, such as doctors and nurses, make informed decisions about the treatment of chronic pain. They typically use algorithms and other tools to analyze patient data, such as medical history, symptoms, and test results, and provide recommendations for treatment options. Some decision support systems for chronic pain management may also take into account patient preferences and values, as well as the latest research and guidelines. These systems can be useful in helping healthcare professionals to select the most appropriate treatment for each individual patient, and to optimize pain management strategies over time.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. There are decision support systems available for chronic pain management.\n2. Decision support systems for chronic pain management are designed to assist healthcare professionals in making treatment decisions.\n3. These systems use algorithms and other tools to analyze patient data including medical history, symptoms, and test results.\n4. Some chronic pain management decision support systems may consider patient preferences, values, and the latest research and guidelines.\n5. These systems can aid healthcare professionals in selecting an appropriate treatment for an individual patient and optimizing pain management strategies over time.",
    "vicuna-13b_fact": [
      "There are decision support systems available for chronic pain management.",
      "Decision support systems for chronic pain management are designed to assist healthcare professionals in making treatment decisions.",
      "These systems use algorithms and other tools to analyze patient data including medical history, symptoms, and test results.",
      "Some chronic pain management decision support systems may consider patient preferences, values, and the latest research and guidelines.",
      "These systems can aid healthcare professionals in selecting an appropriate treatment for an individual patient and optimizing pain management strategies over time."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "vicuna-13b_response": "Angiogenin is a protein that plays a role in the process of angiogenesis, which is the formation of new blood vessels. The subcellular localization of angiogenin is not well understood, but it is thought to be involved in the regulation of various cellular processes, including cell division and differentiation. Some studies have suggested that angiogenin may be localized in the cytoplasm and the nucleus of cells, and that it may be involved in the regulation of gene expression. However, further research is needed to fully understand the subcellular localization of angiogenin and its role in cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Angiogenin is a protein.\n2. This protein plays a role in the process of angiogenesis.\n3. Angiogenesis is the formation of new blood vessels.\n4. Some studies suggest that angiogenin may be localized in the cytoplasm and the nucleus of cells.\n5. It is thought that angiogenin may be involved in the regulation of gene expression.",
    "vicuna-13b_fact": [
      "Angiogenin is a protein.",
      "This protein plays a role in the process of angiogenesis.",
      "Angiogenesis is the formation of new blood vessels.",
      "Some studies suggest that angiogenin may be localized in the cytoplasm and the nucleus of cells.",
      "It is thought that angiogenin may be involved in the regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "vicuna-13b_response": "Ranolazine is a medication that is used to treat angina (chest pain) and heart rhythm disorders. It works by blocking the late sodium channels in the heart, which helps to reduce the amount of oxygen needed by the heart muscle during exercise.\nRanolazine has also been shown to affect kinase signaling activation in the heart. Kinases are enzymes that play a role in cell signaling and are involved in a variety of cellular processes, including the regulation of cell growth and division.\nRanolazine has been shown to inhibit the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways. These kinases are involved in the regulation of cell survival and proliferation, and their inhibition has been shown to have a negative impact on cardiac function.\nIn addition, ranolazine has been shown to inhibit the activation of the protein kinase C (PKC) pathway in the heart. The PKC pathway is involved in the regulation of cardiac contractility and is thought to play a role in the development of heart failure.\nOverall, the effects of ranolazine on kinase signaling activation in the heart are complex and depend on the specific kinase pathway being considered. While ranolazine has been shown to have a negative impact on cardiac function in some cases, it is still an important treatment option for certain heart conditions.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ranolazine is a medication used to treat angina and heart rhythm disorders.\n2. Ranolazine works by blocking the late sodium channels in the heart.\n3. Ranolazine has been shown to inhibit the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways. \n4. Ranolazine has been shown to inhibit the activation of the protein kinase C (PKC) pathway in the heart. \n5. The effects of ranolazine on kinase signaling activation in the heart are complex and depend on the specific kinase pathway being considered.",
    "vicuna-13b_fact": [
      "Ranolazine is a medication used to treat angina and heart rhythm disorders.",
      "Ranolazine works by blocking the late sodium channels in the heart.",
      "Ranolazine has been shown to inhibit the activation of certain kinases in the heart, including the Akt and extracellular signal-regulated kinase (ERK) pathways.",
      "Ranolazine has been shown to inhibit the activation of the protein kinase C (PKC) pathway in the heart.",
      "The effects of ranolazine on kinase signaling activation in the heart are complex and depend on the specific kinase pathway being considered."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "vicuna-13b_response": "The regulation of Vsr endonuclease is not necessarily independent of the growth phase of bacteria. Vsr endonuclease is an enzyme that is involved in the regulation of gene expression in bacteria, and its activity can be affected by various factors, including the growth phase of the bacteria.\nStudies have shown that the expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA, which is involved in the regulation of virulence genes in bacteria. The expression of VcrA is itself regulated by the global transcriptional regulator Lrp, which is involved in the regulation of bacterial metabolism and stress responses.\nIn addition, the activity of Vsr endonuclease can be affected by the growth phase of the bacteria. For example, Vsr endonuclease activity has been shown to be highest in the exponential growth phase and lowest in the stationary phase of bacteria. This suggests that the regulation of Vsr endonuclease may be influenced by the growth phase of the bacteria.\nOverall, while the regulation of Vsr endonuclease is not necessarily independent of the growth phase of bacteria, it is a complex process that is influenced by a variety of factors, including the transcription factor VcrA, the global transcriptional regulator Lrp, and the growth phase of the bacteria.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vsr endonuclease is an enzyme that is involved in the regulation of gene expression in bacteria.\n2. The expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA, which is involved in the regulation of virulence genes in bacteria.\n3. The expression of VcrA is regulated by the global transcriptional regulator Lrp, which is involved in the regulation of bacterial metabolism and stress responses.\n4. Vsr endonuclease activity has been shown to be highest in the exponential growth phase and lowest in the stationary phase of bacteria.\n5. The regulation of Vsr endonuclease is influenced by factors, including the transcription factor VcrA, the global transcriptional regulator Lrp, and the growth phase of the bacteria.",
    "vicuna-13b_fact": [
      "Vsr endonuclease is an enzyme that is involved in the regulation of gene expression in bacteria.",
      "The expression of the Vsr endonuclease gene is regulated by the transcription factor VcrA, which is involved in the regulation of virulence genes in bacteria.",
      "The expression of VcrA is regulated by the global transcriptional regulator Lrp, which is involved in the regulation of bacterial metabolism and stress responses.",
      "Vsr endonuclease activity has been shown to be highest in the exponential growth phase and lowest in the stationary phase of bacteria.",
      "The regulation of Vsr endonuclease is influenced by factors, including the transcription factor VcrA, the global transcriptional regulator Lrp, and the growth phase of the bacteria."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "vicuna-13b_response": "Beta-barrel transmembrane proteins are a type of protein that are characterized by having a beta-sheet structure that forms a barrel-shaped structure across the membrane. These proteins play important roles in various cellular processes, such as transport of molecules across the cell membrane, and are often targets for drug development. There are several computational tools that can be used for the prediction of beta-barrel transmembrane proteins, including:\n1. TMHMM: TMHMM (Transmembrane Helix Membrane Modeling) is a widely used tool for predicting transmembrane proteins, including beta-barrel proteins. It uses a combination of machine learning and statistical methods to predict transmembrane helices and the location of the membrane-spanning segments.\n2. Phobos: Phobos is a web-based tool that uses a combination of sequence and structural features to predict transmembrane proteins, including beta-barrel proteins. It can also predict the topology of the protein and the location of the transmembrane segments.\n3. BetaBarrel: BetaBarrel is a standalone tool that can be used for the prediction of beta-barrel transmembrane proteins. It uses a combination of sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.\n4. TOPCONS: TOPCONS (Transmembrane Protein Structure Prediction using Consensus Sites) is a tool that uses a combination of machine learning and consensus sites to predict the topology and structure of transmembrane proteins, including beta-barrel proteins.\n5. BetaRod: BetaRod is a web-based tool that can be used for the prediction of beta-barrel transmembrane proteins. It uses a combination of sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.\nThese are some of the computational tools that can be used for the prediction of beta-barrel transmembrane proteins. It is important to note that these tools are not perfect and may have some limitations in their predictions. Therefore, it is important to validate the predictions using experimental data.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Beta-barrel transmembrane proteins are characterized by a beta-sheet structure that forms a barrel-shaped structure across the membrane.\n2. TMHMM is used for predicting transmembrane proteins, using a combination of machine learning and statistical methods.\n3. Phobos is a tool that uses sequence and structural features to predict transmembrane proteins including their topology and the location of the transmembrane segments.\n4. BetaBarrel uses sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.\n5. TOPCONS uses machine learning and consensus sites to predict the topology and structure of transmembrane proteins.\n6. BetaRod uses sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.",
    "vicuna-13b_fact": [
      "Beta-barrel transmembrane proteins are characterized by a beta-sheet structure that forms a barrel-shaped structure across the membrane.",
      "TMHMM is used for predicting transmembrane proteins, using a combination of machine learning and statistical methods.",
      "Phobos is a tool that uses sequence and structural features to predict transmembrane proteins including their topology and the location of the transmembrane segments.",
      "BetaBarrel uses sequence and structural features to predict the presence of beta-barrel domains in a protein sequence.",
      "TOPCONS uses machine learning and consensus sites to predict the topology and structure of transmembrane proteins.",
      "BetaRod uses sequence and structural features to predict the presence of beta-barrel domains in a protein sequence."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Phobius is a tool that uses sequence and structural features to predict transmembrane proteins including their topology and the location of the transmembrane segments.\n4. UNKNOWN\n5. TRUE\n6. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "vicuna-13b_response": "Galassi classification is used for the classification of mental and behavioral disorders. It is a system of classification that was developed by the Italian psychiatrist, Enrico Galassi, in the early 20th century. The Galassi classification system is based on the principle of grouping disorders based on their underlying psychological mechanisms, rather than on their symptoms or external features.\nThe Galassi classification system is divided into three main categories:\n1. Psychoneurotic disorders: These are disorders that are characterized by anxiety, depression, and other emotional disturbances.\n2. Personality disorders: These are disorders that are characterized by long-term patterns of behavior and thinking that deviate from the norm of the individual's culture.\n3. Organic mental disorders: These are disorders that are caused by physical illness or injury, or by the use of certain medications.\nThe Galassi classification system is not widely used in modern psychiatry, as it has been replaced by other classification systems, such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD). However, the principles of the Galassi classification system continue to influence the way that mental and behavioral disorders are understood and treated.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Galassi classification is used for the classification of mental and behavioral disorders.\n2. The Galassi classification system was developed by Italian psychiatrist, Enrico Galassi.\n3. The Galassi classification divides disorders into three categories: Psychoneurotic disorders, Personality disorders, and Organic mental disorders.\n4. The Galassi classification system is not widely used in modern psychiatry.\n5. The Galassi classification system has been replaced by the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD).",
    "vicuna-13b_fact": [
      "Galassi classification is used for the classification of mental and behavioral disorders.",
      "The Galassi classification system was developed by Italian psychiatrist, Enrico Galassi.",
      "The Galassi classification divides disorders into three categories: Psychoneurotic disorders, Personality disorders, and Organic mental disorders.",
      "The Galassi classification system is not widely used in modern psychiatry.",
      "The Galassi classification system has been replaced by the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD)."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Galassi classification is not used for the classification of mental and behavioral disorders. It is a classification system for types of femoral neck fractures.\n2. FALSE [correction]: The Galassi classification system was not developed by Italian psychiatrist, Enrico Galassi. It is a classification system for types of femoral neck fractures developed by orthopedic surgeon, Arthur G. Galassi.\n3. FALSE [correction]: The Galassi classification does not divide disorders into three categories: Psychoneurotic disorders, Personality disorders, and Organic mental disorders. It classifies femoral neck fractures into three types based on the complexity and location of the fracture.\n4. UNKNOWN \n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "vicuna-13b_response": "Shapiro syndrome, also known as Shapiro-Thompson syndrome, is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body. Some common features of this condition include:\n1. Developmental delays: Children with Shapiro syndrome may experience developmental delays in reaching certain milestones, such as crawling, walking, and talking.\n2. Intellectual disability: Many individuals with Shapiro syndrome have some degree of intellectual disability, which can range from mild to severe.\n3. Eye abnormalities: People with Shapiro syndrome often have abnormalities of the eyes, such as cataracts, glaucoma, and strabismus (a condition in which the eyes do not align properly).\n4. Hearing loss: Many individuals with Shapiro syndrome have hearing loss, which can range from mild to severe.\n5. Facial abnormalities: Some people with Shapiro syndrome have distinctive facial features, such as a flat face, a small jaw, and a broad nasal bridge.\n6. Skeletal abnormalities: People with Shapiro syndrome may have abnormalities of the skeletal system, such as short stature, joint laxity, and loose ligaments.\n7. Cardiovascular problems: Some individuals with Shapiro syndrome may have heart defects or other cardiovascular problems.\n8. Kidney problems: Some people with Shapiro syndrome may have kidney problems, such as nephrotic syndrome (a condition in which the kidneys do not properly filter waste and fluids from the blood).\nIt's important to note that not everyone with Shapiro syndrome will have all of these features, and the severity of the condition can vary from person to person.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Shapiro syndrome is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body.\n2. People with Shapiro syndrome may experience developmental delays.\n3. Intellectual disability can often be seen in individuals with Shapiro syndrome.\n4. Abnormalities of the eyes, such as cataracts, glaucoma, and strabismus are often present in people with Shapiro syndrome.\n5. Many individuals with Shapiro syndrome have hearing loss.\n6. Distinctive facial features may exist in some people with Shapiro syndrome, such as a flat face, a small jaw, and a broad nasal bridge.\n7. Shapiro Syndrome can result in skeletal abnormalities, such as short stature, joint laxity, and loose ligaments.\n8. Some individuals with Shapiro syndrome may have heart defects or other cardiovascular problems.\n9. Some people with Shapiro syndrome may have kidney problems, such as nephrotic syndrome.",
    "vicuna-13b_fact": [
      "Shapiro syndrome is a rare genetic disorder that affects the development of the eyes, ears, and other parts of the body.",
      "People with Shapiro syndrome may experience developmental delays.",
      "Intellectual disability can often be seen in individuals with Shapiro syndrome.",
      "Abnormalities of the eyes, such as cataracts, glaucoma, and strabismus are often present in people with Shapiro syndrome.",
      "Many individuals with Shapiro syndrome have hearing loss.",
      "Distinctive facial features may exist in some people with Shapiro syndrome, such as a flat face, a small jaw, and a broad nasal bridge.",
      "Shapiro Syndrome can result in skeletal abnormalities, such as short stature, joint laxity, and loose ligaments.",
      "Some individuals with Shapiro syndrome may have heart defects or other cardiovascular problems.",
      "Some people with Shapiro syndrome may have kidney problems, such as nephrotic syndrome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Shapiro syndrome is a rare genetic disorder characterized by recurrent episodes of excessive sweating and heat intolerance, along with a loss of deep tendon reflexes and a decrease in muscle tone.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: While Shapiro syndrome can involve ocular abnormalities, they do not typically include cataracts, glaucoma, and strabismus.\n5. UNKNOWN\n6. UNKNOWN\n7. FALSE [correction]: Shapiro Syndrome does not directly result in skeletal abnormalities such as short stature, joint laxity, and loose ligaments.\n8. UNKNOWN\n9. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "vicuna-13b_response": "BRAG1 is a gene that plays a role in regulating cell growth and division. Mutations in the BRAG1 gene have been linked to the development of certain types of cancer, including ovarian cancer, glioblastoma, and acute myeloid leukemia. BRAG1 mutations have also been associated with the development of other diseases, such as inherited bone marrow disorders and neurodegenerative diseases. However, it is important to note that not all diseases are directly linked to mutations within BRAG1, and the specific disease associated with BRAG1 mutations can vary depending on the specific mutation and other factors.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BRAG1 is a gene that regulates cell growth and division.\n2. Mutations in the BRAG1 gene have been linked to the development of certain types of cancer.\n3. The types of cancer associated with BRAG1 mutations include ovarian cancer, glioblastoma, and acute myeloid leukemia.\n4. BRAG1 mutations have also been associated with the development of inherited bone marrow disorders and neurodegenerative diseases.\n5. The specific disease associated with BRAG1 mutations can vary depending on the specific mutation and other factors.",
    "vicuna-13b_fact": [
      "BRAG1 is a gene that regulates cell growth and division.",
      "Mutations in the BRAG1 gene have been linked to the development of certain types of cancer.",
      "The types of cancer associated with BRAG1 mutations include ovarian cancer, glioblastoma, and acute myeloid leukemia.",
      "BRAG1 mutations have also been associated with the development of inherited bone marrow disorders and neurodegenerative diseases.",
      "The specific disease associated with BRAG1 mutations can vary depending on the specific mutation and other factors."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "vicuna-13b_response": "Protein phosphatase 1 (PP1) is a ubiquitous serine/threonine phosphatase that plays a critical role in regulating a wide range of cellular processes, including cell growth, differentiation, and survival. PP1 is regulated by a number of different proteins, including inhibitors that modulate its activity.\nOne of the main inhibitors of PP1 is a protein called PP1-binding protein (PP1B). PP1B is a large, structurally complex protein that binds to the regulatory subunit of PP1 and inhibits its activity. PP1B is expressed in a variety of tissues and cells, and its expression is regulated by a number of different signaling pathways.\nAnother inhibitor of PP1 is a protein called PP1-interacting protein (PP1IP). PP1IP is a small protein that binds to the catalytic subunit of PP1 and inhibits its activity. PP1IP is expressed in a variety of tissues and cells, and its expression is regulated by a number of different signaling pathways.\nIn summary, PP1 is inhibited by PP1-binding protein (PP1B) and PP1-interacting protein (PP1IP). These inhibitors play important roles in regulating the activity of PP1 and modulating its effects on cellular processes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Protein phosphatase 1 (PP1) is a serine/threonine phosphatase that regulates a wide range of cellular processes.\n2. PP1 is regulated by different proteins including inhibitors.\n3. One main inhibitor of PP1 is a protein called PP1-binding protein (PP1B), which binds to the regulatory subunit of PP1 and inhibits its activity.\n4. Another inhibitor of PP1 is a protein called PP1-interacting protein (PP1IP), which binds to the catalytic subunit of PP1 and inhibits its activity.\n5. The expression of both PP1-binding protein (PP1B) and PP1-interacting protein (PP1IP) is regulated by different signaling pathways.",
    "vicuna-13b_fact": [
      "Protein phosphatase 1 (PP1) is a serine/threonine phosphatase that regulates a wide range of cellular processes.",
      "PP1 is regulated by different proteins including inhibitors.",
      "One main inhibitor of PP1 is a protein called PP1-binding protein (PP1B), which binds to the regulatory subunit of PP1 and inhibits its activity.",
      "Another inhibitor of PP1 is a protein called PP1-interacting protein (PP1IP), which binds to the catalytic subunit of PP1 and inhibits its activity.",
      "The expression of both PP1-binding protein (PP1B) and PP1-interacting protein (PP1IP) is regulated by different signaling pathways."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "vicuna-13b_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a phenomenon observed in Bacillus subtilis where the rate of spontaneous mutations increases during the stationary phase of growth. This occurs when the bacteria have reached a state of exponential growth and are no longer able to increase their population size.\nSeveral mechanisms have been proposed to underlie adaptive mutagenesis in Bacillus subtilis. One of the main mechanisms is the activation of stress response pathways, such as the DNA damage response and the SOS response, during the stationary phase of growth. These pathways induce the expression of genes that promote mutagenesis, such as those involved in DNA repair and replication, as well as those that inhibit translesion DNA synthesis.\nAnother mechanism that has been proposed to contribute to adaptive mutagenesis is the accumulation of mutations in key genes involved in DNA repair and replication during the stationary phase of growth. These mutations can lead to changes in the activity of these genes, which can further increase the rate of mutations.\nAdditionally, it has been suggested that the decrease in the rate of bacterial division during the stationary phase of growth may lead to an increase in the rate of mutations, as the cells are more likely to undergo DNA replication errors.\nOverall, the mechanisms underlying adaptive mutagenesis in Bacillus subtilis are complex and multifactorial, and likely involve a combination of the mechanisms mentioned above.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Adaptive mutagenesis is a phenomenon observed in Bacillus subtilis where the rate of spontaneous mutations increases during the stationary phase of growth.\n2. One proposed mechanism for adaptive mutagenesis is the activation of stress response pathways, such as the DNA damage response and the SOS response, during the stationary phase of growth.\n3. The activation of these pathways can induce the expression of genes that promote mutagenesis.\n4. Another suggested mechanism is the accumulation of mutations in key genes involved in DNA repair and replication in the stationary phase of growth.\n5. A decrease in bacterial division during the stationary phase of growth may lead to an increase in the rate of mutations due to more likely DNA replication errors.",
    "vicuna-13b_fact": [
      "Adaptive mutagenesis is a phenomenon observed in Bacillus subtilis where the rate of spontaneous mutations increases during the stationary phase of growth.",
      "One proposed mechanism for adaptive mutagenesis is the activation of stress response pathways, such as the DNA damage response and the SOS response, during the stationary phase of growth.",
      "The activation of these pathways can induce the expression of genes that promote mutagenesis.",
      "Another suggested mechanism is the accumulation of mutations in key genes involved in DNA repair and replication in the stationary phase of growth.",
      "A decrease in bacterial division during the stationary phase of growth may lead to an increase in the rate of mutations due to more likely DNA replication errors."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: A decrease in bacterial division during the stationary phase of growth may lead to a decrease in the rate of mutations due to less frequent DNA replication.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "vicuna-13b_response": "Erucism is a term that refers to the phenomenon of feeling an itching or tickling sensation on the skin, often in response to an external stimulus such as the presence of an insect or a piece of lint on the skin. There are several possible causes of erucism:\n1. Insect bites or stings: Insects such as mosquitoes, ticks, and bed bugs can cause an itchy sensation on the skin when they bite or sting the person.\n2. Contact dermatitis: This is a type of skin irritation that occurs when the skin comes into contact with an irritant, such as a chemical or an allergen. The itching sensation that occurs with contact dermatitis is often accompanied by redness, swelling, and blisters.\n3. Dry skin: When the skin becomes dry, it can become itchy and flaky. This can be caused by a lack of moisture in the air, or by using harsh soaps or detergents on the skin.\n4. Allergies: Some people are allergic to certain substances, such as pollen or animal dander, which can cause an itchy rash on the skin.\n5. Psychological factors: In some cases, the itching sensation on the skin can be caused by psychological factors such as stress, anxiety, or obsessive-compulsive disorder (OCD).\nOverall, erucism can be caused by a variety of factors, and the specific cause will depend on the individual case. If you are experiencing persistent or severe itching, it is important to speak with a healthcare provider to determine the underlying cause and to receive appropriate treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Erucism refers to the phenomenon of feeling an itching or tickling sensation on the skin.\n2. Insect bites or stings can cause an itchy sensation on the skin.\n3. Contact dermatitis, a skin irritation caused by contact with an irritant, can cause erucism.\n4. Dry skin, often due to a lack of moisture in the air or using harsh soaps or detergents, can result in itching and flakiness.\n5. Allergies to substances like pollen or animal dander might cause an itchy rash on the skin.\n6. In some cases, psychological factors like stress, anxiety, or obsessive-compulsive disorder can cause the itching sensation associated with erucism.",
    "vicuna-13b_fact": [
      "Erucism refers to the phenomenon of feeling an itching or tickling sensation on the skin.",
      "Insect bites or stings can cause an itchy sensation on the skin.",
      "Contact dermatitis, a skin irritation caused by contact with an irritant, can cause erucism.",
      "Dry skin, often due to a lack of moisture in the air or using harsh soaps or detergents, can result in itching and flakiness.",
      "Allergies to substances like pollen or animal dander might cause an itchy rash on the skin.",
      "In some cases, psychological factors like stress, anxiety, or obsessive-compulsive disorder can cause the itching sensation associated with erucism."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Erucism refers to a type of contact dermatitis caused by the stinging hairs or bristles of caterpillars or moth larvae.\n2. TRUE\n3. FALSE [correction]: Contact dermatitis, a skin irritation caused by contact with an irritant, can cause itchiness but it is not called erucism.\n4. TRUE\n5. TRUE\n6. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "vicuna-13b_response": "Hydrochlorothiazide is a diuretic medication that is primarily used to treat hypertension (high blood pressure) and edema (swelling). It is also sometimes used in combination with other medications to treat diabetes insipidus, a condition in which the body produces too much urine and has an excessive thirst. Hydrochlorothiazide works by increasing the excretion of sodium and chloride ions in the urine, which in turn helps to lower blood pressure and reduce edema. It is usually taken orally, and the dosage and duration of treatment will depend on the individual patient's condition and response to the medication.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hydrochlorothiazide is a diuretic medication.\n2. Hydrochlorothiazide is primarily used to treat hypertension and edema.\n3. This medication can sometimes be used to treat diabetes insipidus.\n4. Hydrochlorothiazide works by increasing the excretion of sodium and chloride ions in the urine.\n5. Hydrochlorothiazide is usually taken orally.",
    "vicuna-13b_fact": [
      "Hydrochlorothiazide is a diuretic medication.",
      "Hydrochlorothiazide is primarily used to treat hypertension and edema.",
      "This medication can sometimes be used to treat diabetes insipidus.",
      "Hydrochlorothiazide works by increasing the excretion of sodium and chloride ions in the urine.",
      "Hydrochlorothiazide is usually taken orally."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "vicuna-13b_response": "Yes, silicone has been used in the treatment of incontinence. Incontinence is the loss of bladder or bowel control, which can be caused by a variety of factors such as aging, childbirth, surgery, or neurological conditions.\nSilicone is a material that is commonly used in medical devices, including those used for incontinence treatment. One type of device that uses silicone is the silicone urethral sling, which is a surgical procedure used to treat stress urinary incontinence in women. In this procedure, a strip of silicone is placed under the urethra to help support it and prevent leakage of urine.\nSilicone is also used in other types of incontinence devices, such as pads and liners, which are designed to absorb urine or feces and prevent skin irritation or rashes. These devices can be worn internally or externally, depending on the type of incontinence and the individual's needs.\nIt's important to note that not all incontinence treatments involve the use of silicone, and the effectiveness of silicone-based treatments may vary depending on the individual's specific condition and needs. If you are experiencing incontinence, it's important to speak with a healthcare provider to determine the best treatment options for you.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Silicone has been used in the treatment of incontinence.\n2. Incontinence is the loss of bladder or bowel control.\n3. A silicone urethral sling is a surgical procedure used to treat stress urinary incontinence in women.\n4. Silicone is used in incontinence devices, such as pads and liners, designed to absorb urine or feces and prevent skin irritation or rashes.\n5. Not all incontinence treatments involve the use of silicone, and the effectiveness of silicone-based treatments may vary depending on the individual's specific condition and needs.",
    "vicuna-13b_fact": [
      "Silicone has been used in the treatment of incontinence.",
      "Incontinence is the loss of bladder or bowel control.",
      "A silicone urethral sling is a surgical procedure used to treat stress urinary incontinence in women.",
      "Silicone is used in incontinence devices, such as pads and liners, designed to absorb urine or feces and prevent skin irritation or rashes.",
      "Not all incontinence treatments involve the use of silicone, and the effectiveness of silicone-based treatments may vary depending on the individual's specific condition and needs."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Some incontinence devices, such as pads and liners, are often made of absorbent materials such as cotton or synthetic fibers, not silicone, to absorb urine or feces and prevent skin irritation or rashes.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "vicuna-13b_response": "There is some evidence to suggest that there may be an association between the moon cycle and the rupture risk of intracranial aneurysms. Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain. They can rupture and cause bleeding into the brain, which can be life-threatening.\nSeveral studies have suggested that there may be a correlation between the moon cycle and the risk of intracranial aneurysm rupture. One study published in the journal Neurosurgery found that there was a significant increase in the number of ruptured aneurysms admitted to the hospital on days corresponding to full moon and new moon phases, compared to other days of the month. Another study published in the journal Stroke found that the risk of ruptured aneurysm was higher on full moon days compared to other days.\nThe exact mechanism by which the moon cycle may affect the rupture risk of intracranial aneurysms is not well understood. Some researchers have suggested that the increased gravitational force of the full moon may contribute to the increased risk of rupture. However, more research is needed to confirm these findings and to determine the underlying mechanisms involved.\nIt is important to note that the association between the moon cycle and intracranial aneurysm rupture risk is still a topic of debate and further research is needed to fully understand this potential relationship.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain.\n2. A ruptured intracranial aneurysm can lead to bleeding into the brain, which can be life-threatening.\n3. A study published in the journal Neurosurgery found a significant increase in the number of ruptured aneurysms admitted to the hospital on full moon and new moon days compared to other days of the month.\n4. Another study in the journal Stroke found the risk of ruptured aneurysm was higher on full moon days.\n5. The relationship between the moon cycle and intracranial aneurysm rupture risk is a topic of debate and further research is needed for clarification.",
    "vicuna-13b_fact": [
      "Intracranial aneurysms are abnormal, weakened areas in the blood vessels that supply blood to the brain.",
      "A ruptured intracranial aneurysm can lead to bleeding into the brain, which can be life-threatening.",
      "A study published in the journal Neurosurgery found a significant increase in the number of ruptured aneurysms admitted to the hospital on full moon and new moon days compared to other days of the month.",
      "Another study in the journal Stroke found the risk of ruptured aneurysm was higher on full moon days.",
      "The relationship between the moon cycle and intracranial aneurysm rupture risk is a topic of debate and further research is needed for clarification."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "vicuna-13b_response": "Yes, the HuR protein is known to regulate the splicing process in cells. Splicing is a process by which the introns (non-coding sequences) are removed from the messenger RNA (mRNA) molecule, resulting in a mature mRNA that can be translated into a protein. The HuR protein is a RNA-binding protein that binds to the untranslated regions of mRNA molecules and regulates their stability and translation.\nHuR has been shown to play a role in the regulation of alternative splicing, a process by which different versions of a gene can be expressed in different cells or under different conditions. HuR can either enhance or repress the inclusion of specific exons in the mRNA molecule, depending on the cellular context and the stage of the cell cycle.\nOverall, the regulation of splicing by the HuR protein is important for proper gene expression and cellular function, and dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. HuR protein regulates the splicing process in cells.\n2. Splicing is a process by which the introns are removed from the mRNA molecule, resulting in a mature mRNA that can be translated into a protein.\n3. HuR protein is a RNA-binding protein that binds to the untranslated regions of mRNA molecules and regulates their stability and translation.\n4. HuR protein plays a role in the regulation of alternative splicing, a process by which different versions of a gene can be expressed in different cells or under different conditions.\n5. Dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders.",
    "vicuna-13b_fact": [
      "HuR protein regulates the splicing process in cells.",
      "Splicing is a process by which the introns are removed from the mRNA molecule, resulting in a mature mRNA that can be translated into a protein.",
      "HuR protein is a RNA-binding protein that binds to the untranslated regions of mRNA molecules and regulates their stability and translation.",
      "HuR protein plays a role in the regulation of alternative splicing, a process by which different versions of a gene can be expressed in different cells or under different conditions.",
      "Dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: HuR protein does not regulate the splicing process in cells. It is involved in the regulation of mRNA stability and translation. \n2. TRUE\n3. TRUE\n4. FALSE [correction]: HuR protein does not play a role in the regulation of alternative splicing, it regulates the stability and translation of mRNA. \n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "vicuna-13b_response": "Prothymosin alpha is a protein that is expressed in many tissues, including the brain, and has been shown to have a variety of functions. One of the known functions of the prothymosin alpha c-terminal peptide is its ability to regulate the activity of certain ion channels, including the NMDA receptor. The NMDA receptor is a type of ion channel that is involved in the transmission of signals between neurons and plays a role in the development and maintenance of synapses, the connections between neurons.\nThe prothymosin alpha c-terminal peptide has been shown to modulate the activity of the NMDA receptor by interacting with a specific region of the receptor called the GluN2B subunit. This interaction can either enhance or inhibit the activity of the NMDA receptor, depending on the specific context in which it occurs.\nIn addition to its effects on ion channels, the prothymosin alpha c-terminal peptide has also been shown to have effects on the activity of certain neurotransmitter receptors, including the dopamine D2 receptor. The prothymosin alpha c-terminal peptide can bind to the D2 receptor and modulate its activity, leading to changes in the levels of dopamine in the brain and potentially affecting mood and behavior.\nOverall, the prothymosin alpha c-terminal peptide plays an important role in the regulation of various aspects of brain function, including the activity of ion channels and neurotransmitter receptors. Further research is needed to fully understand the mechanisms by which the prothymosin alpha c-terminal peptide exerts its effects and to determine its potential as a therapeutic target for a variety of neurological disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Prothymosin alpha is a protein expressed in many tissues, including the brain.\n2. The prothymosin alpha c-terminal peptide has the ability to regulate the activity of certain ion channels, such as the NMDA receptor.\n3. The NMDA receptor is involved in the transmission of signals between neurons and plays a role in the development and maintenance of synapses.\n4. Prothymosin alpha c-terminal peptide has shown to modulate the activity of the dopamine D2 receptor.\n5. The modulation of the dopamine D2 receptor by the prothymosin alpha c-terminal peptide can lead to changes in the levels of dopamine in the brain and could potentially affect mood and behavior.",
    "vicuna-13b_fact": [
      "Prothymosin alpha is a protein expressed in many tissues, including the brain.",
      "The prothymosin alpha c-terminal peptide has the ability to regulate the activity of certain ion channels, such as the NMDA receptor.",
      "The NMDA receptor is involved in the transmission of signals between neurons and plays a role in the development and maintenance of synapses.",
      "Prothymosin alpha c-terminal peptide has shown to modulate the activity of the dopamine D2 receptor.",
      "The modulation of the dopamine D2 receptor by the prothymosin alpha c-terminal peptide can lead to changes in the levels of dopamine in the brain and could potentially affect mood and behavior."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "vicuna-13b_response": "Cystatin C is a protein that is involved in regulating the activity of other proteins, known as cysteine proteases. It is a potent inhibitor of a variety of proteases, including the papain-like cysteine proteases, such as cathepsin B, C, and L, and the chymotrypsin-like cysteine proteases, such as elastase and plasmin. Cystatin C is a key player in the regulation of proteolytic activity in various physiological and pathological processes, including inflammation, fibrosis, and cancer.\nIn terms of its role in human cystatin C fibrillization, it is important to note that cystatin C is a large, hydrophilic protein that is composed of three identical chains of 110 amino acids. It has a unique, highly conserved structure that includes a tightly folded core region and a more flexible, disordered C-terminal tail. This structure is thought to play a key role in the aggregation of cystatin C into amyloid fibrils, which is a hallmark of a number of protein misfolding diseases, including Alzheimer's disease, Parkinson's disease, and prion diseases.\nSeveral studies have suggested that the C-terminal tail of cystatin C is particularly important in the formation of amyloid fibrils. For example, mutations in the C-terminal tail of cystatin C have been shown to increase its propensity to form amyloid fibrils, and to enhance its aggregation behavior in vitro. Additionally, the C-terminal tail of cystatin C has been shown to interact with the core region of the protein, and to play a key role in the formation of stable, cross-beta structure in amyloid fibrils.\nOverall, while there are several peptides that play a role in human cystatin C fibrillization, the C-terminal tail of the protein is thought to be particularly important in this process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cystatin C is a protein that regulates the activity of other proteins, known as cysteine proteases.\n2. Cystatin C is composed of three identical chains of 110 amino acids.\n3. Cystatin C has a unique, highly conserved structure that includes a tightly folded core region and a more flexible, disordered C-terminal tail.\n4. Aggregation of cystatin C into amyloid fibrils is a hallmark of a number of protein misfolding diseases, including Alzheimer's disease, Parkinson's disease, and prion diseases.\n5. The C-terminal tail of cystatin C is thought to play a particularly important role in the formation of amyloid fibrils.",
    "vicuna-13b_fact": [
      "Cystatin C is a protein that regulates the activity of other proteins, known as cysteine proteases.",
      "Cystatin C is composed of three identical chains of 110 amino acids.",
      "Cystatin C has a unique, highly conserved structure that includes a tightly folded core region and a more flexible, disordered C-terminal tail.",
      "Aggregation of cystatin C into amyloid fibrils is a hallmark of a number of protein misfolding diseases, including Alzheimer's disease, Parkinson's disease, and prion diseases.",
      "The C-terminal tail of cystatin C is thought to play a particularly important role in the formation of amyloid fibrils."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Cystatin C is composed of a single chain of 120 amino acids.\n3. TRUE\n4. FALSE [correction]: Aggregation of cystatin C into amyloid fibrils is a hallmark of a disease called hereditary cystatin C amyloid angiopathy.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "vicuna-13b_response": "Yes, the concentration of protein HIF-1α has been shown to increase after the administration of the cytoprotective prodrug \"amifostine\" (ethyol). Amifostine is a cytoprotective agent that has been used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation. It is also being studied for its potential to protect against ischemia-reperfusion injury, which is a type of tissue damage that can occur when blood flow is restored to an area after a period of ischemia (reduced blood flow).\nOne of the mechanisms by which amifostine exerts its cytoprotective effects is through the activation of the hypoxia-inducible factor (HIF) signaling pathway. HIF is a transcription factor that regulates the expression of genes that help cells to adapt to low oxygen levels. Amifostine has been shown to increase the expression and activity of HIF-1α, a subunit of HIF, in cells. This increase in HIF-1α activity can lead to the expression of genes that promote cell survival and protect against oxidative stress and inflammation.\nIn conclusion, the administration of amifostine has been shown to increase the concentration of protein HIF-1α, which plays a crucial role in the cytoprotective effects of the drug.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The concentration of protein HIF-1α increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).\n2. Amifostine is a cytoprotective agent used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation.\n3. Amifostine is also being studied for its potential to protect against ischemia-reperfusion injury.\n4. Amifostine increases the expression and activity of HIF-1α, a subunit of the hypoxia-inducible factor (HIF).\n5. Increase in HIF-1α activity can lead to the expression of genes that promote cell survival and protect against oxidative stress and inflammation.",
    "vicuna-13b_fact": [
      "The concentration of protein HIF-1α increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).",
      "Amifostine is a cytoprotective agent used in cancer treatment to protect normal cells from the toxic effects of chemotherapy and radiation.",
      "Amifostine is also being studied for its potential to protect against ischemia-reperfusion injury.",
      "Amifostine increases the expression and activity of HIF-1α, a subunit of the hypoxia-inducible factor (HIF).",
      "Increase in HIF-1α activity can lead to the expression of genes that promote cell survival and protect against oxidative stress and inflammation."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "vicuna-13b_response": "Set7 is a histone methyltransferase enzyme that deposits methyl groups on histone H3 at position K4, also known as H3K4me. This modification is often referred to as \"Set7 modification\" or \"H3K4me1\". Set7 is involved in various cellular processes, including transcriptional regulation, DNA repair, and chromosome segregation. The Set7 enzyme is recruited to specific target genes through interactions with other proteins, such as the transcription factor YY1, and is thought to play a role in the regulation of gene expression. In addition to H3K4me, Set7 has also been shown to deposit methyl groups on histone H4 at position K16, also known as H4K16me, although this is less well characterized.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Set7 is a histone methyltransferase enzyme.\n2. Set7 deposits methyl groups on histone H3 at position K4.\n3. The modification by Set7 on H3K4 is often referred to as \"Set7 modification\" or \"H3K4me1\".\n4. Set7 is involved in various cellular processes, including transcriptional regulation, DNA repair, and chromosome segregation.\n5. Set7 has been shown to deposit methyl groups on histone H4 at position K16, also known as H4K16me.",
    "vicuna-13b_fact": [
      "Set7 is a histone methyltransferase enzyme.",
      "Set7 deposits methyl groups on histone H3 at position K4.",
      "The modification by Set7 on H3K4 is often referred to as \"Set7 modification\" or \"H3K4me1\".",
      "Set7 is involved in various cellular processes, including transcriptional regulation, DNA repair, and chromosome segregation.",
      "Set7 has been shown to deposit methyl groups on histone H4 at position K16, also known as H4K16me."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Set7 does not deposit methyl groups on histone H4 at position K16, it acts on histone H3.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "vicuna-13b_response": "Hepcidin is a small peptide hormone that plays a crucial role in regulating iron homeostasis in the body. It has a total of four disulfide bridges, which are essential for its stability and function. These disulfide bridges are formed between the following pairs of cysteine residues: Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6. The presence of these disulfide bridges is necessary for hepcidin to bind to its receptor, ferroportin, and inhibit iron uptake in cells. Mutations in the disulfide bridges of hepcidin can lead to defects in iron regulation and can result in iron overload disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Hepcidin is a small peptide hormone that plays a crucial role in regulating iron homeostasis in the body.\n2. Hepcidin has a total of four disulfide bridges.\n3. These disulfide bridges in Hepcidin are formed between the following pairs of cysteine residues: Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6.\n4. The presence of these disulfide bridges is necessary for hepcidin to bind to its receptor, ferroportin, and inhibit iron uptake in cells.\n5. Mutations in the disulfide bridges of hepcidin can lead to defects in iron regulation and can result in iron overload disorders.",
    "vicuna-13b_fact": [
      "Hepcidin is a small peptide hormone that plays a crucial role in regulating iron homeostasis in the body.",
      "Hepcidin has a total of four disulfide bridges.",
      "These disulfide bridges in Hepcidin are formed between the following pairs of cysteine residues: Cys1-Cys3, Cys2-Cys4, Cys1-Cys5, and Cys3-Cys6.",
      "The presence of these disulfide bridges is necessary for hepcidin to bind to its receptor, ferroportin, and inhibit iron uptake in cells.",
      "Mutations in the disulfide bridges of hepcidin can lead to defects in iron regulation and can result in iron overload disorders."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hepcidin has a total of eight cysteines forming four disulfide bridges.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "vicuna-13b_response": "Localization of a protein refers to its distribution and location within a cell or organism. The localization of a protein can be crucial for its function, as it determines where the protein can interact with other molecules and carry out its intended role.\nThe localization of the protein encoded by the gene DNAJC11 has not been extensively studied, and there is limited information available on this topic. However, based on the function of similar proteins, it is possible that DNAJC11 may be localized to the cytoplasm or endoplasmic reticulum (ER).\nDNAJC11 is a member of the heat shock protein (HSP) family, which are proteins that play a role in protein folding and transport. HSPs are known to be localized to the cytoplasm and ER, where they assist in the proper folding and transport of proteins. It is therefore possible that DNAJC11 is also localized to these areas.\nHowever, further research is needed to confirm the localization of DNAJC11 and to understand its specific function in the cell.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Localization of a protein refers to its distribution and location within a cell or organism.\n2. The localization of the protein can be crucial for its function.\n3. The protein encoded by the gene DNAJC11 is a member of the heat shock protein (HSP) family.\n4. HSPs play a role in protein folding and transport.\n5. HSPs are known to be localized to the cytoplasm and ER.",
    "vicuna-13b_fact": [
      "Localization of a protein refers to its distribution and location within a cell or organism.",
      "The localization of the protein can be crucial for its function.",
      "The protein encoded by the gene DNAJC11 is a member of the heat shock protein (HSP) family.",
      "HSPs play a role in protein folding and transport.",
      "HSPs are known to be localized to the cytoplasm and ER."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "vicuna-13b_response": "Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species and are thought to play important roles in maintaining genome stability and function. Copy number variants (CNVs) are DNA alterations that involve changes in the number of copies of a particular gene or genomic region.\nSeveral studies have reported that UCEs are depleted among CNVs. For example, a study published in the journal Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs, compared to non-CNV regions. This suggests that UCEs may be more susceptible to disruption by CNVs, which could have important implications for genome stability and function.\nAnother study published in the journal Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions that are associated with disease, such as those involved in cancer. This suggests that UCEs may play important roles in the development and progression of disease, and that disruptions to UCEs may contribute to disease pathology.\nOverall, while the evidence is not conclusive, there is some suggestion that UCEs may be depleted among CNVs, and that this could have important implications for genome stability and function, as well as disease pathology. Further research is needed to fully understand the relationship between UCEs and CNVs, and to determine the functional and clinical significance of these DNA alterations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species.\n2. Copy number variants (CNVs) are DNA alterations that involve changes in the number of copies of a particular gene or genomic region.\n3. A study published in the journal Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs.\n4. A study published in the journal Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions that are associated with disease.\n5. The alteration of UCEs may be associated with the development and progression of diseases, such as cancer.",
    "vicuna-13b_fact": [
      "Ultraconserved elements (UCEs) are DNA sequences that are highly conserved across multiple species.",
      "Copy number variants (CNVs) are DNA alterations that involve changes in the number of copies of a particular gene or genomic region.",
      "A study published in the journal Nature Genetics in 2011 found that UCEs are significantly underrepresented in regions with CNVs.",
      "A study published in the journal Genome Research in 2012 found that UCEs are more likely to be affected by CNVs in regions that are associated with disease.",
      "The alteration of UCEs may be associated with the development and progression of diseases, such as cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "vicuna-13b_response": "The Haspin kinase is a protein that plays a role in regulating the progression of mitosis, which is the process by which a cell divides into two daughter cells. The substrate of the Haspin kinase during mitosis is not yet clear, as it is still an area of active research. However, it is known that the Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C), which is a complex that plays a critical role in the progression of mitosis by promoting the degradation of proteins that are necessary for the progression of the cell cycle.\nIt is thought that the Haspin kinase may act as a regulator of the APC/C, either by activating it or by inhibiting its activity. The Haspin kinase may also play a role in the regulation of other proteins that are involved in the progression of mitosis, such as the polo-like kinase 1 (PLK1).\nOverall, the substrate of the Haspin kinase during mitosis is still not well understood, but it is clear that this protein plays a critical role in the regulation of the progression of mitosis. Further research is needed to fully understand the role of the Haspin kinase in this process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Haspin kinase is a protein that plays a role in regulating the progression of mitosis.\n2. The substrate of the Haspin kinase during mitosis is still an area of active research.\n3. The Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C).\n4. The APC/C plays a critical role in the progression of mitosis by promoting the degradation of proteins.\n5. The Haspin kinase may also regulate other proteins that are involved in the progression of mitosis, such as the polo-like kinase 1 (PLK1).",
    "vicuna-13b_fact": [
      "The Haspin kinase is a protein that plays a role in regulating the progression of mitosis.",
      "The substrate of the Haspin kinase during mitosis is still an area of active research.",
      "The Haspin kinase is involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C).",
      "The APC/C plays a critical role in the progression of mitosis by promoting the degradation of proteins.",
      "The Haspin kinase may also regulate other proteins that are involved in the progression of mitosis, such as the polo-like kinase 1 (PLK1)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Haspin kinase is not typically involved in the regulation of the anaphase-promoting complex/cyclosome (APC/C). It is involved in the regulation of histone H3 phosphorylation.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "vicuna-13b_response": "Viroids are non-cellular, single-stranded RNA viruses that replicate through a rolling-circle mechanism. This mechanism involves the annealing of complementary strands of RNA, followed by the synthesis of a new strand by a viral RNA-dependent RNA polymerase. The new strand is then used as a template for the synthesis of more virus particles. The rolling-circle mechanism allows for the efficient replication of viroids, as it does not require the synthesis of a new strand of DNA or RNA, and it allows for the production of multiple copies of the virus in a short amount of time.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Viroids are non-cellular, single-stranded RNA viruses.\n2. Viroids replicate through a rolling-circle mechanism.\n3. The rolling-circle mechanism of replication involves the annealing of complementary strands of RNA.\n4. In the rolling-circle mechanism, a new strand is synthesized by a viral RNA-dependent RNA polymerase.\n5. The rolling-circle mechanism allows for the efficient replication of viroids and does not require the synthesis of a new strand of DNA or RNA.",
    "vicuna-13b_fact": [
      "Viroids are non-cellular, single-stranded RNA viruses.",
      "Viroids replicate through a rolling-circle mechanism.",
      "The rolling-circle mechanism of replication involves the annealing of complementary strands of RNA.",
      "In the rolling-circle mechanism, a new strand is synthesized by a viral RNA-dependent RNA polymerase.",
      "The rolling-circle mechanism allows for the efficient replication of viroids and does not require the synthesis of a new strand of DNA or RNA."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Viroids are non-cellular, single-stranded RNA molecules, not viruses.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In the rolling-circle mechanism, a new strand is synthesized by a host RNA-dependent RNA polymerase, not a viral one. \n5. FALSE [correction]: The rolling-circle mechanism allows for the efficient replication of viroids and does require the synthesis of a new strand of RNA.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "vicuna-13b_response": "Fibronectin is a protein that is involved in a variety of biological processes, including cell adhesion and migration. In the context of Duchenne muscular dystrophy (DMD), fibronectin has been studied as a potential biomarker for the disease.\nDMD is a genetic disorder that affects muscle function and results from mutations in the dystrophin gene. Dystrophin is a protein that is important for maintaining the integrity of muscle cells and protecting them from damage. In DMD, the lack of dystrophin leads to progressive muscle degeneration and weakness.\nFibronectin has been found to be elevated in the blood of individuals with DMD, and this has led to its consideration as a potential biomarker for the disease. However, the exact relationship between fibronectin levels and the severity of DMD is not well understood, and more research is needed to determine the utility of fibronectin as a diagnostic biomarker for the disease.\nIn summary, while fibronectin has been studied as a potential biomarker for DMD, its utility as a diagnostic tool is still being evaluated and more research is needed to fully understand its role in the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Fibronectin is a protein that is involved in cell adhesion and migration.\n2. Duchenne muscular dystrophy (DMD) is a genetic disorder that affects muscle function and results from mutations in the dystrophin gene.\n3. Dystrophin is a protein that is important for maintaining the integrity of muscle cells and protecting them from damage.\n4. Fibronectin has been found to be elevated in the blood of individuals with DMD.\n5. The relationship between fibronectin levels and the severity of DMD is not well understood.",
    "vicuna-13b_fact": [
      "Fibronectin is a protein that is involved in cell adhesion and migration.",
      "Duchenne muscular dystrophy (DMD) is a genetic disorder that affects muscle function and results from mutations in the dystrophin gene.",
      "Dystrophin is a protein that is important for maintaining the integrity of muscle cells and protecting them from damage.",
      "Fibronectin has been found to be elevated in the blood of individuals with DMD.",
      "The relationship between fibronectin levels and the severity of DMD is not well understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "vicuna-13b_response": "The DeepBlue epigenomic data server is a comprehensive database of epigenomic data from a variety of organisms and experimental conditions. Some of the major epigenome projects that are contained in the DeepBlue database include:\n1. The Roadmap Epigenomics Project: This project is a comprehensive study of the epigenomes of over 100 different cell types from human, mouse, and rat. The data is available for browsing and download on the DeepBlue website.\n2. The ENCODE Project: This project is a large-scale effort to characterize the functional elements in the human genome, including the epigenome. The data from the ENCODE project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\n3. The Epigenome Atlas Project: This project is a collaborative effort to generate and analyze epigenomic data from a variety of organisms, including human, mouse, and fruit fly. The data from the Epigenome Atlas Project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\n4. The Single Cell Epigenomics Project: This project is a comprehensive study of the epigenomes of individual cells, including both normal and disease cells. The data from the Single Cell Epigenomics Project is available on the DeepBlue website, and includes information on chromatin accessibility, DNA methylation, and histone modifications.\nThese are just a few examples of the major epigenome projects that are contained in the DeepBlue epigenomic data server. The database is constantly being updated with new data, so it is a valuable resource for researchers in the field of epigenetics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics Project.\n2. Data from the ENCODE Project is available on the DeepBlue website.\n3. The Epigenome Atlas Project data, which includes a variety of organisms, is contained in the DeepBlue database.\n4. The DeepBlue database includes data from the Single Cell Epigenomics Project.\n5. The DeepBlue epigenomic data server is constantly being updated with new data.",
    "vicuna-13b_fact": [
      "The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics Project.",
      "Data from the ENCODE Project is available on the DeepBlue website.",
      "The Epigenome Atlas Project data, which includes a variety of organisms, is contained in the DeepBlue database.",
      "The DeepBlue database includes data from the Single Cell Epigenomics Project.",
      "The DeepBlue epigenomic data server is constantly being updated with new data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Epigenome Atlas Project data, which includes a variety of human tissues, is contained in the DeepBlue database.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "vicuna-13b_response": "A self-organizing map (SOM) is a type of neural network that can be used to map high-dimensional input data to a lower-dimensional representation. In the context of analyzing codon usage in molecular biology, SOMs can be used to identify groups of codons that are functionally equivalent, despite differences in their nucleotide sequence. This can be useful for understanding how cells translate genetic information into proteins, and for identifying potential targets for genetic engineering and synthetic biology applications. Some tools that employ SOMs for analyzing synonymous codon usage include the CodonUsage tool, which is part of the Bioinformatics Toolbox in MATLAB, and the CodonW tool, which is a standalone software package for analyzing codon usage in protein-coding genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Self-organizing map (SOM) is a type of neural network used to map high-dimensional input data to a lower-dimensional representation.\n2. Self-organizing maps can be used to analyze codon usage in molecular biology.\n3. SOMs assist in identifying groups of codons that are functionally equivalent, despite differences in their nucleotide sequences.\n4. The CodonUsage tool, part of the Bioinformatics Toolbox in MATLAB, employs self-organizing maps for analyzing synonymous codon usage.\n5. The CodonW tool, a standalone software package, employs self-organizing maps for analyzing codon usage in protein-coding genes.",
    "vicuna-13b_fact": [
      "Self-organizing map (SOM) is a type of neural network used to map high-dimensional input data to a lower-dimensional representation.",
      "Self-organizing maps can be used to analyze codon usage in molecular biology.",
      "SOMs assist in identifying groups of codons that are functionally equivalent, despite differences in their nucleotide sequences.",
      "The CodonUsage tool, part of the Bioinformatics Toolbox in MATLAB, employs self-organizing maps for analyzing synonymous codon usage.",
      "The CodonW tool, a standalone software package, employs self-organizing maps for analyzing codon usage in protein-coding genes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "vicuna-13b_response": "MINDY-1 is a type of neural network architecture that is designed for natural language processing tasks. It stands for Multi-layer Intent Detection and You-detection, and it is a deep learning model that is capable of understanding the intent behind a given text and identifying the person who wrote it.\nThe MINDY-1 architecture is composed of several layers, including a convolutional layer, a bidirectional layer, and a fully connected layer. The convolutional layer is used to extract features from the input text, while the bidirectional layer is used to capture the context and dependencies between words. The fully connected layer is responsible for making predictions about the intent and author of the text.\nThe MINDY-1 model was trained on a large dataset of text samples and is capable of accurately identifying the intent and author of new, unseen text. It has been used for a variety of natural language processing tasks, including sentiment analysis, named entity recognition, and text classification.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MINDY-1 is a type of neural network architecture.\n2. MINDY-1 is designed for natural language processing tasks.\n3. The MINDY-1 architecture is composed of several layers, including a convolutional layer, a bidirectional layer, and a fully connected layer. \n4. MINDY-1 was trained on a large dataset of text samples.\n5. MINDY-1 has been used for a variety of natural language processing tasks, including sentiment analysis, named entity recognition, and text classification.",
    "vicuna-13b_fact": [
      "MINDY-1 is a type of neural network architecture.",
      "MINDY-1 is designed for natural language processing tasks.",
      "The MINDY-1 architecture is composed of several layers, including a convolutional layer, a bidirectional layer, and a fully connected layer.",
      "MINDY-1 was trained on a large dataset of text samples.",
      "MINDY-1 has been used for a variety of natural language processing tasks, including sentiment analysis, named entity recognition, and text classification."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "vicuna-13b_response": "There are several software packages available for the analysis of conserved genomic loci. Some of the popular ones are:\n1. Conserved Elements in Regulatory Networks (CERN): It is a web-based tool that identifies conserved non-coding elements (CNEs) in the genomic regions surrounding a gene of interest. It can also predict the potential regulatory functions of these CNEs based on their evolutionary conservation and functional annotations.\n2. PhyloBayes: It is a software package that can be used to identify conserved genomic regions based on their evolutionary history. It uses Bayesian methods to infer the evolutionary history of multiple genomes and identifies regions that are conserved across different species.\n3. Genomic Regions Enriched in Annotation (GREAT): It is a web-based tool that can be used to identify genomic regions that are enriched in functional annotations, such as transcription factor binding sites or regulatory motifs. It can also identify conserved regions based on their evolutionary conservation.\n4. Regulatory Genomic Units (RGUs): It is a software package that can be used to identify regulatory elements in the genome, including enhancers, promoters, and silencers. It can also identify conserved RGUs across different species.\n5. Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST): It is a software package that can be used to identify functional elements in the genome based on their evolutionary conservation. It can identify conserved regions, regulatory motifs, and other functional elements.\nThese are just a few examples of the software packages available for the analysis of conserved genomic loci. The choice of software depends on the specific research question and the type of data being analyzed.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Conserved Elements in Regulatory Networks (CERN) is a software that identifies conserved non-coding elements in the genomic regions surrounding a gene of interest.\n2. PhyloBayes is a software package used to identify conserved genomic regions based on evolutionary history using Bayesian methods.\n3. Genomic Regions Enriched in Annotation (GREAT) is a web-based tool used to identify genomic regions that are enriched in functional annotations.\n4. Regulatory Genomic Units (RGUs) is a software package that identifies regulatory elements in the genome, including enhancers, promoters, and silencers.\n5. Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST) is used to identify functional elements in the genome based on their evolutionary conservation.",
    "vicuna-13b_fact": [
      "Conserved Elements in Regulatory Networks (CERN) is a software that identifies conserved non-coding elements in the genomic regions surrounding a gene of interest.",
      "PhyloBayes is a software package used to identify conserved genomic regions based on evolutionary history using Bayesian methods.",
      "Genomic Regions Enriched in Annotation (GREAT) is a web-based tool used to identify genomic regions that are enriched in functional annotations.",
      "Regulatory Genomic Units (RGUs) is a software package that identifies regulatory elements in the genome, including enhancers, promoters, and silencers.",
      "Genome-wide Identification of Functional Elements Using Comparative Genomics (GIFEST) is used to identify functional elements in the genome based on their evolutionary conservation."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "vicuna-13b_response": "PIEZO2 is a gene that is associated with several diseases, including:\n1. Piezo2-related primary ciliary dyskinesia (PKD): PKD is a rare genetic disorder that affects the function of cilia, which are small, hair-like structures that line the airways and help to clear mucus and debris from the lungs. Mutations in the PIEZO2 gene have been identified as a cause of PKD.\n2. Autosomal recessive lymphoedema (ARL): ARL is a genetic disorder that affects the development and function of the lymphatic system, which helps to regulate fluid balance in the body. Mutations in the PIEZO2 gene have been identified as a cause of ARL.\n3. Joubert syndrome: Joubert syndrome is a rare genetic disorder that affects the development of the brain and the cilia. Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The PIEZO2 gene is associated with several diseases including Piezo2-related primary ciliary dyskinesia, autosomal recessive lymphoedema and Joubert syndrome.\n2. Piezo2-related primary ciliary dyskinesia is a rare genetic disorder that affects the function of cilia.\n3. Mutations in the PIEZO2 gene have been identified as a cause of Piezo2-related primary ciliary dyskinesia.\n4. Autosomal recessive lymphoedema is a disorder that affects the development and function of the lymphatic system.\n5. Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome.",
    "vicuna-13b_fact": [
      "The PIEZO2 gene is associated with several diseases including Piezo2-related primary ciliary dyskinesia, autosomal recessive lymphoedema and Joubert syndrome.",
      "Piezo2-related primary ciliary dyskinesia is a rare genetic disorder that affects the function of cilia.",
      "Mutations in the PIEZO2 gene have been identified as a cause of Piezo2-related primary ciliary dyskinesia.",
      "Autosomal recessive lymphoedema is a disorder that affects the development and function of the lymphatic system.",
      "Mutations in the PIEZO2 gene have been identified as a cause of Joubert syndrome."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Primary ciliary dyskinesia is a rare genetic disorder that affects the function of cilia. Piezo2-related is not typically used to describe it.\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "vicuna-13b_response": "ERAP1-ERAP2 dimerization is a process that occurs in the endoplasmic reticulum (ER) of cells. The ER is a network of membranes that is responsible for many cellular functions, including protein synthesis and folding.\nERAP1 and ERAP2 are two proteins that are involved in the transport of proteins from the ER to the Golgi apparatus, which is another organelle responsible for protein processing and packaging. When ERAP1 and ERAP2 dimerize, they form a complex that can bind to and transport certain proteins from the ER to the Golgi apparatus.\nThis process is important for maintaining the proper functioning of the ER and Golgi apparatus, as well as for ensuring that proteins are transported to the correct locations within the cell. Dysfunction in ERAP1-ERAP2 dimerization has been linked to a number of diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ERAP1-ERAP2 dimerization is a process that occurs in the endoplasmic reticulum (ER) of cells.\n2. The ER is responsible for many cellular functions, including protein synthesis and folding.\n3. ERAP1 and ERAP2 are proteins involved in the transport of proteins from the ER to the Golgi apparatus.\n4. ERAP1-ERAP2 dimerization is necessary for the correct transport of proteins within the cell.\n5. Dysfunction in ERAP1-ERAP2 dimerization has been linked to diseases, including neurodegenerative disorders and cancer.",
    "vicuna-13b_fact": [
      "ERAP1-ERAP2 dimerization is a process that occurs in the endoplasmic reticulum (ER) of cells.",
      "The ER is responsible for many cellular functions, including protein synthesis and folding.",
      "ERAP1 and ERAP2 are proteins involved in the transport of proteins from the ER to the Golgi apparatus.",
      "ERAP1-ERAP2 dimerization is necessary for the correct transport of proteins within the cell.",
      "Dysfunction in ERAP1-ERAP2 dimerization has been linked to diseases, including neurodegenerative disorders and cancer."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: ERAP1 and ERAP2 are enzymes involved in the trimming of peptides in the endoplasmic reticulum, not in the transport of proteins from the ER to the Golgi apparatus.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "vicuna-13b_response": "R-spondin 1 and noggin are two proteins that are involved in various cellular processes in the body. In the non-damaged gallbladder, R-spondin 1 and noggin play important roles in the development and function of the gallbladder.\nR-spondin 1 is a protein that is expressed in the gallbladder and other tissues, and it has been shown to play a role in the development of the gallbladder and bile ducts. R-spondin 1 is involved in the regulation of cell proliferation and differentiation, and it has been shown to be important for the normal function of the gallbladder.\nNoggin, on the other hand, is a protein that is involved in the regulation of cellular differentiation and proliferation. In the gallbladder, noggin is involved in the development and function of the epithelial cells that line the gallbladder. Noggin is also involved in the regulation of the activity of other proteins that are important for gallbladder function.\nIn summary, R-spondin 1 and noggin play important roles in the development and function of the gallbladder. They are involved in the regulation of cellular processes, including proliferation, differentiation, and the activity of other proteins that are important for gallbladder function.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. R-spondin 1 and noggin are two proteins involved in various cellular processes in the body.\n2. R-spondin 1 is expressed in the gallbladder and other tissues.\n3. R-spondin 1 plays a role in the development of the gallbladder and bile ducts.\n4. Noggin is a protein that is involved in the regulation of cellular differentiation and proliferation.\n5. Noggin is involved in the development and function of the epithelial cells that line the gallbladder.",
    "vicuna-13b_fact": [
      "R-spondin 1 and noggin are two proteins involved in various cellular processes in the body.",
      "R-spondin 1 is expressed in the gallbladder and other tissues.",
      "R-spondin 1 plays a role in the development of the gallbladder and bile ducts.",
      "Noggin is a protein that is involved in the regulation of cellular differentiation and proliferation.",
      "Noggin is involved in the development and function of the epithelial cells that line the gallbladder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "vicuna-13b_response": "NADPH oxidase 5, also known as NOX5, is a complex enzyme that generates reactive oxygen species (ROS) in response to various stimuli. While NOX5 can function as a homodimer, it also requires the presence of specific subunits for full activity.\nThe NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox. The first three subunits, p22phox, p40phox, and p47phox, are essential for the assembly and function of NOX5. The p22phox subunit contains the flavin adenine dinucleotide (FAD) binding site, while the p40phox and p47phox subunits contribute to the cytochrome b558 domain. The p67phox subunit, also known as RAC2, is not essential for NOX5 function but can modulate its activity.\nMutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction, and some of these mutations have been associated with human diseases such as chronic granulomatous disease (CGD) and age-related macular degeneration (AMD).\nIn summary, while NOX5 can function as a homodimer, it requires the presence of specific subunits for full activity. The p22phox, p40phox, and p47phox subunits are essential for NOX5 assembly and function, while the p67phox subunit can modulate its activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. NADPH oxidase 5, also known as NOX5, generates reactive oxygen species (ROS) in response to various stimuli.\n2. NOX5 can function as a homodimer, but also requires specific subunits for full activity.\n3. The NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox. \n4. Mutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction. \n5. Some mutations in NOX5 subunits have been associated with human diseases such as chronic granulomatous disease (CGD) and age-related macular degeneration (AMD).",
    "vicuna-13b_fact": [
      "NADPH oxidase 5, also known as NOX5, generates reactive oxygen species (ROS) in response to various stimuli.",
      "NOX5 can function as a homodimer, but also requires specific subunits for full activity.",
      "The NOX5 enzyme consists of four subunits: p22phox, p40phox, p47phox, and p67phox.",
      "Mutations in any of the NOX5 subunits can lead to altered enzymatic activity or dysfunction.",
      "Some mutations in NOX5 subunits have been associated with human diseases such as chronic granulomatous disease (CGD) and age-related macular degeneration (AMD)."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: NOX5 does not require specific subunits to function and can function as a monomer.\n3. FALSE [correction]: The NOX5 enzyme does not consist of these subunits. It is the other NOX enzymes (e.g., NOX2) that have these four subunits.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "vicuna-13b_response": "Furin and hepcidin are both proteases, which are enzymes that break down other proteins. Furin is a type of protease that is involved in the processing of many different proteins, including the precursor of hepcidin.\nHepcidin is a small peptide hormone that is involved in regulating iron metabolism in the body. It is produced by the liver and released into the bloodstream, where it binds to and inhibits the activity of the iron transport protein transferrin. This causes the liver to release stored iron into the bloodstream, where it can be used by other tissues.\nThe connection between furin and hepcidin is that furin is involved in the processing of the precursor protein that is converted into hepcidin. Specifically, furin cleaves the precursor protein at a specific site, releasing the mature hepcidin peptide. This processing step is necessary for the proper functioning of hepcidin and its regulation of iron metabolism in the body.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Furin and hepcidin are both proteases.\n2. Furin is involved in the processing of many different proteins, including the precursor of hepcidin.\n3. Hepcidin is a small peptide hormone that regulates iron metabolism in the body.\n4. Hepcidin is produced by the liver and inhibits the activity of the iron transport protein transferrin.\n5. The connection between furin and hepcidin is that furin cleaves the precursor protein at a specific site, releasing the mature hepcidin peptide.",
    "vicuna-13b_fact": [
      "Furin and hepcidin are both proteases.",
      "Furin is involved in the processing of many different proteins, including the precursor of hepcidin.",
      "Hepcidin is a small peptide hormone that regulates iron metabolism in the body.",
      "Hepcidin is produced by the liver and inhibits the activity of the iron transport protein transferrin.",
      "The connection between furin and hepcidin is that furin cleaves the precursor protein at a specific site, releasing the mature hepcidin peptide."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Furin is a protease, but hepcidin is not. Hepcidin is a small peptide hormone that regulates iron metabolism in the body.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Hepcidin is produced by the liver and inhibits the activity of the iron transport protein ferroportin, not transferrin.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "vicuna-13b_response": "The largest metabolic gene cluster in yeast is the glycolytic pathway, which is responsible for the breakdown of glucose into carbon dioxide and ethanol. This pathway involves a series of enzymatic reactions that convert glucose into pyruvate, which is then converted into ethanol and carbon dioxide through the fermentation process. The glycolytic pathway is essential for the survival of yeast, as it provides the energy required for cell growth and reproduction.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The largest metabolic gene cluster in yeast is the glycolytic pathway.\n2. The glycolytic pathway in yeast is responsible for the breakdown of glucose into carbon dioxide and ethanol.\n3. This pathway involves enzymatic reactions that convert glucose into pyruvate, which is then converted into ethanol and carbon dioxide.\n4. The glycolytic pathway is essential for the survival of yeast, providing the energy required for cell growth and reproduction.",
    "vicuna-13b_fact": [
      "The largest metabolic gene cluster in yeast is the glycolytic pathway.",
      "The glycolytic pathway in yeast is responsible for the breakdown of glucose into carbon dioxide and ethanol.",
      "This pathway involves enzymatic reactions that convert glucose into pyruvate, which is then converted into ethanol and carbon dioxide.",
      "The glycolytic pathway is essential for the survival of yeast, providing the energy required for cell growth and reproduction."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "vicuna-13b_response": "Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides in length and does not code for proteins. One example of an lncRNA is called LINC (Liver-Enriched Transcript 1, LncRNA) which is also known as LIMT (Liver-Enriched Motif-Containing).\nThe role of LIMT lncRNA is not yet fully understood, but studies have suggested that it plays an important role in regulating gene expression. LIMT lncRNA is specifically expressed in the liver and other tissues, and it has been shown to interact with microRNAs, which are small non-coding RNAs that play a role in regulating gene expression by binding to messenger RNAs (mRNAs) and preventing their translation into proteins.\nOne study found that LIMT lncRNA can act as a sponge for microRNAs, binding to them and preventing them from binding to their target mRNAs. This suggests that LIMT lncRNA may play a role in regulating the expression of specific genes by controlling the levels of microRNAs.\nAdditionally, LIMT lncRNA has been shown to be involved in the regulation of cell proliferation and differentiation, and it has been suggested that it may play a role in the development of liver cancer.\nOverall, the role of LIMT lncRNA is still an active area of research, and more studies are needed to fully understand its function and the specific mechanisms by which it regulates gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides in length and does not code for proteins.\n2. LINC (Liver-Enriched Transcript 1, LncRNA) is also known as LIMT (Liver-Enriched Motif-Containing).\n3. LIMT lncRNA has been suggested to play a role in regulating gene expression.\n4. A study found that LIMT lncRNA can act as a sponge for microRNAs, binding to them and preventing them from binding to their target mRNAs.\n5. LIMT lncRNA has been implicated in the regulation of cell proliferation and differentiation and has been suggested that it may play a role in the development of liver cancer.",
    "vicuna-13b_fact": [
      "Long non-coding RNA (lncRNA) is a type of RNA that is longer than 200 nucleotides in length and does not code for proteins.",
      "LINC (Liver-Enriched Transcript 1, LncRNA) is also known as LIMT (Liver-Enriched Motif-Containing).",
      "LIMT lncRNA has been suggested to play a role in regulating gene expression.",
      "A study found that LIMT lncRNA can act as a sponge for microRNAs, binding to them and preventing them from binding to their target mRNAs.",
      "LIMT lncRNA has been implicated in the regulation of cell proliferation and differentiation and has been suggested that it may play a role in the development of liver cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "vicuna-13b_response": "The R/Bioconductor package that is commonly used for performing SNP enrichment analysis is \"Sleuth.\"",
    "vicuna-13b_fact_raw": "The factual statement is:\n1. The \"Sleuth\" is a commonly used R/Bioconductor package for performing SNP enrichment analysis.",
    "vicuna-13b_fact": [
      "The \"Sleuth\" is a commonly used R/Bioconductor package for performing SNP enrichment analysis."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The \"Sleuth\" is a commonly used R/Bioconductor package for performing RNA-seq data analysis, not SNP enrichment analysis.",
    "vicuna-13b_judge": [
      "false"
    ]
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "vicuna-13b_response": "Radial glial cells are a type of neural stem cell that give rise to various types of neural cells, including ependymal cells, during development. The process of radial glial cell specification into ependymal cells is a complex process that involves a number of key players.\nOne of the key transcription factors involved in radial glial cell specification is the Sox2 gene. Sox2 is a transcription factor that is expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.\nAnother key player in radial glial cell specification is the Wt1 gene. Wt1 is a transcription factor that is expressed in radial glial cells and is required for their differentiation into ependymal cells.\nAdditionally, the Notch signaling pathway plays a crucial role in radial glial cell specification. The Notch pathway is involved in cell-cell communication and regulates the differentiation of radial glial cells into ependymal cells.\nOverall, the process of radial glial cell specification into ependymal cells is a complex process that involves the interplay of multiple genetic and signaling pathways.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Radial glial cells are a type of neural stem cell that give rise to various types of neural cells, including ependymal cells.\n2. The Sox2 gene is a transcription factor expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.\n3. The Wt1 gene is a transcription factor that is expressed in radial glial cells and is needed for their differentiation into ependymal cells.\n4. The Notch signaling pathway plays a role in the differentiation of radial glial cells into ependymal cells.\n5. The process of radial glial cell specification into ependymal cells involves the interplay of multiple genetic and signaling pathways.",
    "vicuna-13b_fact": [
      "Radial glial cells are a type of neural stem cell that give rise to various types of neural cells, including ependymal cells.",
      "The Sox2 gene is a transcription factor expressed in radial glial cells and is required for their maintenance and differentiation into ependymal cells.",
      "The Wt1 gene is a transcription factor that is expressed in radial glial cells and is needed for their differentiation into ependymal cells.",
      "The Notch signaling pathway plays a role in the differentiation of radial glial cells into ependymal cells.",
      "The process of radial glial cell specification into ependymal cells involves the interplay of multiple genetic and signaling pathways."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "vicuna-13b_response": "Triple negative gliomas are a type of brain tumor that are characterized by the absence of three key molecular markers: EGFR (epidermal growth factor receptor), P53 (tumor suppressor protein), and ER (estrogen receptor). These markers are often used to classify and diagnose different types of brain tumors, and their absence in triple negative gliomas distinguishes them from other types of gliomas.\nTriple negative gliomas are typically classified as grade III or IV astrocytomas, which are malignant brain tumors that arise from astrocyte cells. These tumors are highly aggressive and have a poor prognosis, with a median survival time of less than 1 year.\nIn addition to the absence of these key molecular markers, triple negative gliomas may also be characterized by other features, such as their location in the brain, their size and shape, and the presence of certain genetic mutations. For example, they are often found in the brain's hemispheres, and they can be large and difficult to remove surgically. They may also harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the amino acid tryptophan.\nOverall, triple negative gliomas are a rare and aggressive type of brain tumor that are characterized by the absence of key molecular markers and other features such as their location, size, and genetic mutations.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Triple negative gliomas are a type of brain tumor characterized by the absence of EGFR, P53, and ER molecular markers.\n2. These markers (EGFR, P53, and ER) are often used to classify and diagnose different types of brain tumors.\n3. Triple negative gliomas are typically classified as grade III or IV astrocytomas.\n4. Grade III or IV astrocytomas are malignant brain tumors that arise from astrocyte cells.\n5. Triple negative gliomas often harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the amino acid tryptophan.",
    "vicuna-13b_fact": [
      "Triple negative gliomas are a type of brain tumor characterized by the absence of EGFR, P53, and ER molecular markers.",
      "These markers (EGFR, P53, and ER) are often used to classify and diagnose different types of brain tumors.",
      "Triple negative gliomas are typically classified as grade III or IV astrocytomas.",
      "Grade III or IV astrocytomas are malignant brain tumors that arise from astrocyte cells.",
      "Triple negative gliomas often harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the amino acid tryptophan."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE \n5. FALSE [correction]: Triple negative gliomas often harbor mutations in genes such as IDH1 and IDH2, which are involved in the metabolism of the molecule isocitrate, not tryptophan.",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "vicuna-13b_response": "TOPAZ1 is a software program developed by the United States government as part of the country's nuclear weapons program. It was used to simulate the behavior of nuclear explosions in various scenarios, including detonations above and below ground, as well as in different atmospheric conditions. The program was developed in the 1950s and was used for many years by the U.S. Department of Energy and its predecessor agencies. It was declassified in the 1990s and is now used for academic research and other non-nuclear purposes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TOPAZ1 is a software program that was developed by the United States government.\n2. The software was part of the United States' nuclear weapons program.\n3. TOPAZ1 was used to simulate the behavior of nuclear explosions in various scenarios.\n4. The program was developed in the 1950s.\n5. TOPAZ1 was declassified in the 1990s and is now used for academic research and other non-nuclear purposes.",
    "vicuna-13b_fact": [
      "TOPAZ1 is a software program that was developed by the United States government.",
      "The software was part of the United States' nuclear weapons program.",
      "TOPAZ1 was used to simulate the behavior of nuclear explosions in various scenarios.",
      "The program was developed in the 1950s.",
      "TOPAZ1 was declassified in the 1990s and is now used for academic research and other non-nuclear purposes."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "vicuna-13b_response": "The expression of GATA-1 isoforms is controlled by several genes, including GATA1, GATA2, and GATA3. These genes are part of the GATA transcription factor family, which plays a crucial role in the development and differentiation of various cell types.\nGATA1 is the founding member of the GATA family and is expressed in a variety of tissues, including the heart, kidney, and liver. Mutations in the GATA1 gene have been linked to several human diseases, including congenital heart defects and anemia.\nGATA2 is expressed in the developing heart and is essential for the development of the cardiac conduction system. Mutations in the GATA2 gene have been associated with the development of heart block, a condition in which the electrical signals that control the heartbeat are disrupted.\nGATA3 is expressed in the developing lung and is essential for the development of the pulmonary circulation. Mutations in the GATA3 gene have been linked to the development of pulmonary hypertension, a condition in which the blood pressure in the lungs is elevated.\nOverall, the expression of GATA-1 isoforms is controlled by multiple genes, and dysregulation of these genes can lead to a variety of human diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GATA-1 isoforms expression is controlled by several genes, including GATA1, GATA2, and GATA3.\n2. Mutations in the GATA1 gene have been linked to several human diseases, including congenital heart defects and anemia.\n3. GATA2 gene is essential for the development of the cardiac conduction system.\n4. Mutations in the GATA2 gene have been associated with the development of heart block.\n5. Mutations in the GATA3 gene have been linked to the development of pulmonary hypertension.",
    "vicuna-13b_fact": [
      "GATA-1 isoforms expression is controlled by several genes, including GATA1, GATA2, and GATA3.",
      "Mutations in the GATA1 gene have been linked to several human diseases, including congenital heart defects and anemia.",
      "GATA2 gene is essential for the development of the cardiac conduction system.",
      "Mutations in the GATA2 gene have been associated with the development of heart block.",
      "Mutations in the GATA3 gene have been linked to the development of pulmonary hypertension."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GATA-1 isoforms expression is controlled by the GATA1 gene.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "vicuna-13b_response": "MIRA-seq (Multiplexed Ion Beam Recognition of Antigens by Sequencing) is a multiplexed sequencing-based assay used to detect and identify antibodies in a sample. It is a highly sensitive and specific method for detecting and measuring the presence of antibodies in a sample, such as blood.\nThe assay works by using a multiplexed ion beam to fragment antibodies in the sample, which are then sequenced to identify the specific antibodies present. This allows for the detection and quantification of a wide range of antibodies in a single sample, with high sensitivity and specificity.\nMIRA-seq has a wide range of applications in the field of immunology, including the detection and measurement of antibodies in disease diagnosis, monitoring of immune responses, and the study of immune system disorders. It is a powerful tool for understanding the immune system and its role in disease, and has the potential to revolutionize the way we diagnose and treat immune-related diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MIRA-seq stands for Multiplexed Ion Beam Recognition of Antigens by Sequencing.\n2. MIRA-seq is used to detect and identify antibodies in a sample.\n3. The MIRA-seq method includes the use of a multiplexed ion beam to fragment antibodies in the sample, which are then sequenced to identify the specific antibodies present.\n4. MIRA-seq can be used in the field of immunology for disease diagnosis, monitoring of immune responses, and the study of immune system disorders.\n5. MIRA-seq allows for the detection and quantification of a wide range of antibodies in a single sample.",
    "vicuna-13b_fact": [
      "MIRA-seq stands for Multiplexed Ion Beam Recognition of Antigens by Sequencing.",
      "MIRA-seq is used to detect and identify antibodies in a sample.",
      "The MIRA-seq method includes the use of a multiplexed ion beam to fragment antibodies in the sample, which are then sequenced to identify the specific antibodies present.",
      "MIRA-seq can be used in the field of immunology for disease diagnosis, monitoring of immune responses, and the study of immune system disorders.",
      "MIRA-seq allows for the detection and quantification of a wide range of antibodies in a single sample."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MIRA-seq stands for Methylated CpG Island Recovery Assay-Sequencing.\n2. FALSE [correction]: MIRA-seq is used to examine DNA methylation patterns in a sample.\n3. FALSE [correction]: The MIRA-seq method includes the use of the MIRA protein to bind to methylated DNA regions, which are then sequenced to identify these methylated regions.\n4. TRUE\n5. FALSE [correction]: MIRA-seq allows for the detection and quantification of methylated DNA regions in a single sample.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "vicuna-13b_response": "ARCALYST (also known as raloxifene) is a medication that is primarily used to treat and prevent osteoporosis in postmenopausal women. It is also sometimes used to reduce the risk of breast cancer in women with a high risk of developing this disease.\nARCALYST works by binding to estrogen receptors in the body, which helps to maintain bone density and prevent bone loss. It also has anti-estrogenic effects on the uterus and breasts, which may help to reduce the risk of certain types of cancer.\nARCALYST is taken orally as a tablet, and the dosage and duration of treatment will depend on the specific condition being treated. It is important to follow your doctor's instructions carefully when taking ARCALYST, as it may interact with certain medications and may have side effects.\nIt is important to note that ARCALYST is not suitable for everyone, and it is important to speak to your doctor before starting treatment to determine if it is the right medication for you.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ARCALYST, also known as raloxifene, is primarily used to treat and prevent osteoporosis in postmenopausal women.\n2. ARCALYST is sometimes used to reduce the risk of breast cancer in women with a high risk of developing this disease.\n3. The medication works by binding to estrogen receptors in the body to maintain bone density and prevent bone loss.\n4. ARCALYST is taken orally as a tablet, and the dosage and duration of treatment depend on the specific condition being treated.\n5. ARCALYST may interact with certain medications and may have side effects.",
    "vicuna-13b_fact": [
      "ARCALYST, also known as raloxifene, is primarily used to treat and prevent osteoporosis in postmenopausal women.",
      "ARCALYST is sometimes used to reduce the risk of breast cancer in women with a high risk of developing this disease.",
      "The medication works by binding to estrogen receptors in the body to maintain bone density and prevent bone loss.",
      "ARCALYST is taken orally as a tablet, and the dosage and duration of treatment depend on the specific condition being treated.",
      "ARCALYST may interact with certain medications and may have side effects."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: ARCALYST, also known as rilonacept, is primarily used to treat certain types of periodic fever syndromes.\n2. FALSE [correction]: ARCALYST is not used to reduce the risk of breast cancer in women. It is primarily used for the treatment of periodic fever syndromes.\n3. FALSE [correction]: ARCALYST works by inhibiting the action of certain proteins in the body that cause inflammation.\n4. FALSE [correction]: ARCALYST is taken by subcutaneous injection, typically once per week.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "vicuna-13b_response": "Robertsonian translocation is a type of chromosomal abnormality that occurs when a part of one chromosome breaks off and attaches to another chromosome. There are several human acrocentric chromosomes that are involved in Robertsonian translocation, including:\n1. Chromosome 1: The most common acrocentric chromosome involved in Robertsonian translocation is chromosome 1, which makes up about 8% of all translocations.\n2. Chromosome 9: Chromosome 9 is the second most common acrocentric chromosome involved in Robertsonian translocation, making up about 7% of all translocations.\n3. Chromosome 21: Chromosome 21 is involved in about 5% of all Robertsonian translocations.\n4. Chromosome 13: Chromosome 13 is involved in about 4% of all Robertsonian translocations.\n5. Chromosome 15: Chromosome 15 is involved in about 3% of all Robertsonian translocations.\nIt is important to note that Robertsonian translocation can occur with any acrocentric chromosome, but the ones listed above are the most commonly involved.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Robertsonian translocation is a type of chromosomal abnormality that occurs when a part of one chromosome breaks off and attaches to another chromosome. \n2. Chromosome 1 is the most common acrocentric chromosome involved in Robertsonian translocation.\n3. Chromosome 9 is the second most common acrocentric chromosome involved in Robertsonian translocation.\n4. Chromosome 21 is involved in about 5% of all Robertsonian translocations.\n5. Chromosome 13 is involved in about 4% of all Robertsonian translocations.",
    "vicuna-13b_fact": [
      "Robertsonian translocation is a type of chromosomal abnormality that occurs when a part of one chromosome breaks off and attaches to another chromosome.",
      "Chromosome 1 is the most common acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 9 is the second most common acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 21 is involved in about 5% of all Robertsonian translocations.",
      "Chromosome 13 is involved in about 4% of all Robertsonian translocations."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Robertsonian translocation is a type of chromosomal abnormality where two whole chromosomes fuse at the centromere.\n2. FALSE [correction]: Chromosome 21 is the most common acrocentric chromosome involved in Robertsonian translocation.\n3. TRUE\n4. FALSE [correction]: Chromosome 21 is involved in about 75% of all Robertsonian translocations.\n5. FALSE [correction]: Chromosome 13 is involved in about 20% of all Robertsonian translocations.",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "vicuna-13b_response": "There are several R packages that can be used for the identification of pediatric brain tumors. Some of the most commonly used packages include:\n1. \"brain\\_metadata\" - This package provides a set of functions for extracting and analyzing metadata from brain tumor imaging studies, including magnetic resonance imaging (MRI) and computed tomography (CT) scans.\n2. \"rpart\" - This package provides a set of functions for performing recursive partitioning, which is a technique used to classify objects into a set of mutually exclusive classes. Recursive partitioning can be used to identify patterns and relationships in brain tumor data, which can aid in the diagnosis and treatment of pediatric brain tumors.\n3. \"survival\" - This package provides a set of functions for analyzing survival data, which is often used in the study of brain tumors. Survival analysis can be used to estimate the probability of survival for patients with brain tumors, as well as to identify factors that are associated with improved survival.\n4. \"limma\" - This package provides a set of functions for performing linear modeling of microarray data, which can be used to identify genes that are associated with the development of brain tumors in pediatric patients.\nOverall, these packages can be used in combination with other tools and techniques to identify and diagnose pediatric brain tumors. It is important to note that the accuracy of any diagnostic tool depends on the quality and quantity of the available data, as well as the expertise of the person using the tool.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"brain\\_metadata\" R package can be used for extracting and analyzing metadata from brain tumor imaging studies.\n2. \"rpart\" is an R package that provides functions for performing recursive partitioning and can be used with brain tumor data.\n3. The \"survival\" R package is used for analyzing survival data.\n4. The \"limma\" R package is used for performing linear modeling of microarray data, which can identify genes associated with the development of brain tumors in pediatric patients.\n5. The accuracy of these diagnostic tools depends on the quality and quantity of the available data, and the expertise of the person using the tool.",
    "vicuna-13b_fact": [
      "The \"brain\\_metadata\" R package can be used for extracting and analyzing metadata from brain tumor imaging studies.",
      "\"rpart\" is an R package that provides functions for performing recursive partitioning and can be used with brain tumor data.",
      "The \"survival\" R package is used for analyzing survival data.",
      "The \"limma\" R package is used for performing linear modeling of microarray data, which can identify genes associated with the development of brain tumors in pediatric patients.",
      "The accuracy of these diagnostic tools depends on the quality and quantity of the available data, and the expertise of the person using the tool."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "vicuna-13b_response": "NEMO (Nuclear Factor of Activated T-Cells, also known as NF-AT) is a transcription factor that plays a role in regulating the expression of genes involved in immune cell function. It is not a zinc finger protein, but it does contain a zinc finger domain, which is a structural motif that is involved in protein-DNA interactions and is found in many transcription factors. The zinc finger domain of NEMO is involved in its binding to specific DNA sequences and regulation of gene expression.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. NEMO is also known as Nuclear Factor of Activated T-Cells or NF-AT.\n2. NEMO is a transcription factor that plays a role in regulating the expression of genes involved in immune cell function.\n3. NEMO is not a zinc finger protein.\n4. NEMO does contain a zinc finger domain.\n5. The zinc finger domain of NEMO is involved in its binding to specific DNA sequences and regulation of gene expression.",
    "vicuna-13b_fact": [
      "NEMO is also known as Nuclear Factor of Activated T-Cells or NF-AT.",
      "NEMO is a transcription factor that plays a role in regulating the expression of genes involved in immune cell function.",
      "NEMO is not a zinc finger protein.",
      "NEMO does contain a zinc finger domain.",
      "The zinc finger domain of NEMO is involved in its binding to specific DNA sequences and regulation of gene expression."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: NEMO, an acronym for NF-kappa-B essential modulator, is not also known as Nuclear Factor of Activated T-Cells or NF-AT. NF-AT is a separate protein.\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: NEMO does not contain a zinc-finger domain.\n5. FALSE [correction]: Since NEMO does not contain a zinc finger domain, it does not use such a domain for binding to specific DNA sequences and regulation of gene expression.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "vicuna-13b_response": "TFIIS (Transcription Factor IIS) is a protein that plays a role in the regulation of gene expression by controlling the initiation of transcription. It is not directly involved in the positioning of nucleosomes.\nNucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core. The positioning of nucleosomes along the DNA sequence is regulated by various factors, including transcription factors, chromatin-modifying enzymes, and the DNA sequence itself.\nWhile TFIIS is not directly involved in nucleosome positioning, it is known to interact with other proteins that are involved in this process. For example, TFIIS has been shown to interact with the chromatin-modifying enzyme, ISWI (Imitation Switch/Whi5-like histone-binding protein), which is involved in the positioning of nucleosomes and other chromatin structures. Additionally, TFIIS has been shown to interact with the transcription factor, TFIIE, which is involved in the initiation of transcription and can affect nucleosome positioning by controlling the access of other transcription factors to the DNA template.\nIn summary, while TFIIS is not directly involved in nucleosome positioning, it is involved in the regulation of gene expression and can interact with other proteins that are involved in this process.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. TFIIS (Transcription Factor IIS) is a protein that plays a role in the regulation of gene expression by controlling the initiation of transcription.\n2. TFIIS is not directly involved in the positioning of nucleosomes.\n3. Nucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core.\n4. TFIIS has been shown to interact with the chromatin-modifying enzyme, ISWI.\n5. TFIIS has been shown to interact with the transcription factor, TFIIE.",
    "vicuna-13b_fact": [
      "TFIIS (Transcription Factor IIS) is a protein that plays a role in the regulation of gene expression by controlling the initiation of transcription.",
      "TFIIS is not directly involved in the positioning of nucleosomes.",
      "Nucleosomes are the basic units of chromatin, consisting of a DNA molecule wrapped around a histone protein core.",
      "TFIIS has been shown to interact with the chromatin-modifying enzyme, ISWI.",
      "TFIIS has been shown to interact with the transcription factor, TFIIE."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "vicuna-13b_response": "The origins of replication close to yeast centromeres can fire either early or late during the cell cycle, depending on the specific conditions and the genetic background of the yeast strain.\nIn general, the firing of origins of replication is regulated by a complex network of signaling pathways and checkpoint mechanisms that ensure proper chromosome segregation and prevent aneuploidy. In yeast, the decision to initiate DNA replication at a specific origin is influenced by a variety of factors, including the availability of replication proteins, the level of cyclin-dependent kinase activity, and the presence of specific transcription factors.\nIn some cases, origins of replication close to yeast centromeres may fire early in the cell cycle, when the levels of cyclin-dependent kinase activity are high and the checkpoint mechanisms are less active. This can lead to the initiation of DNA replication before the proper assembly of the replication fork, which can result in errors and potentially lead to aneuploidy.\nIn other cases, origins of replication close to yeast centromeres may fire late in the cell cycle, when the levels of cyclin-dependent kinase activity are low and the checkpoint mechanisms are more active. This can lead to the initiation of DNA replication after the proper assembly of the replication fork, which can result in more accurate and efficient DNA replication.\nOverall, the firing of origins of replication close to yeast centromeres is a complex process that is influenced by a variety of factors, and the specific timing of replication initiation can vary depending on the genetic background and the specific conditions of the yeast strain.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The origins of replication close to yeast centromeres can fire either early or late during the cell cycle.\n2. The firing of origins of replication is regulated by signaling pathways and checkpoint mechanisms.\n3. In yeast, initiating DNA replication at a specific origin is influenced by the availability of replication proteins, the level of cyclin-dependent kinase activity, and the presence of specific transcription factors.\n4. Origins of replication close to yeast centromeres may fire early when the levels of cyclin-dependent kinase activity are high and the checkpoint mechanisms are less active.\n5. Origins of replication close to yeast centromeres may fire late when the levels of cyclin-dependent kinase activity are low and the checkpoint mechanisms are more active.",
    "vicuna-13b_fact": [
      "The origins of replication close to yeast centromeres can fire either early or late during the cell cycle.",
      "The firing of origins of replication is regulated by signaling pathways and checkpoint mechanisms.",
      "In yeast, initiating DNA replication at a specific origin is influenced by the availability of replication proteins, the level of cyclin-dependent kinase activity, and the presence of specific transcription factors.",
      "Origins of replication close to yeast centromeres may fire early when the levels of cyclin-dependent kinase activity are high and the checkpoint mechanisms are less active.",
      "Origins of replication close to yeast centromeres may fire late when the levels of cyclin-dependent kinase activity are low and the checkpoint mechanisms are more active."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "vicuna-13b_response": "GA-sequences are a type of non-coding RNA that play important roles in gene regulation in mammalian cells. Some of the properties of mammalian GA-sequences include:\n1. Structure: GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.\n2. Localization: GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules and can act as microRNA (miRNA) precursors.\n3. Function: GA-sequences can act as miRNA precursors, which means they can be processed by the cell's miRNA biogenesis machinery to produce mature miRNA molecules that can regulate gene expression.\n4. Diversity: There are many different GA-sequence variants in mammalian cells, which can be generated through a process called alternative processing.\n5. Regulation: The expression and processing of GA-sequences can be regulated by a variety of factors, including cell type, developmental stage, and environmental cues.\nOverall, GA-sequences are important regulators of gene expression in mammalian cells and play a role in a wide range of biological processes, including development, differentiation, and disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GA-sequences are a type of non-coding RNA that play roles in gene regulation in mammalian cells.\n2. GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.\n3. GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules and can act as microRNA (miRNA) precursors.\n4. GA-sequences can be processed by the cell's miRNA biogenesis machinery to produce mature miRNA molecules that can regulate gene expression.\n5. There are many different GA-sequence variants in mammalian cells, which can be generated through a process called alternative processing.",
    "vicuna-13b_fact": [
      "GA-sequences are a type of non-coding RNA that play roles in gene regulation in mammalian cells.",
      "GA-sequences are typically around 200 nucleotides in length and contain a single stem-loop structure.",
      "GA-sequences are typically found in the 3' untranslated region (3' UTR) of mRNA molecules and can act as microRNA (miRNA) precursors.",
      "GA-sequences can be processed by the cell's miRNA biogenesis machinery to produce mature miRNA molecules that can regulate gene expression.",
      "There are many different GA-sequence variants in mammalian cells, which can be generated through a process called alternative processing."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "vicuna-13b_response": "Groucho-related genes (GRGs) are a family of transcription factors that play important roles in development and differentiation in various organisms, including mice. The exact number of GRGs in the mouse genome can vary depending on the source and the specific definition of \"GRG\" used.\nAccording to the latest annotation of the mouse genome (mm11), there are at least 11 genes that are annotated as \"Groucho-related transcription factor\" (GRTF) or \"Groucho-related gene\" (GRG). These genes are:\n* Groucho (Grt1)\n* Groucho-related transcription factor 1 (Grt2)\n* Groucho-related transcription factor 2 (Grt3)\n* Groucho-related transcription factor 3 (Grt4)\n* Groucho-related transcription factor 5 (Grt5)\n* Groucho-related transcription factor 6 (Grt6)\n* Groucho-related transcription factor 7 (Grt7)\n* Groucho-related transcription factor 8 (Grt8)\n* Groucho-related transcription factor 9 (Grt9)\n* Groucho-related transcription factor 10 (Grt10)\n* Groucho-related transcription factor 11 (Grt11)\nIt's worth noting that some sources may include additional genes in the GRG family, or use a broader definition of \"Groucho-related gene\" to include genes that are not strictly related to the Groucho transcription factor.",
    "vicuna-13b_fact_raw": "1. Groucho-related genes (GRGs) are a family of transcription factors that play important roles in development and differentiation in various organisms, including mice.\n2. The number of GRGs in the mouse genome can vary depending on the source and the specific definition of \"GRG\" used.\n3. According to the latest annotation of the mouse genome (mm11), there are at least 11 genes that are annotated as \"Groucho-related transcription factor\" (GRTF) or \"Groucho-related gene\" (GRG).\n4. Listed GRGs in the mouse genome include Groucho (Grt1), Groucho-related transcription factor 1-3, 5-11 (Grt2-3, Grt5-11).\n5. Some sources may include additional genes in the GRG family, or use a broader definition of \"Groucho-related gene\" to include genes that are not strictly related to the Groucho transcription factor.",
    "vicuna-13b_fact": [
      "Groucho-related genes (GRGs) are a family of transcription factors that play important roles in development and differentiation in various organisms, including mice.",
      "The number of GRGs in the mouse genome can vary depending on the source and the specific definition of \"GRG\" used.",
      "According to the latest annotation of the mouse genome (mm11), there are at least 11 genes that are annotated as \"Groucho-related transcription factor\" (GRTF) or \"Groucho-related gene\" (GRG).",
      "Listed GRGs in the mouse genome include Groucho (Grt1), Groucho-related transcription factor 1-3, 5-11 (Grt2-3, Grt5-11).",
      "Some sources may include additional genes in the GRG family, or use a broader definition of \"Groucho-related gene\" to include genes that are not strictly related to the Groucho transcription factor."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "vicuna-13b_response": "RNA cleavage activity is not a function of RNA polymerase II subunits. RNA cleavage is typically carried out by enzymes such as RNases, which are responsible for cleaving RNA molecules. RNA polymerase II is an enzyme that is responsible for transcribing DNA into RNA. It is composed of several subunits, including a large catalytic subunit (Pol II) and several regulatory subunits. The regulatory subunits play a role in controlling the activity of Pol II and the specific genes that are transcribed. However, they do not have RNA cleavage activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. RNA cleavage activity is not a function of RNA polymerase II subunits. \n2. RNA cleavage is typically carried out by enzymes such as RNases.\n3. RNA polymerase II is an enzyme that is responsible for transcribing DNA into RNA.\n4. RNA polymerase II is composed of several subunits, including a large catalytic subunit (Pol II) and several regulatory subunits.\n5. The regulatory subunits of RNA polymerase II play a role in controlling the activity of Pol II and the specific genes that are transcribed.",
    "vicuna-13b_fact": [
      "RNA cleavage activity is not a function of RNA polymerase II subunits.",
      "RNA cleavage is typically carried out by enzymes such as RNases.",
      "RNA polymerase II is an enzyme that is responsible for transcribing DNA into RNA.",
      "RNA polymerase II is composed of several subunits, including a large catalytic subunit (Pol II) and several regulatory subunits.",
      "The regulatory subunits of RNA polymerase II play a role in controlling the activity of Pol II and the specific genes that are transcribed."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "vicuna-13b_response": "Ohdo syndrome is a rare genetic disorder that is caused by mutations in the SLC25A20 gene. This gene provides instructions for making a protein that is involved in the transport of zinc and other metals across cell membranes.\nMutations in the SLC25A20 gene can lead to reduced zinc transport, which can cause a range of symptoms, including intellectual disability, developmental delay, and movement difficulties. The severity of these symptoms can vary widely, depending on the specific mutation and the presence of other genetic factors.\nOhdo syndrome is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disorder. Carriers of one copy of the mutated gene do not typically have any symptoms, but they can pass the mutation on to their children.\nDiagnosis of Ohdo syndrome is typically based on a combination of clinical features, genetic testing, and other medical tests. There is currently no cure for Ohdo syndrome, but treatment is focused on managing symptoms and providing supportive care. This may include physical therapy, occupational therapy, and other interventions to help individuals with the disorder reach their full potential.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Ohdo syndrome is a rare genetic disorder that is caused by mutations in the SLC25A20 gene.\n2. This gene provides instructions for making a protein that is involved in the transport of zinc and other metals across cell membranes.\n3. Ohdo syndrome is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene to develop the disorder.\n4. Diagnosis of Ohdo syndrome is typically based on a combination of clinical features, genetic testing, and other medical tests.\n5. There is currently no cure for Ohdo syndrome, but treatment is focused on managing symptoms and providing supportive care.",
    "vicuna-13b_fact": [
      "Ohdo syndrome is a rare genetic disorder that is caused by mutations in the SLC25A20 gene.",
      "This gene provides instructions for making a protein that is involved in the transport of zinc and other metals across cell membranes.",
      "Ohdo syndrome is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene to develop the disorder.",
      "Diagnosis of Ohdo syndrome is typically based on a combination of clinical features, genetic testing, and other medical tests.",
      "There is currently no cure for Ohdo syndrome, but treatment is focused on managing symptoms and providing supportive care."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Ohdo syndrome is a rare genetic disorder that is caused by mutations in the MED12 gene.\n2. FALSE [correction]: The SLC25A20 gene provides instructions for making a protein that play a crucial role in the breakdown of lipids (fats) for energy. It is not involved in the transport of zinc and other metals across cell membranes.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "vicuna-13b_response": "There are several R/Bioconductor packages that are commonly used for the analysis of psychiatric disease genes. Some of the most popular ones include:\n1. PsychArray: This package provides a set of functions for the analysis of gene expression data in psychiatric diseases. It includes functions for quality control, normalization, and differential expression analysis.\n2. BrainArray: This package provides a set of functions for the analysis of gene expression data in brain tissue. It includes functions for quality control, normalization, and differential expression analysis, and it is specifically designed for brain-related studies.\n3. PsychTranscriptomics: This package provides a set of functions for the analysis of transcriptomics data in psychiatric diseases. It includes functions for quality control, normalization, and differential expression analysis, and it also allows for the analysis of alternative splicing and gene fusion events.\n4. BrainTranscriptomics: This package provides a set of functions for the analysis of transcriptomics data in brain tissue. It includes functions for quality control, normalization, and differential expression analysis, and it is specifically designed for brain-related studies.\n5. RvDREAM: This package provides a set of functions for the analysis of ChIP-seq and DNase-seq data in brain tissue. It includes functions for quality control, peak calling, and peak annotation, and it is specifically designed for brain-related studies.\nIt's worth noting that these packages are not exclusive to psychiatric disease analysis, they can be used for other types of studies as well, but they have been developed with the specific aim of analyzing psychiatric disease genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. PsychArray is an R/Bioconductor package designed for the analysis of gene expression data in psychiatric diseases.\n2. BrainArray is an R/Bioconductor package intended for the analysis of gene expression data in brain tissue.\n3. PsychTranscriptomics is an R/Bioconductor package designed to analyze transcriptomics data in psychiatric diseases, including the analysis of alternative splicing and gene fusion events.\n4. BrainTranscriptomics is an R/Bioconductor package for the analysis of transcriptomics data in brain tissue.\n5. RvDREAM is an R/Bioconductor package for the analysis of ChIP-seq and DNase-seq data in brain tissue, with features for quality control, peak calling, and peak annotation.",
    "vicuna-13b_fact": [
      "PsychArray is an R/Bioconductor package designed for the analysis of gene expression data in psychiatric diseases.",
      "BrainArray is an R/Bioconductor package intended for the analysis of gene expression data in brain tissue.",
      "PsychTranscriptomics is an R/Bioconductor package designed to analyze transcriptomics data in psychiatric diseases, including the analysis of alternative splicing and gene fusion events.",
      "BrainTranscriptomics is an R/Bioconductor package for the analysis of transcriptomics data in brain tissue.",
      "RvDREAM is an R/Bioconductor package for the analysis of ChIP-seq and DNase-seq data in brain tissue, with features for quality control, peak calling, and peak annotation."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "vicuna-13b_response": "Swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage (ICH), which is a type of stroke caused by bleeding into the brain tissue. It is also known as a \"rice-grain\" sign or a \"floret sign\".\nThe swirl sign is caused by the presence of small, round, hyperdense areas (called \"rice grains\") within the hemorrhage. These small, round lesions are formed by the coagulation of blood within the brain tissue, and they are typically seen in the setting of ICH due to hypertension or other vascular conditions.\nThe swirl sign is often seen on CT scans of the brain, and it is a useful indicator of the presence and extent of ICH. It is important to note that the swirl sign is not specific to ICH and can also be seen in other types of brain injury or inflammation.\nIn summary, the swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage, and it is caused by the presence of small, round, hyperdense areas within the hemorrhage. It is a useful indicator of the presence and extent of ICH, and it is often seen on CT scans of the brain.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage (ICH).\n2. Intracerebral hemorrhage is a type of stroke caused by bleeding into the brain tissue.\n3. The swirl sign is caused by the presence of small, round, hyperdense areas within the hemorrhage.\n4. The swirl sign is often seen on CT scans of the brain.\n5. The swirl sign is a useful indicator of the presence and extent of intracerebral hemorrhage.",
    "vicuna-13b_fact": [
      "Swirl sign is a radiologic finding that is commonly seen in patients with intracerebral hemorrhage (ICH).",
      "Intracerebral hemorrhage is a type of stroke caused by bleeding into the brain tissue.",
      "The swirl sign is caused by the presence of small, round, hyperdense areas within the hemorrhage.",
      "The swirl sign is often seen on CT scans of the brain.",
      "The swirl sign is a useful indicator of the presence and extent of intracerebral hemorrhage."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Swirl sign is not commonly seen in patients with intracerebral hemorrhage (ICH). It's seen in patients with epidural hematomas.\n2. TRUE\n3. FALSE [correction]: The swirl sign is not characterized by the presence of small, round, hyperdense areas within the hemorrhage. It's seen as a heterogeneous mixture of hyperdense (blood clots) and hypodense (unclotted blood) areas within the hematoma.\n4. TRUE\n5. FALSE [correction]: The swirl sign is not a useful indicator of the presence and extent of intracerebral hemorrhage but it can indicate active bleeding in a hematoma or worsening condition.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "vicuna-13b_response": "ROF1 is a transcription factor that is involved in regulating the response of Arabidopsis thaliana to various environmental stresses, including drought, salt, and cold. The expression of ROF1 is induced in response to these stresses, and it plays a role in the activation of genes that are involved in stress response pathways.\nSeveral studies have identified different factors that can induce the expression of ROF1 in Arabidopsis. For example, exposure to high levels of salt or mannitol can induce ROF1 expression, as can exposure to low temperatures or high light intensity. Additionally, ROF1 expression can be induced by certain hormones, such as abscisic acid or ethylene.\nIn general, the induction of ROF1 expression is thought to be mediated by a combination of environmental signals and intracellular signaling pathways. For example, ROF1 expression may be induced by the activation of specific transcription factors, such as DREB1 or HSF, which are known to be involved in regulating stress response pathways in Arabidopsis. Additionally, the activity of ROF1 itself may be regulated by post-translational modifications, such as phosphorylation or acetylation, which can affect its ability to bind to DNA and regulate gene expression.\nOverall, the induction of ROF1 expression in Arabidopsis is a complex process that is influenced by a variety of environmental and intracellular signals, and it is likely that the specific mechanisms involved in ROF1 induction will vary depending on the specific stress conditions being experienced by the plant.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ROF1 is a transcription factor that is involved in regulating the response of Arabidopsis thaliana to various environmental stresses, including drought, salt, and cold.\n2. The expression of ROF1 in Arabidopsis can be induced by exposure to high levels of salt or mannitol, low temperatures, or high light intensity.\n3. ROF1 expression can also be induced by certain hormones, such as abscisic acid or ethylene.\n4. The expression of ROF1 can be induced by the activation of specific transcription factors, such as DREB1 or HSF.\n5. The activity of ROF1 may be regulated by post-translational modifications, such as phosphorylation or acetylation.",
    "vicuna-13b_fact": [
      "ROF1 is a transcription factor that is involved in regulating the response of Arabidopsis thaliana to various environmental stresses, including drought, salt, and cold.",
      "The expression of ROF1 in Arabidopsis can be induced by exposure to high levels of salt or mannitol, low temperatures, or high light intensity.",
      "ROF1 expression can also be induced by certain hormones, such as abscisic acid or ethylene.",
      "The expression of ROF1 can be induced by the activation of specific transcription factors, such as DREB1 or HSF.",
      "The activity of ROF1 may be regulated by post-translational modifications, such as phosphorylation or acetylation."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "vicuna-13b_response": "The most common cause of hereditary renal amyloidosis is the accumulation of the protein transthyretin (TTR) in the kidneys. TTR is a protein that is produced in the liver and transported to the kidneys, where it is normally eliminated in the urine. In hereditary renal amyloidosis, there is a mutation in the TTR gene that causes the protein to misfold and accumulate in the kidneys, leading to the formation of amyloid fibrils. These fibrils can cause damage to the kidneys and lead to progressive kidney failure. Other proteins can also cause hereditary renal amyloidosis, but TTR is the most common.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common cause of hereditary renal amyloidosis is the accumulation of the protein transthyretin (TTR) in the kidneys.\n2. TTR is a protein that is produced in the liver and is usually transported to the kidneys to be eliminated in the urine.\n3. In cases of hereditary renal amyloidosis with TTR, there is a mutation in the TTR gene causing the protein to misfold and accumulate in the kidneys.\n4. The accumulation of amyloid fibrils can damage the kidneys and lead to progressive kidney failure.\n5. Other proteins besides TTR can cause hereditary renal amyloidosis.",
    "vicuna-13b_fact": [
      "The most common cause of hereditary renal amyloidosis is the accumulation of the protein transthyretin (TTR) in the kidneys.",
      "TTR is a protein that is produced in the liver and is usually transported to the kidneys to be eliminated in the urine.",
      "In cases of hereditary renal amyloidosis with TTR, there is a mutation in the TTR gene causing the protein to misfold and accumulate in the kidneys.",
      "The accumulation of amyloid fibrils can damage the kidneys and lead to progressive kidney failure.",
      "Other proteins besides TTR can cause hereditary renal amyloidosis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Transthyretin (TTR) is a protein that is produced in the liver, it is not usually transported to the kidneys to be eliminated in the urine.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "vicuna-13b_response": "Yes, the proteome of mice hippocampus has been analyzed. The hippocampus is a structure in the brain that plays a key role in memory and spatial navigation, and it is an important region to study in the context of neuroscience and brain disease.\nSeveral proteomic studies have been conducted on the hippocampus of mice, using techniques such as 2D gel electrophoresis, mass spectrometry, and other advanced proteomics tools. These studies have identified a large number of proteins that are expressed in the hippocampus, including structural proteins, enzymes, transport proteins, and signaling molecules.\nFor example, a study published in the journal \"Proteomics\" in 2012 used 2D gel electrophoresis and mass spectrometry to identify 462 proteins in the hippocampus of mice. Another study published in the journal \"Journal of Neuroscience\" in 2015 used a combination of 2D gel electrophoresis and liquid chromatography-tandem mass spectrometry to identify 1,325 proteins in the hippocampus of mice.\nThese studies have provided valuable insights into the proteins that are involved in various brain functions, such as learning and memory, and have also helped to identify potential targets for the development of new treatments for brain diseases. However, it is important to note that these studies are still ongoing, and there is still much to be learned about the proteome of the mouse hippocampus.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The proteome of mice hippocampus has been analyzed.\n2. The hippocampus is a structure in the brain that plays a key role in memory and spatial navigation.\n3. Several proteomic studies have been conducted on the hippocampus of mice, using techniques such as 2D gel electrophoresis, mass spectrometry, and other advanced proteomics tools.\n4. A study published in the journal \"Proteomics\" in 2012 identified 462 proteins in the hippocampus of mice.\n5. Another study published in the journal \"Journal of Neuroscience\" in 2015 identified 1,325 proteins in the hippocampus of mice.",
    "vicuna-13b_fact": [
      "The proteome of mice hippocampus has been analyzed.",
      "The hippocampus is a structure in the brain that plays a key role in memory and spatial navigation.",
      "Several proteomic studies have been conducted on the hippocampus of mice, using techniques such as 2D gel electrophoresis, mass spectrometry, and other advanced proteomics tools.",
      "A study published in the journal \"Proteomics\" in 2012 identified 462 proteins in the hippocampus of mice.",
      "Another study published in the journal \"Journal of Neuroscience\" in 2015 identified 1,325 proteins in the hippocampus of mice."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "vicuna-13b_response": "Mouse chromosomes are not acrocentric. Acrocentric chromosomes are those in which the centromere is located at the tip of the chromosome. Mouse chromosomes have a different type of centromere organization, called \"pericentromeric heterochromatin,\" which is located closer to the center of the chromosome.\nIn mice, the X and Y chromosomes are acrocentric, while the other chromosomes are metacentric or submetacentric. The X and Y chromosomes have a unique structure, with a large amount of heterochromatin at their tips, which is why they are considered acrocentric.\nIt's worth noting that the chromosome structure and organization can vary between different species, and even between different individuals of the same species.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Mouse chromosomes are not acrocentric.\n2. Acrocentric chromosomes are those in which the centromere is located at the tip of the chromosome.\n3. Mouse chromosomes have an organization called \"pericentromeric heterochromatin,\" which is located closer to the center of the chromosome.\n4. In mice, the X and Y chromosomes are acrocentric.\n5. The chromosome structure and organization can vary between different species and even between different individuals of the same species.",
    "vicuna-13b_fact": [
      "Mouse chromosomes are not acrocentric.",
      "Acrocentric chromosomes are those in which the centromere is located at the tip of the chromosome.",
      "Mouse chromosomes have an organization called \"pericentromeric heterochromatin,\" which is located closer to the center of the chromosome.",
      "In mice, the X and Y chromosomes are acrocentric.",
      "The chromosome structure and organization can vary between different species and even between different individuals of the same species."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Mouse chromosomes are predominantly acrocentric.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "vicuna-13b_response": "One siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer is called \"Onpattro\" (patisiran). Onpattro is a targeted therapy that uses RNA interference (RNAi) technology to inhibit the production of a protein called \"hematopoietic growth factor receptor 2\" (CD47), which is expressed on the surface of many types of cancer cells, including pancreatic cancer cells. By inhibiting CD47, Onpattro can help to enhance the immune system's ability to recognize and attack cancer cells.\nOnpattro is administered intravenously and has been studied in several clinical trials for the treatment of pancreatic cancer, including a phase 1b/2 clinical trial (NCT02822612) and a phase 3 clinical trial (NCT03003075). The results of these trials have shown that Onpattro can be effective in treating pancreatic cancer, with some patients experiencing significant reductions in tumor size and improvements in overall survival.\nIt's important to note that while Onpattro has shown promise in clinical trials, it is not yet approved by the FDA for the treatment of pancreatic cancer, and more research is needed to fully understand its safety and efficacy in this context.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Onpattro is an siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer.\n2. Onpattro uses RNA interference technology to inhibit the production of the protein CD47.\n3. CD47 is expressed on the surface of many types of cancer cells, including pancreatic cancer cells.\n4. Onpattro has been studied in a phase 1b/2 clinical trial (NCT02822612) and a phase 3 clinical trial (NCT03003075) for the treatment of pancreatic cancer.\n5. Onpattro is not yet approved by the FDA for the treatment of pancreatic cancer.",
    "vicuna-13b_fact": [
      "Onpattro is an siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer.",
      "Onpattro uses RNA interference technology to inhibit the production of the protein CD47.",
      "CD47 is expressed on the surface of many types of cancer cells, including pancreatic cancer cells.",
      "Onpattro has been studied in a phase 1b/2 clinical trial (NCT02822612) and a phase 3 clinical trial (NCT03003075) for the treatment of pancreatic cancer.",
      "Onpattro is not yet approved by the FDA for the treatment of pancreatic cancer."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Onpattro (patisiran) is an siRNA-based drug that is approved for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR), not pancreatic cancer.\n2. FALSE [correction]: Onpattro uses RNA interference technology to inhibit the production of the protein transthyretin (TTR), not CD47.\n3. TRUE\n4. FALSE [correction]: Onpattro has been studied in clinical trials for hATTR, not pancreatic cancer. The specific trial identifiers provided do not appear to be linked to studies of Onpattro for the treatment of pancreatic cancer.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "vicuna-13b_response": "The HPG pore, also known as the hypothalamic-pituitary-gonadal (HPG) axis, is a complex network of endocrine glands and tissues that work together to regulate various physiological processes in the body, including growth and development, reproduction, and stress response.\nThe hypothalamus is a small region of the brain that serves as the central control center for many of the body's autonomic functions, such as body temperature, hunger, and thirst. The pituitary gland, located at the base of the brain, is a small endocrine gland that plays a critical role in regulating various bodily functions through the production of hormones.\nThe gonads, which are the reproductive organs that produce gametes (testes in males, ovaries in females), are also part of the HPG axis. The HPG axis works by releasing various hormones that regulate the production and release of other hormones, creating a complex feedback loop that helps maintain homeostasis in the body.\nOverall, the HPG pore is a vital part of the endocrine system that plays a critical role in regulating many aspects of the body's physiology.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The HPG pore, also known as the hypothalamic-pituitary-gonadal (HPG) axis, is a complex network of endocrine glands and tissues.\n2. The HPG axis regulates various physiological processes in the body, including growth and development, reproduction, and stress response.\n3. The hypothalamus is a small region of the brain that serves as the central control center for many of the body's autonomic functions.\n4. The pituitary gland is a small endocrine gland that is located at the base of the brain and regulates various bodily functions through the production of hormones.\n5. The gonads, which produce gametes (testes in males, ovaries in females), are also part of the HPG axis.",
    "vicuna-13b_fact": [
      "The HPG pore, also known as the hypothalamic-pituitary-gonadal (HPG) axis, is a complex network of endocrine glands and tissues.",
      "The HPG axis regulates various physiological processes in the body, including growth and development, reproduction, and stress response.",
      "The hypothalamus is a small region of the brain that serves as the central control center for many of the body's autonomic functions.",
      "The pituitary gland is a small endocrine gland that is located at the base of the brain and regulates various bodily functions through the production of hormones.",
      "The gonads, which produce gametes (testes in males, ovaries in females), are also part of the HPG axis."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The HPG axis, also known as the hypothalamic-pituitary-gonadal axis, is a complex network of endocrine glands and tissues, not a pore.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "vicuna-13b_response": "The 959 Nematode Genomes initiative is a large-scale research project aimed at sequencing and analyzing the genomes of 959 species of nematodes, which are a type of roundworm. The project is a collaboration between researchers from around the world and is being funded by the National Science Foundation in the United States.\nThe goal of the project is to gain a better understanding of the biology and evolution of nematodes, which are among the most diverse and abundant organisms on Earth. By sequencing the genomes of such a large number of nematode species, researchers hope to identify genetic changes that have occurred over time and to study the ways in which these changes have influenced the evolution of the organisms.\nIn addition to providing insights into the biology and evolution of nematodes, the 959 Nematode Genomes initiative is also expected to have broader implications for the field of genomics and the study of other organisms. By providing a large and diverse dataset of genomic information, researchers will be able to develop new tools and techniques for analyzing genetic data and studying the evolution of complex organisms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The 959 Nematode Genomes initiative is a research project aimed at sequencing and analyzing the genomes of 959 species of nematodes.\n2. The project is a collaboration between researchers from around the world.\n3. Funding for the 959 Nematode Genomes initiative is provided by the National Science Foundation in the United States.\n4. The goal of the project is to better understand the biology and evolution of nematodes.\n5. As part of the project's broader implications, it aims to contribute to the field of genomics and the study of other organisms by providing a large dataset of genomic information.",
    "vicuna-13b_fact": [
      "The 959 Nematode Genomes initiative is a research project aimed at sequencing and analyzing the genomes of 959 species of nematodes.",
      "The project is a collaboration between researchers from around the world.",
      "Funding for the 959 Nematode Genomes initiative is provided by the National Science Foundation in the United States.",
      "The goal of the project is to better understand the biology and evolution of nematodes.",
      "As part of the project's broader implications, it aims to contribute to the field of genomics and the study of other organisms by providing a large dataset of genomic information."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "vicuna-13b_response": "The \"nipy\" package is a popular R package for analyzing Non-invasive prenatal testing (NIPT) data. It provides functions for processing NIPT data, including calling variants, estimating fraction of cells, and calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA. The package also includes functions for visualizing NIPT data, including scatter plots and heatmaps. Additionally, there are other packages such as \"nipst\" and \"prenet\" that can be used for NIPT data analysis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The \"nipy\" package is an R package used for analyzing Non-invasive prenatal testing (NIPT) data.\n2. The \"nipy\" package provides functions for processing NIPT data.\n3. The \"nipy\" package has functionalities such as calling variants, estimating fraction of cells, and calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA.\n4. The \"nipy\" package includes functions for visualizing NIPT data.\n5. Other packages such as \"nipst\" and \"prenet\" can also be used for NIPT data analysis.",
    "vicuna-13b_fact": [
      "The \"nipy\" package is an R package used for analyzing Non-invasive prenatal testing (NIPT) data.",
      "The \"nipy\" package provides functions for processing NIPT data.",
      "The \"nipy\" package has functionalities such as calling variants, estimating fraction of cells, and calculating metrics such as cell-free DNA (cfDNA) and percent fetal DNA.",
      "The \"nipy\" package includes functions for visualizing NIPT data.",
      "Other packages such as \"nipst\" and \"prenet\" can also be used for NIPT data analysis."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The \"nipy\" package is a Python package used for analysis of the structure of brain images, not for Non-invasive prenatal testing (NIPT) data. \n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbach’s syndrome.",
    "vicuna-13b_response": "Achenbach's syndrome is a rare congenital disorder characterized by the association of a cranial nerve palsy (usually of the third, fourth, or sixth cranial nerve) with a limb deformity, most commonly a congenital talipes equinovarus (clubfoot) or a congenital hip dislocation. The condition is named after the German pediatrician Franz Achenbach, who first described it in 1914.\nThe exact cause of Achenbach's syndrome is not known, but it is thought to be due to a developmental abnormality of the brain or spinal cord. The cranial nerve palsy is usually present at birth or within the first few months of life, and the limb deformity may be apparent at birth or become apparent later in infancy or early childhood.\nThe clinical features of Achenbach's syndrome include a cranial nerve palsy (usually of the third, fourth, or sixth cranial nerve) resulting in weakness or paralysis of the muscles of the face, arm, or leg on the affected side. The limb deformity may be mild or severe, and may be unilateral (affecting one limb) or bilateral (affecting both limbs).\nDiagnosis of Achenbach's syndrome is typically made through a combination of physical examination, medical imaging (such as MRI), and genetic testing. Treatment of Achenbach's syndrome is typically focused on managing the symptoms of the condition, and may include physical therapy, orthotic devices, or surgery to correct the limb deformity. In some cases, medications may be prescribed to manage the symptoms of the cranial nerve palsy.\nIt is important to note that Achenbach's syndrome is a rare condition, and the prognosis for individuals with the condition can vary widely depending on the severity of the cranial nerve palsy and limb deformity, as well as the response to treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Achenbach's syndrome is a rare congenital disorder often associated with a cranial nerve palsy and a limb deformity.\n2. The condition is named after the German pediatrician Franz Achenbach, who first described it in 1914.\n3. The cranial nerve palsy in Achenbach's syndrome is usually present at birth or within the first few months of life.\n4. Diagnosis of Achenbach's syndrome is typically made through physical examination, medical imaging, and genetic testing.\n5. Treatment of Achenbach's syndrome may include physical therapy, orthotic devices, surgery or medications.",
    "vicuna-13b_fact": [
      "Achenbach's syndrome is a rare congenital disorder often associated with a cranial nerve palsy and a limb deformity.",
      "The condition is named after the German pediatrician Franz Achenbach, who first described it in 1914.",
      "The cranial nerve palsy in Achenbach's syndrome is usually present at birth or within the first few months of life.",
      "Diagnosis of Achenbach's syndrome is typically made through physical examination, medical imaging, and genetic testing.",
      "Treatment of Achenbach's syndrome may include physical therapy, orthotic devices, surgery or medications."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is a rare condition that causes sudden temporary episodes of pain, bruising, and swelling in the fingers.\n2. TRUE\n3. FALSE [correction]: Achenbach's syndrome is not associated with cranial nerve palsy, but sudden episodes of hand and finger pain.\n4. FALSE [correction]: Diagnosis of Achenbach's syndrome is typically made by patient history and clinical examination.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "vicuna-13b_response": "There are several algorithms that can be used for the detection of long repeat expansions, including:\n1. Longest Common Subsequence (LCS) algorithm: This algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings. In the context of detecting long repeat expansions, the LCS algorithm can be used to identify the presence of long repeat sequences in a genome.\n2. Smith-Waterman algorithm: This algorithm is a dynamic programming algorithm that is commonly used for comparing biological sequences. It can be used to identify the presence of long repeat sequences in a genome by comparing the sequence to a known reference sequence.\n3. Repeat-induced polymerase chain reaction (RIP-PCR): This is a PCR-based method that can be used to amplify and detect long repeat sequences in a genome. RIP-PCR is based on the fact that repeat sequences can act as templates for the polymerase chain reaction, leading to the amplification of the repeat sequence.\n4. Next-generation sequencing (NGS) technologies: NGS technologies, such as whole-genome sequencing, can be used to identify long repeat expansions directly from the genome sequence. NGS technologies allow for the simultaneous detection of multiple repeat sequences, making them a powerful tool for the study of repeat disorders.\nOverall, the choice of algorithm will depend on the specific needs of the research question and the available resources.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Longest Common Subsequence (LCS) algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings.\n2. The Smith-Waterman algorithm is a dynamic programming algorithm used for comparing biological sequences.\n3. Repeat-induced polymerase chain reaction (RIP-PCR) is a PCR-based method that can be used to amplify and detect long repeat sequences in a genome.\n4. Next-generation sequencing (NGS) technologies, like whole-genome sequencing, can be used to identify long repeat expansions directly from the genome sequence.\n5. The choice of algorithm for the detection of long repeat expansions will depend on the specific research question and available resources.",
    "vicuna-13b_fact": [
      "The Longest Common Subsequence (LCS) algorithm is used to find the longest sequence of consecutive characters that are common to two or more strings.",
      "The Smith-Waterman algorithm is a dynamic programming algorithm used for comparing biological sequences.",
      "Repeat-induced polymerase chain reaction (RIP-PCR) is a PCR-based method that can be used to amplify and detect long repeat sequences in a genome.",
      "Next-generation sequencing (NGS) technologies, like whole-genome sequencing, can be used to identify long repeat expansions directly from the genome sequence.",
      "The choice of algorithm for the detection of long repeat expansions will depend on the specific research question and available resources."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Longest Common Subsequence (LCS) algorithm is used to find the longest sequence of characters that are common to two or more strings, not necessarily consecutive.\n2. TRUE\n3. FALSE [correction]: Repeat-induced point mutation (RIP) is a mechanism that introduces mutations specifically into repeated DNA sequences during the sexual cycle, not a PCR-based method.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "vicuna-13b_response": "Neuroligin-3 is a protein that is expressed on the surface of neurons and plays a role in synaptic transmission. It has been implicated in the development and progression of certain types of brain tumors, specifically glioblastoma and medulloblastoma.\nGlioblastoma is a highly aggressive and malignant brain tumor that arises from astrocytes, a type of glial cell. Studies have shown that high levels of neuroligin-3 are associated with a poor prognosis in patients with glioblastoma. Increased expression of neuroligin-3 has been linked to increased cell proliferation, migration, and invasion, all of which are characteristics of cancer cells.\nMedulloblastoma is a type of brain tumor that arises from embryonic cells in the cerebellum. Studies have also shown that neuroligin-3 is expressed in medulloblastoma cells and that high levels of neuroligin-3 are associated with a poor prognosis in patients with this type of brain tumor.\nIt is important to note that while neuroligin-3 has been implicated in the development and progression of certain types of brain tumors, it is not the only factor that contributes to the development and progression of these tumors. Other genetic and environmental factors also play a role.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neuroligin-3 is a protein expressed on the surface of neurons.\n2. Neuroligin-3 plays a role in synaptic transmission.\n3. Glioblastoma is a type of brain tumor that arises from astrocytes and its development and progression have been linked to neuroligin-3.\n4. High levels of neuroligin-3 are associated with poor prognosis in patients with glioblastoma.\n5. Medulloblastoma is a type of brain tumor that arises from embryonic cells in the cerebellum and it's also connected to neuroligin-3 expression.",
    "vicuna-13b_fact": [
      "Neuroligin-3 is a protein expressed on the surface of neurons.",
      "Neuroligin-3 plays a role in synaptic transmission.",
      "Glioblastoma is a type of brain tumor that arises from astrocytes and its development and progression have been linked to neuroligin-3.",
      "High levels of neuroligin-3 are associated with poor prognosis in patients with glioblastoma.",
      "Medulloblastoma is a type of brain tumor that arises from embryonic cells in the cerebellum and it's also connected to neuroligin-3 expression."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "vicuna-13b_response": "Gas vesicles are small, hollow, gas-filled structures that are found in certain types of aquatic plants and animals, such as blue-green algae, dinoflagellates, and some species of fish. The size of gas vesicles can vary depending on the species, but they are typically very small, ranging in size from a few micrometers to a few hundred micrometers in diameter.\nIn general, gas vesicles are much smaller than the cells that contain them, and they are used by the organism to float in the water or to adjust its buoyancy. The size and shape of the gas vesicles can also vary depending on the function they serve in the organism. For example, some gas vesicles may be larger and more spherical in shape, while others may be smaller and more elongated.\nOverall, the size of gas vesicles is an important characteristic of the organism that produces them, and it can be used to help identify different species and to understand their ecological role in the aquatic environment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gas vesicles are small, hollow, gas-filled structures found in some aquatic plants and animals.\n2. Gas vesicles are found in blue-green algae, dinoflagellates, and some species of fish.\n3. The size of gas vesicles varies depending on the species, ranging from a few micrometers to a few hundred micrometers in diameter.\n4. Gas vesicles are generally smaller than the cells that contain them.\n5. The size and shape of the gas vesicles vary depending on the function they serve in the organism.",
    "vicuna-13b_fact": [
      "Gas vesicles are small, hollow, gas-filled structures found in some aquatic plants and animals.",
      "Gas vesicles are found in blue-green algae, dinoflagellates, and some species of fish.",
      "The size of gas vesicles varies depending on the species, ranging from a few micrometers to a few hundred micrometers in diameter.",
      "Gas vesicles are generally smaller than the cells that contain them.",
      "The size and shape of the gas vesicles vary depending on the function they serve in the organism."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Gas vesicles are small, rigid, gas-filled structures found in some bacteria and archaea.\n2. FALSE [correction]: Gas vesicles are found in bacteria, archaea, and cyanobacteria (also known as blue-green algae), not dinoflagellates or fish.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "vicuna-13b_response": "BET (bromodomain and extraterminal) proteins are a family of transcription factors that play a critical role in regulating gene expression in response to environmental cues. There are three main members of the BET family: BRD2, BRD3, and BRD4.\nBRD2 is a ubiquitously expressed protein that is involved in the regulation of many different genes. It has been shown to play a role in the development of hematopoietic cells, and mutations in BRD2 have been linked to the development of certain types of leukemia.\nBRD3 is a protein that is primarily expressed in the brain, and it has been shown to play a role in the regulation of neuronal differentiation and survival. Mutations in BRD3 have been linked to the development of certain types of brain tumors.\nBRD4 is a protein that is expressed in many different tissues, and it has been shown to play a role in the regulation of cell proliferation and differentiation. Mutations in BRD4 have been linked to the development of certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes.\nOverall, BET proteins are important regulators of gene expression, and dysregulation of BET proteins has been linked to the development of a variety of diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. BET proteins are a family of transcription factors that regulate gene expression in response to environmental cues.\n2. The BET family primarily includes three members: BRD2, BRD3, and BRD4.\n3. Mutations in BRD2 have been linked to the development of certain types of leukemia.\n4. BRD3 has been shown to play a role in the regulation of neuronal differentiation and survival and its mutations have been linked to certain types of brain tumors.\n5. BRD4 is involved in the regulation of cell proliferation and differentiation, and mutations in this protein have been associated with certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes.",
    "vicuna-13b_fact": [
      "BET proteins are a family of transcription factors that regulate gene expression in response to environmental cues.",
      "The BET family primarily includes three members: BRD2, BRD3, and BRD4.",
      "Mutations in BRD2 have been linked to the development of certain types of leukemia.",
      "BRD3 has been shown to play a role in the regulation of neuronal differentiation and survival and its mutations have been linked to certain types of brain tumors.",
      "BRD4 is involved in the regulation of cell proliferation and differentiation, and mutations in this protein have been associated with certain types of cancer, including acute myeloid leukemia and myelodysplastic syndromes."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: BET proteins are a family of proteins that recognized acetylated histones, not transcription factors per se. They influence gene expression in response to environmental cues.\n2. FALSE [correction]: The BET family primarily includes four members: BRD2, BRD3, BRD4, and BRDT.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "vicuna-13b_response": "There are several algorithms that have been developed for prediction of protein subcellular localization using deep learning. Some of the popular ones are:\n1. DeepLoc: This algorithm uses a deep convolutional neural network (CNN) to predict the subcellular localization of proteins based on their amino acid sequences. The CNN is trained on a large dataset of protein sequences and their corresponding subcellular localization labels.\n2. LocNet: This algorithm is a fully convolutional network that is designed to predict the subcellular localization of proteins. It uses a combination of convolutional and fully connected layers to extract features from the protein sequences and then uses these features to make predictions.\n3. ProtTrans: This algorithm uses a multi-task learning approach to predict both the subcellular localization and the protein's function. It uses a combination of convolutional and recurrent neural networks to extract features from the protein sequences and then uses these features to make predictions.\n4. DeepPLoc: This algorithm uses a deep belief network (DBN) to predict the subcellular localization of proteins. It uses a hierarchical architecture that consists of multiple layers of DBNs to learn the complex patterns in the protein sequences.\nThese algorithms have been shown to achieve high accuracy in predicting the subcellular localization of proteins, and they have become popular in the field of protein bioinformatics.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DeepLoc is an algorithm that uses a deep convolutional neural network to predict the subcellular localization of proteins based on their amino acid sequences.\n2. LocNet is a fully convolutional network designed to predict the subcellular localization of proteins using a combination of convolutional and fully connected layers.\n3. ProtTrans uses a multi-task learning approach to predict both the subcellular localization and the protein's function.\n4. DeepPLoc uses a deep belief network to predict the subcellular localization of proteins and has a hierarchical architecture that consists of multiple layers of DBNs.\n5. These algorithms have been shown to achieve high accuracy in predicting the subcellular localization of proteins.",
    "vicuna-13b_fact": [
      "DeepLoc is an algorithm that uses a deep convolutional neural network to predict the subcellular localization of proteins based on their amino acid sequences.",
      "LocNet is a fully convolutional network designed to predict the subcellular localization of proteins using a combination of convolutional and fully connected layers.",
      "ProtTrans uses a multi-task learning approach to predict both the subcellular localization and the protein's function.",
      "DeepPLoc uses a deep belief network to predict the subcellular localization of proteins and has a hierarchical architecture that consists of multiple layers of DBNs.",
      "These algorithms have been shown to achieve high accuracy in predicting the subcellular localization of proteins."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "vicuna-13b_response": "MULTOVL is a programming language that is designed to be easy to learn and use, while also being powerful and flexible. It is a high-level language, which means that it allows developers to write code in a more natural and intuitive way, without having to worry about the low-level details of how the code is executed.\nOne of the key features of MULTOVL is its support for multiple inheritance. This means that a class can inherit properties and methods from multiple other classes, rather than just one. This allows for more flexible and reusable code, as well as the ability to create more complex and hierarchical structures.\nMULTOVL also supports polymorphism, which allows objects of different classes to be treated as if they were the same type. This makes it easier to write code that can work with different types of objects in a consistent way.\nOverall, MULTOVL is a powerful and versatile programming language that is well-suited for a wide range of applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. MULTOVL is a programming language.\n2. MULTOVL is designed to be easy to learn and use. \n3. MULTOVL supports multiple inheritance. \n4. MULTOVL supports polymorphism.\n5. MULTOVL is a high-level language, allowing developers to code without worrying about low-level execution details.",
    "vicuna-13b_fact": [
      "MULTOVL is a programming language.",
      "MULTOVL is designed to be easy to learn and use.",
      "MULTOVL supports multiple inheritance.",
      "MULTOVL supports polymorphism.",
      "MULTOVL is a high-level language, allowing developers to code without worrying about low-level execution details."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "vicuna-13b_response": "GDF15, also known as growth differentiation factor 15, is a protein that has been studied in the context of metformin treatment for type 2 diabetes. Metformin is a widely used oral medication for the treatment of type 2 diabetes, and it works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.\nSeveral studies have suggested that GDF15 may be a potential biomarker for the effectiveness of metformin treatment in patients with type 2 diabetes. GDF15 levels have been shown to decrease in response to metformin treatment, and this decrease has been associated with improvements in glycemic control and insulin sensitivity.\nHowever, more research is needed to fully understand the role of GDF15 as a biomarker for metformin treatment. It is also important to note that other biomarkers, such as HbA1c and fasting plasma glucose, are more widely used and established as markers of glycemic control in patients with type 2 diabetes.\nIn conclusion, while GDF15 may have potential as a biomarker for metformin treatment in patients with type 2 diabetes, further research is needed to fully understand its role and to establish its clinical utility.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GDF15, also known as growth differentiation factor 15, is a protein that has been studied in the context of metformin treatment for type 2 diabetes.\n2. Metformin is an oral medication for the treatment of type 2 diabetes which works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.\n3. Several studies have suggested that GDF15 may be a potential biomarker for the effectiveness of metformin treatment in patients with type 2 diabetes.\n4. GDF15 levels have been observed to decrease in response to metformin treatment, and this decrease has been associated with improvements in glycemic control and insulin sensitivity.\n5. Other biomarkers, like HbA1c and fasting plasma glucose, are more widely used and established as markers of glycemic control in patients with type 2 diabetes.",
    "vicuna-13b_fact": [
      "GDF15, also known as growth differentiation factor 15, is a protein that has been studied in the context of metformin treatment for type 2 diabetes.",
      "Metformin is an oral medication for the treatment of type 2 diabetes which works by decreasing glucose production in the liver and increasing insulin sensitivity in muscle and fat tissue.",
      "Several studies have suggested that GDF15 may be a potential biomarker for the effectiveness of metformin treatment in patients with type 2 diabetes.",
      "GDF15 levels have been observed to decrease in response to metformin treatment, and this decrease has been associated with improvements in glycemic control and insulin sensitivity.",
      "Other biomarkers, like HbA1c and fasting plasma glucose, are more widely used and established as markers of glycemic control in patients with type 2 diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "vicuna-13b_response": "Recursive splicing is a process in which a splicing event occurs within a previously spliced intron. It is a form of alternative splicing, which is a process in which a single gene can produce multiple mRNA isoforms by using different combinations of exons.\nRecursive splicing can occur in both long and short introns, but it is more common in short introns. This is because short introns have a lower energy state, which makes them more susceptible to splicing events. Additionally, short introns are more likely to be included in the splicing machinery's search for a splice site, as they are more accessible to the splicing factors.\nRecursive splicing can also occur in introns that are too short to be spliced out, this is called intron retention. This process can be regulated by different factors such as the presence of specific proteins or RNA elements in the intron.\nIt's important to note that the length of the intron is not the only factor that determines whether recursive splicing will occur, other factors such as the presence of specific proteins or RNA elements in the intron, the presence of specific miRNA, and the chromatin structure can also regulate recursive splicing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Recursive splicing is a process in which a splicing event occurs within a previously spliced intron. \n2. In recursive splicing, a single gene can produce multiple mRNA isoforms by using different combinations of exons.\n3. Recursive splicing is more common in short introns because they have a lower energy state, making them more susceptible to splicing events.\n4. Intron retention occurs when introns that are too short to be spliced out undergo recursive splicing.\n5. The occurrence of recursive splicing is not only determined by the length of the intron, but also other factors such as the presence of specific proteins or RNA elements, the presence of specific miRNA, and the chromatin structure.",
    "vicuna-13b_fact": [
      "Recursive splicing is a process in which a splicing event occurs within a previously spliced intron.",
      "In recursive splicing, a single gene can produce multiple mRNA isoforms by using different combinations of exons.",
      "Recursive splicing is more common in short introns because they have a lower energy state, making them more susceptible to splicing events.",
      "Intron retention occurs when introns that are too short to be spliced out undergo recursive splicing.",
      "The occurrence of recursive splicing is not only determined by the length of the intron, but also other factors such as the presence of specific proteins or RNA elements, the presence of specific miRNA, and the chromatin structure."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Recursive splicing is more common in long introns due to their complex structure, not because of a lower energy state or susceptibility to splicing events.\n4. FALSE [correction]: Intron retention is a form of alternative splicing where the intron is not removed. It does not involve recursive splicing.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "vicuna-13b_response": "The TALE-iD method is a systematic approach to identifying potential ecological risks associated with the use of engineered nanomaterials (ENMs) in various applications. The acronym TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose,\" which describes the key components of the method.\nThe TALE-iD method is used to evaluate the potential ecological risks of ENMs by considering the interactions between the ENMs and various components of the environment, including living organisms, their life cycle stages, and the various endpoints that may be affected. The method is designed to be used in the early stages of ENM development, to help identify potential risks and inform the design of safer and more sustainable ENMs.\nThe TALE-iD method involves a systematic process of identifying the potential target organisms and life cycle stages that may be affected by the ENMs, as well as the endpoints that may be affected, such as reproductive success, survival, or behavior. The method also considers the individual dose of the ENMs, which is the amount of ENMs that may be taken up by an individual organism or cell.\nOverall, the TALE-iD method is a valuable tool for identifying potential ecological risks associated with the use of ENMs, and can help inform the development of safer and more sustainable ENMs.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The TALE-iD method is used to identify potential ecological risks associated with the use of engineered nanomaterials (ENMs).\n2. The acronym TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose.\"\n3. This method involves a systematic process of identifying potential target organisms and life cycle stages that may be affected by the ENMs.\n4. Endpoints like reproductive success, survival, or behavior are considered in the TALE-iD method.\n5. The individual dose of the ENMs, which is the amount of ENMs that may be taken up by an individual organism or cell, is also taken into account in this method.",
    "vicuna-13b_fact": [
      "The TALE-iD method is used to identify potential ecological risks associated with the use of engineered nanomaterials (ENMs).",
      "The acronym TALE-iD stands for \"Target-Organism-Affected-Life-cycle-Stage-Endpoint-Individual-Dose.\"",
      "This method involves a systematic process of identifying potential target organisms and life cycle stages that may be affected by the ENMs.",
      "Endpoints like reproductive success, survival, or behavior are considered in the TALE-iD method.",
      "The individual dose of the ENMs, which is the amount of ENMs that may be taken up by an individual organism or cell, is also taken into account in this method."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "vicuna-13b_response": "One popular Lisp framework for image processing is called \"CL-PNG\". CL-PNG is a Common Lisp library for working with PNG (Portable Network Graphics) images. It provides a simple and efficient way to read, manipulate, and write PNG images in Lisp. The library supports all the features of the PNG format, including transparency, gamma correction, and interlacing.\nCL-PNG is just one example of a Lisp framework for image processing. There are many other Lisp libraries and frameworks available for image processing, including CL-GD (for working with GIF images), CL-JPEG (for working with JPEG images), and CL-GIF (for working with animated GIF images).\nTo use CL-PNG or any other Lisp image processing library, you will need to have a working installation of a Common Lisp compiler or interpreter. You can then load the library into your Lisp program and use its functions to process images.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CL-PNG is a Common Lisp library for working with PNG images.\n2. The CL-PNG library supports all the features of the PNG format, including transparency, gamma correction, and interlacing.\n3. There are other Lisp libraries for image processing such as CL-GD, CL-JPEG, and CL-GIF.\n4. You need a working installation of a Common Lisp compiler or interpreter to use CL-PNG or any other Lisp image processing library.\n5. CL-PNG provides a way to read, manipulate, and write PNG images in Lisp.",
    "vicuna-13b_fact": [
      "CL-PNG is a Common Lisp library for working with PNG images.",
      "The CL-PNG library supports all the features of the PNG format, including transparency, gamma correction, and interlacing.",
      "There are other Lisp libraries for image processing such as CL-GD, CL-JPEG, and CL-GIF.",
      "You need a working installation of a Common Lisp compiler or interpreter to use CL-PNG or any other Lisp image processing library.",
      "CL-PNG provides a way to read, manipulate, and write PNG images in Lisp."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "vicuna-13b_response": "Whole genome duplication (WGD) events are known to have occurred in the evolutionary history of many eukaryotic species, including Saccharomyces cerevisiae, the baker's yeast. WGD events result in the duplication of an entire genome, leading to the creation of multiple copies of each gene. The exact number of genes in S. cerevisiae that are the result of an ancient WGD event is not well established, but it is estimated to be around 50-100 genes. These genes are thought to be responsible for a variety of functions, including the regulation of gene expression, DNA repair, and the maintenance of chromosome stability.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Whole genome duplication (WGD) events have occurred in the evolutionary history of many eukaryotic species, including Saccharomyces cerevisiae.\n2. WGD events result in the duplication of an entire genome, creating multiple copies of each gene.\n3. The exact number of genes in S. cerevisiae that are a result of an ancient WGD event is not well established.\n4. It's estimated that around 50-100 genes in S. cerevisiae are the result of an ancient WGD event.\n5. These duplicated genes in S. cerevisiae are thought to be responsible for functions such as the regulation of gene expression, DNA repair, and the maintenance of chromosome stability.",
    "vicuna-13b_fact": [
      "Whole genome duplication (WGD) events have occurred in the evolutionary history of many eukaryotic species, including Saccharomyces cerevisiae.",
      "WGD events result in the duplication of an entire genome, creating multiple copies of each gene.",
      "The exact number of genes in S. cerevisiae that are a result of an ancient WGD event is not well established.",
      "It's estimated that around 50-100 genes in S. cerevisiae are the result of an ancient WGD event.",
      "These duplicated genes in S. cerevisiae are thought to be responsible for functions such as the regulation of gene expression, DNA repair, and the maintenance of chromosome stability."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "vicuna-13b_response": "Estrogen-related receptor β (Esrrb) is a transcription factor that binds to specific DNA sequences to regulate gene expression. Esrrb is known to bind to a variety of estrogen response elements (EREs) in the promoter regions of target genes, and plays a role in the regulation of cell proliferation, differentiation, and apoptosis.\nIn terms of which complex is bound by Esrrb, it is not clear if Esrrb binds to a specific complex or if it interacts with multiple complexes. However, Esrrb has been shown to interact with other transcription factors, such as AP-1, Sp1, and NF-κB, and these interactions can modulate its transcriptional activity. Additionally, Esrrb has been shown to interact with coactivators and corepressors, such as p300 and HDAC1, which can affect its ability to bind to DNA and regulate gene expression.\nOverall, while Esrrb is known to bind to specific DNA sequences, it is not clear if it is specifically bound to a particular complex.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Estrogen-related receptor β (Esrrb) is a transcription factor.\n2. Esrrb binds to specific DNA sequences to regulate gene expression.\n3. Esrrb binds to a variety of estrogen response elements (EREs) in the promoter regions of target genes.\n4. Esrrb interacts with other transcription factors, such as AP-1, Sp1, and NF-κB.\n5. Esrrb interacts with coactivators and corepressors, such as p300 and HDAC1.",
    "vicuna-13b_fact": [
      "Estrogen-related receptor β (Esrrb) is a transcription factor.",
      "Esrrb binds to specific DNA sequences to regulate gene expression.",
      "Esrrb binds to a variety of estrogen response elements (EREs) in the promoter regions of target genes.",
      "Esrrb interacts with other transcription factors, such as AP-1, Sp1, and NF-κB.",
      "Esrrb interacts with coactivators and corepressors, such as p300 and HDAC1."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Estrogen-related receptor β (Esrrb) does not bind to estrogen response elements (EREs), but to ERR response elements.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "vicuna-13b_response": "ZCCHC17 is a protein that plays a critical role in regulating the activity of other proteins in the body. Specifically, it is a chaperone protein, which helps to fold and assemble other proteins into their proper, functional forms.\nChaperone proteins are important because they help to ensure that proteins are properly folded and assembled, which is critical for their function. If proteins are not properly folded and assembled, they can become misfolded and aggregate, leading to harmful effects on the body.\nZCCHC17 is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to stress or other adverse conditions in the body. HSPs help to protect cells from damage and promote the proper folding and assembly of proteins.\nOverall, the role of ZCCHC17 is to help regulate the activity of other proteins in the body, ensuring that they are properly folded and assembled into their functional forms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ZCCHC17 is a protein that regulates the activity of other proteins in the body.\n2. ZCCHC17 is a chaperone protein.\n3. Chaperone proteins help to fold and assemble other proteins into their proper, functional forms.\n4. ZCCHC17 belongs to the heat shock protein (HSP) family.\n5. Heat shock proteins are expressed in response to stress or other adverse conditions in the body.",
    "vicuna-13b_fact": [
      "ZCCHC17 is a protein that regulates the activity of other proteins in the body.",
      "ZCCHC17 is a chaperone protein.",
      "Chaperone proteins help to fold and assemble other proteins into their proper, functional forms.",
      "ZCCHC17 belongs to the heat shock protein (HSP) family.",
      "Heat shock proteins are expressed in response to stress or other adverse conditions in the body."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "vicuna-13b_response": "The nuclear pore basket in human cells is formed by a complex of proteins known as nuclear pore complex (NPC) proteins. The NPC is a large macromolecular structure that spans the nuclear envelope and forms the nuclear pore. It is composed of multiple copies of different NPC proteins, which are arranged in a specific order to form a filamentous structure that extends across the nuclear envelope.\nThere are several different types of NPC proteins that are involved in forming the nuclear pore basket in human cells. These include:\n1. Nup1-100: These are the most abundant NPC proteins and form the core of the nuclear pore basket. They are responsible for the formation of the central channel of the nuclear pore, which is the pathway for the movement of molecules between the cytoplasm and the nucleus.\n2. Nup11-16: These NPC proteins are involved in the formation of the nuclear pore basket and help to anchor the NPC to the nuclear envelope.\n3. Nup17-18: These NPC proteins are involved in the formation of the nuclear pore basket and are thought to play a role in the regulation of nuclear transport.\n4. Nup21-20: These NPC proteins are involved in the formation of the nuclear pore basket and are thought to play a role in the regulation of nuclear transport.\nOverall, the nuclear pore basket is a complex structure that is formed by multiple copies of different NPC proteins, and it plays a critical role in regulating the movement of molecules between the cytoplasm and the nucleus in human cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The nuclear pore basket in human cells is formed by a complex of proteins known as nuclear pore complex (NPC) proteins.\n2. The NPC is a large macromolecular structure that spans the nuclear envelope and forms the nuclear pore.\n3. The NPC is composed of multiple copies of different NPC proteins, which are arranged in a specific order to form a filamentous structure that extends across the nuclear envelope.\n4. The nuclear pore basket is involved in regulating the movement of molecules between the cytoplasm and the nucleus in human cells.\n5. The most abundant NPC proteins are Nup1-100, and they form the core of the nuclear pore basket and the central channel of the nuclear pore.",
    "vicuna-13b_fact": [
      "The nuclear pore basket in human cells is formed by a complex of proteins known as nuclear pore complex (NPC) proteins.",
      "The NPC is a large macromolecular structure that spans the nuclear envelope and forms the nuclear pore.",
      "The NPC is composed of multiple copies of different NPC proteins, which are arranged in a specific order to form a filamentous structure that extends across the nuclear envelope.",
      "The nuclear pore basket is involved in regulating the movement of molecules between the cytoplasm and the nucleus in human cells.",
      "The most abundant NPC proteins are Nup1-100, and they form the core of the nuclear pore basket and the central channel of the nuclear pore."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "vicuna-13b_response": "Gepotidacin is a type of topoisomerase inhibitor known as a pyrazole-containing topoisomerase inhibitor. Topoisomerase inhibitors are a class of antibiotics that target the enzymes responsible for regulating the topology of DNA, which is the way that the DNA molecule is organized and folded within a cell. Topoisomerase inhibitors are commonly used to treat bacterial infections, particularly those caused by Gram-positive bacteria. Gepotidacin is a newer antibiotic that has been shown to be effective against a wide range of bacterial pathogens, including those that are resistant to other types of antibiotics. It is currently in clinical trials for the treatment of various bacterial infections.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Gepotidacin is a pyrazole-containing topoisomerase inhibitor.\n2. Topoisomerase inhibitors are a class of antibiotics.\n3. Topoisomerase inhibitors aim at enzymes responsible for regulating the topology of DNA.\n4. Gepotidacin is effective against a wide range of bacterial pathogens, including drug-resistant ones.\n5. Gepotidacin is currently in clinical trials for the treatment of various bacterial infections.",
    "vicuna-13b_fact": [
      "Gepotidacin is a pyrazole-containing topoisomerase inhibitor.",
      "Topoisomerase inhibitors are a class of antibiotics.",
      "Topoisomerase inhibitors aim at enzymes responsible for regulating the topology of DNA.",
      "Gepotidacin is effective against a wide range of bacterial pathogens, including drug-resistant ones.",
      "Gepotidacin is currently in clinical trials for the treatment of various bacterial infections."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "vicuna-13b_response": "Canvas SPW (Single Page Web) is a web application that allows users to create and edit web pages using a simple, intuitive interface. It is designed to be easy to use for both beginners and experienced web developers.\nCanvas SPW allows users to create and edit web pages using a variety of tools, including a visual editor, a code editor, and a range of design and layout tools. Users can choose to work in the visual editor, which provides a WYSIWYG (What You See Is What You Get) interface for creating and editing web pages, or they can use the code editor to work directly with HTML, CSS, and JavaScript code.\nOne of the key features of Canvas SPW is its support for responsive design, which allows users to create web pages that are optimized for viewing on a range of devices, including smartphones, tablets, and desktop computers. Canvas SPW also includes a range of templates and themes that users can use to quickly create professional-looking web pages.\nIn addition to its core web page creation and editing tools, Canvas SPW also includes a range of other features, such as a file manager for uploading and organizing files, a project manager for managing multiple web pages and sites, and a range of integrations with other tools and services.\nOverall, Canvas SPW is a powerful and versatile web application that provides users with a wide range of tools and features for creating and editing web pages. Its intuitive interface and support for responsive design make it an excellent choice for both beginners and experienced web developers.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Canvas SPW (Single Page Web) is a web application that allows users to create and edit web pages.\n2. The application includes tools like a visual editor, a code editor, and design and layout tools.\n3. Canvas SPW has a feature that supports responsive design, optimizing web pages for different devices including smartphones, tablets, and desktop computers.\n4. Canvas SPW includes a file manager for uploading and organizing files and a project manager for managing multiple web pages and sites.\n5. It allows direct work with HTML, CSS, and JavaScript code using the code editor.",
    "vicuna-13b_fact": [
      "Canvas SPW (Single Page Web) is a web application that allows users to create and edit web pages.",
      "The application includes tools like a visual editor, a code editor, and design and layout tools.",
      "Canvas SPW has a feature that supports responsive design, optimizing web pages for different devices including smartphones, tablets, and desktop computers.",
      "Canvas SPW includes a file manager for uploading and organizing files and a project manager for managing multiple web pages and sites.",
      "It allows direct work with HTML, CSS, and JavaScript code using the code editor."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "vicuna-13b_response": "STING (Stimulator of Interferon Genes) is a critical sensor of the cGAS-cGAS sensor complex that detects intracellular DNA and triggers an interferon response. Inhibition of STING has been shown to be a promising strategy for treating viral infections and cancer. Here are some known STING agonists:\n1. Cyclic dinucleotides (CDNs): CDNs are small molecules that mimic the activity of viral DNA and activate STING. CDNs include the natural product cytidine-5'-triphosphate (cGMP) and synthetic analogs such as 2',3'-cGAMP and 2',6'-cGAMP.\n2. Synthetic STING agonists: Synthetic molecules that directly bind to STING and activate it have also been developed. Examples include compounds such as JQ1, MRT68111, and JNJ-752605.\n3. Endogenous STING agonists: Certain viruses and bacteria have evolved mechanisms to activate STING through the use of viral DNA sensors or bacterial toxins. For example, the herpesvirus US11 activates STING through its viral DNA sensor, while the bacterial toxin anthrax protective antigen activates STING through a different mechanism.\nOverall, STING agonists have shown promise as potential therapeutics for treating viral infections and cancer, and further research is ongoing to identify and develop new and more effective STING agonists.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. STING is a critical sensor of the cGAS-cGAS sensor complex that detects intracellular DNA and triggers an interferon response.\n2. Inhibition of STING is a strategy for treating viral infections and cancer.\n3. Cyclic dinucleotides (CDNs) are small molecules that mimic the activity of viral DNA and activate STING.\n4. Synthetic STING agonists such as JQ1, MRT68111, and JNJ-752605 directly bind to STING and activate it.\n5. Certain viruses and bacteria have evolved mechanisms to activate STING through the use of viral DNA sensors or bacterial toxins.",
    "vicuna-13b_fact": [
      "STING is a critical sensor of the cGAS-cGAS sensor complex that detects intracellular DNA and triggers an interferon response.",
      "Inhibition of STING is a strategy for treating viral infections and cancer.",
      "Cyclic dinucleotides (CDNs) are small molecules that mimic the activity of viral DNA and activate STING.",
      "Synthetic STING agonists such as JQ1, MRT68111, and JNJ-752605 directly bind to STING and activate it.",
      "Certain viruses and bacteria have evolved mechanisms to activate STING through the use of viral DNA sensors or bacterial toxins."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: cGAS is a sensor of the cGAS-STING sensor complex that detects intracellular DNA and triggers an interferon response, not STING.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Certain viruses and bacteria have evolved mechanisms to evade STING activation, not to activate it.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "vicuna-13b_response": "SLIC-CAGE (Spatially Localized Implicit Computational Assemblies for Geometric Engineering) is a computational framework for designing and optimizing the geometry of structures. It is a combination of two methods: SLIC (Spatially Localized Implicit Computation) and CAGE (Computational Assembly of Geometric Elements).\nSLIC is a method for solving partial differential equations (PDEs) that describe the behavior of materials in response to external loads. It does this by dividing the solution domain into small, non-overlapping elements, and solving for each element independently using the finite element method. The key innovation of SLIC is that it uses a sparse linear algebra solver to solve the system of equations, which makes it much more efficient than traditional finite element methods.\nCAGE is a method for designing the geometry of structures by optimizing a set of design variables that define the shape of the structure. It does this by using a optimization algorithm to find the configuration of the design variables that minimizes a cost function that reflects the desired behavior of the structure.\nThe combination of SLIC and CAGE in SLIC-CAGE allows for the efficient and accurate design and optimization of the geometry of structures. By using SLIC to solve the PDEs that describe the behavior of the structure, and CAGE to optimize the geometry, SLIC-CAGE can find the optimal shape of a structure that satisfies a set of design constraints and performance requirements. This can be used in a wide range of applications, such as in the design of bridges, buildings, and aircraft.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SLIC-CAGE (Spatially Localized Implicit Computational Assemblies for Geometric Engineering) is a computational framework for designing and optimizing the geometry of structures.\n2. SLIC-CAGE is a combination of two methods: Spatially Localized Implicit Computation (SLIC) and Computational Assembly of Geometric Elements (CAGE).\n3. SLIC method solves partial differential equations that describe the behavior of materials in response to external loads.\n4. SLIC uses a sparse linear algebra solver to solve the system of equations.\n5. CAGE method designs the geometry of structures by optimizing a set of design variables.",
    "vicuna-13b_fact": [
      "SLIC-CAGE (Spatially Localized Implicit Computational Assemblies for Geometric Engineering) is a computational framework for designing and optimizing the geometry of structures.",
      "SLIC-CAGE is a combination of two methods: Spatially Localized Implicit Computation (SLIC) and Computational Assembly of Geometric Elements (CAGE).",
      "SLIC method solves partial differential equations that describe the behavior of materials in response to external loads.",
      "SLIC uses a sparse linear algebra solver to solve the system of equations.",
      "CAGE method designs the geometry of structures by optimizing a set of design variables."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "vicuna-13b_response": "LEM-3 stands for Lunar Exploration Module-3, which was a spacecraft designed by NASA to land on the Moon during the Apollo 15 mission in 1971. The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.\nThe LEM-3 was a two-stage spacecraft, consisting of a descent stage and an ascent stage. The descent stage was designed to land on the Moon and support the astronauts during their stay on the lunar surface. It had a landing gear system that allowed it to touch down on the Moon's surface and a rocket engine that enabled it to take off from the lunar surface and return to orbit.\nThe ascent stage, on the other hand, was designed to carry the astronauts back to the command module in orbit around the Moon. It had a rocket engine that propelled it upward and a cabin that housed the astronauts during their journey back to orbit.\nIn addition to its primary role, LEM-3 also served as a laboratory for the astronauts to conduct scientific experiments on the lunar surface. The spacecraft was equipped with various instruments and tools that allowed the astronauts to study the lunar environment, including the Moon's surface, rocks, and soil.\nOverall, the LEM-3 played a crucial role in the Apollo 15 mission, enabling the astronauts to successfully land on the Moon and conduct a range of scientific experiments on the lunar surface.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. LEM-3 stands for Lunar Exploration Module-3, a spacecraft designed by NASA for the Apollo 15 mission in 1971.\n2. The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.\n3. LEM-3 was a two-stage spacecraft, consisting of a descent stage and an ascent stage.\n4. The descent stage of LEM-3 was designed to land on the Moon and support the astronauts during their stay on the lunar surface.\n5. The ascent stage of LEM-3 was designed to carry the astronauts back to the command module in orbit around the Moon.",
    "vicuna-13b_fact": [
      "LEM-3 stands for Lunar Exploration Module-3, a spacecraft designed by NASA for the Apollo 15 mission in 1971.",
      "The primary role of LEM-3 was to transport astronauts and their equipment to the lunar surface and back to the command module in orbit around the Moon.",
      "LEM-3 was a two-stage spacecraft, consisting of a descent stage and an ascent stage.",
      "The descent stage of LEM-3 was designed to land on the Moon and support the astronauts during their stay on the lunar surface.",
      "The ascent stage of LEM-3 was designed to carry the astronauts back to the command module in orbit around the Moon."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: There's no record of a spacecraft named Lunar Exploration Module-3 (LEM-3) in the Apollo program. Apollo 15 used the Lunar Module-10, often referred as \"Falcon\".\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "vicuna-13b_response": "Here is a list of releases of `tmVar`, which is a package for managing temporary variables in Haskell:\n* `tmVar` version 1.0.0\n* `tmVar` version 1.1.0\n* `tmVar` version 1.2.0\n* `tmVar` version 1.2.1\n* `tmVar` version 1.2.2\n* `tmVar` version 1.2.3\n* `tmVar` version 1.2.4\n* `tmVar` version 1.2.5\n* `tmVar` version 1.2.6\n* `tmVar` version 1.2.7\n* `tmVar` version 1.2.8\n* `tmVar` version 1.2.9\n* `tmVar` version 1.2.10\n* `tmVar` version 1.2.11\n* `tmVar` version 1.2.12\n* `tmVar` version 1.2.13\n* `tmVar` version 1.2.14\n* `tmVar` version 1.2.15\n* `tmVar` version 1.2.16\n* `tmVar` version 1.2.17\n* `tmVar` version 1.2.18\n* `tmVar` version 1.2.19\n* `tmVar` version 1.2.20\n* `tmVar` version 1.2.21\n* `tmVar` version 1.2.22\n* `tmVar` version 1.2.23\n* `tmVar` version 1.2.24\n* `tmVar` version 1.2.25\n* `tmVar` version 1.2.26\n* `tmVar` version 1.2.27\n* `tmVar` version 1.2.28\n* `tmVar` version 1.2.29\n* `tmVar` version 1.2.30\n* `tmVar` version 1.2.31\n* `tmVar` version 1.2.32\n* `tmVar` version 1",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. `tmVar` is a package for managing temporary variables in Haskell.\n2. `tmVar` version 1.0.0 was released.\n3. `tmVar` version 1.1.0 was released.\n4. `tmVar` version 1.2.0 was released.\n5. `tmVar` version 1.2.1 was released.",
    "vicuna-13b_fact": [
      "`tmVar` is a package for managing temporary variables in Haskell.",
      "`tmVar` version 1.0.0 was released.",
      "`tmVar` version 1.1.0 was released.",
      "`tmVar` version 1.2.0 was released.",
      "`tmVar` version 1.2.1 was released."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: `TMVar` is a package for managing temporary variables in Haskell, not `tmVar`.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "vicuna-13b_response": "There are several databases of somatic mutations in normal cells, including:\n1. The Cancer Genome Atlas (TCGA) - a publicly available database that provides genomic and molecular characterization of a variety of cancer types, including somatic mutations in normal cells.\n2. The International Cancer Genome Consortium (ICGC) - a global collaboration that aims to perform comprehensive genomic analyses of a range of cancer types, including somatic mutations in normal cells.\n3. The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database - a resource that provides detailed information on somatic mutations in non-small cell lung cancer, including those that occur in normal cells.\n4. The Clinical Somatic Genome Project (CSGP) - a large-scale effort to analyze the genomes of patients with a range of somatic diseases, including those that involve normal cells.\nThese databases provide valuable resources for researchers and clinicians interested in understanding the genetic changes that occur in normal cells during the development of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Cancer Genome Atlas (TCGA) is a publicly available database that provides genomic and molecular characterization of a variety of cancer types.\n2. The International Cancer Genome Consortium (ICGC) is a global collaboration that aims to perform comprehensive genomic analyses of a range of cancer types.\n3. The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database is a resource that provides information on somatic mutations in non-small cell lung cancer.\n4. The Clinical Somatic Genome Project (CSGP) is a project to analyze the genomes of patients with a range of somatic diseases.\n5. These databases provide resources for researchers and clinicians interested in understanding the genetic changes that occur in normal cells during the development of cancer.",
    "vicuna-13b_fact": [
      "The Cancer Genome Atlas (TCGA) is a publicly available database that provides genomic and molecular characterization of a variety of cancer types.",
      "The International Cancer Genome Consortium (ICGC) is a global collaboration that aims to perform comprehensive genomic analyses of a range of cancer types.",
      "The Mutation Analysis in Non-small Cell Lung Cancer (Miracle) database is a resource that provides information on somatic mutations in non-small cell lung cancer.",
      "The Clinical Somatic Genome Project (CSGP) is a project to analyze the genomes of patients with a range of somatic diseases.",
      "These databases provide resources for researchers and clinicians interested in understanding the genetic changes that occur in normal cells during the development of cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "vicuna-13b_response": "Yes, there are several graph kernel libraries available that are implemented in Java. Some of the popular ones are:\n1. JUNG: JUNG (Java Universal Network/Graph) is a Java library for graph data structures and graph algorithms. It provides a wide range of graph algorithms, including PageRank, Breadth-First Search, Dijkstra's algorithm, and more.\n2. GraphX: GraphX is a distributed graph processing system for Apache Spark. It provides a set of graph algorithms and allows for efficient processing of large-scale graph data.\n3. GraphML Java: GraphML Java is a Java library for parsing and generating GraphML, a standard format for graph data. It provides a set of tools for working with GraphML files, including parsing, serialization, and visualization.\n4. Gephi: Gephi is a popular graph visualization tool that also provides a Java API for working with graph data. The API allows for custom visualizations and provides access to the graph's data and layout.\n5. NetworkX: NetworkX is a Python library for graph data structures and graph algorithms, but it also has a Java port called JNetworkX. It provides a wide range of graph algorithms and data structures, including directed and undirected graphs, weighted and unweighted graphs, and more.\nThese libraries provide a variety of tools and algorithms for working with graph data in Java, and can be used for tasks such as graph analysis, visualization, and processing.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. JUNG is a Java library for graph data structures and graph algorithms.\n2. GraphX is a distributed graph processing system for Apache Spark.\n3. GraphML Java is a Java library for parsing and generating GraphML, a standard format for graph data.\n4. Gephi is a graph visualization tool that also provides a Java API for working with graph data.\n5. NetworkX, a Python library for graph data structures and graph algorithms, has a Java port called JNetworkX.",
    "vicuna-13b_fact": [
      "JUNG is a Java library for graph data structures and graph algorithms.",
      "GraphX is a distributed graph processing system for Apache Spark.",
      "GraphML Java is a Java library for parsing and generating GraphML, a standard format for graph data.",
      "Gephi is a graph visualization tool that also provides a Java API for working with graph data.",
      "NetworkX, a Python library for graph data structures and graph algorithms, has a Java port called JNetworkX."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: NetworkX is a Python library for the creation, manipulation, and study of the structure of complex networks. There is no Java port called JNetworkX.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "vicuna-13b_response": "SHERLOCKv2 is an advanced platform for automated threat intelligence and active defense. It integrates four key advances to provide comprehensive and effective cybersecurity capabilities. These advances are:\n1. Data Science: SHERLOCKv2 leverages data science techniques to provide advanced analytics and machine learning capabilities. This allows the platform to automatically detect and respond to threats in real-time, and to continuously learn and adapt to new threats and attack techniques.\n2. Automation: SHERLOCKv2 automates many of the tasks involved in threat intelligence and active defense, such as data collection, analysis, and response. This enables security teams to focus on higher-level tasks and strategic decision-making, while the platform handles the day-to-day operational tasks.\n3. Artificial Intelligence (AI): SHERLOCKv2 incorporates AI technologies such as natural language processing (NLP) and computer vision to provide advanced threat detection and response capabilities. For example, the platform can automatically analyze and interpret threat intelligence feeds, network traffic, and other data sources to identify potential threats and take appropriate action.\n4. Open Architecture: SHERLOCKv2 is built on an open architecture that allows it to integrate with other security tools and systems. This enables the platform to leverage existing security investments and to provide a seamless and integrated security solution that can meet the needs of organizations of all sizes and types.\nOverall, the integration of these four advances makes SHERLOCKv2 a powerful and effective platform for automated threat intelligence and active defense. It provides organizations with the advanced capabilities they need to detect and respond to threats quickly and effectively, and to stay ahead of the constantly evolving threat landscape.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SHERLOCKv2 integrates four major advances to enhance its cybersecurity capabilities. \n2. SHERLOCKv2 uses data science techniques for advanced analytics, machine learning capabilities and threat detection and response.\n3. Many tasks in threat intelligence and active defense, such as collection, analysis and response to data, are automated by SHERLOCKv2.\n4. Artificial Intelligence technologies like natural language processing (NLP) and computer vision are incorporated into SHERLOCKv2 for advanced threat detection and response.\n5. SHERLOCKv2 has an open architecture that enables it to integrate with other security tools and systems.",
    "vicuna-13b_fact": [
      "SHERLOCKv2 integrates four major advances to enhance its cybersecurity capabilities.",
      "SHERLOCKv2 uses data science techniques for advanced analytics, machine learning capabilities and threat detection and response.",
      "Many tasks in threat intelligence and active defense, such as collection, analysis and response to data, are automated by SHERLOCKv2.",
      "Artificial Intelligence technologies like natural language processing (NLP) and computer vision are incorporated into SHERLOCKv2 for advanced threat detection and response.",
      "SHERLOCKv2 has an open architecture that enables it to integrate with other security tools and systems."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "vicuna-13b_response": "The bartender algorithm is a heuristic search algorithm that is used to find the shortest path between two nodes in a graph. It is commonly used in artificial intelligence applications, such as in robotics and computer games, to find the optimal path between two points.\nThe algorithm works by simulating a bartender who is trying to minimize the distance that customers have to travel to reach their desired location. The bartender starts at the starting node and selects the closest unvisited neighbor. The bartender then moves to the selected neighbor and selects the closest unvisited neighbor again. This process continues until the bartender reaches the goal node.\nThe bartender algorithm uses a heuristic function to guide the search process. The heuristic function estimates the distance between the current node and the goal node. The bartender algorithm uses this heuristic function to determine which neighbor to select next, based on the estimated distance to the goal node.\nOne of the advantages of the bartender algorithm is that it is very efficient and can find the shortest path between two nodes in a graph. However, it is not guaranteed to find the optimal path, and there may be other algorithms that are better suited for certain types of problems.\nOverall, the bartender algorithm is a useful tool for finding the shortest path between two nodes in a graph, and it is commonly used in a variety of artificial intelligence applications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The bartender algorithm is a heuristic search algorithm used to find the shortest path between two nodes in a graph.\n2. This algorithm is commonly used in artificial intelligence applications such as robotics and computer games.\n3. The bartender algorithm works by starting at the initial node and selecting the closest unvisited neighbor.\n4. This algorithm uses a heuristic function to guide the search process, which estimates the distance between the current node and the goal node.\n5. The bartender algorithm is efficient in finding the shortest path between two nodes in a graph, but it is not guaranteed to find the optimal path.",
    "vicuna-13b_fact": [
      "The bartender algorithm is a heuristic search algorithm used to find the shortest path between two nodes in a graph.",
      "This algorithm is commonly used in artificial intelligence applications such as robotics and computer games.",
      "The bartender algorithm works by starting at the initial node and selecting the closest unvisited neighbor.",
      "This algorithm uses a heuristic function to guide the search process, which estimates the distance between the current node and the goal node.",
      "The bartender algorithm is efficient in finding the shortest path between two nodes in a graph, but it is not guaranteed to find the optimal path."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Dijkstra's algorithm is a heuristic search algorithm used to find the shortest path between two nodes in a graph, not the bartender algorithm.\n2. TRUE\n3. FALSE [correction]: This is a description of Dijkstra's algorithm, not the bartender algorithm.\n4. FALSE [correction]: The A* search algorithm uses a heuristic function to guide the search process, which estimates the distance between the current node and the goal node.\n5. FALSE [correction]: Dijkstra's or A* algorithms are efficient in finding the shortest path between two nodes in a graph and are guaranteed to find the optimal path, not the bartender algorithm.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "vicuna-13b_response": "There are several web-based pedigree editors available, including:\n1. GenoPro: A free, open-source, web-based genealogy software that allows users to create and edit family trees.\n2. MyHeritage: A paid web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n3. Ancestry: A paid web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n4. FamilySearch: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n5. Geni: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\n6. WikiTree: A free, web-based genealogy software that allows users to create and edit family trees, as well as search for ancestors and collaborate with other family members.\nIt is important to note that the features and capabilities of these web-based pedigree editors may vary, and it is recommended to research and compare them before making a decision.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GenoPro is a free, open-source, web-based genealogy software.\n2. MyHeritage is a paid web-based genealogy software.\n3. Ancestry is a paid web-based genealogy software.\n4. FamilySearch is a free web-based genealogy software.\n5. Geni and WikiTree are free web-based genealogy softwares.",
    "vicuna-13b_fact": [
      "GenoPro is a free, open-source, web-based genealogy software.",
      "MyHeritage is a paid web-based genealogy software.",
      "Ancestry is a paid web-based genealogy software.",
      "FamilySearch is a free web-based genealogy software.",
      "Geni and WikiTree are free web-based genealogy softwares."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: GenoPro is a paid, genealogy software but it is not open-source nor web-based.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "vicuna-13b_response": "There are several curated databases that contain information on spider venom toxins. Some of the most well-known databases include:\n1. The Spider Venom Database (SVD): This database is maintained by the Australian Venom Research Unit and contains information on the venoms of spiders from around the world. It includes information on the toxins found in spider venom, their molecular structures, and their biological activities.\n2. The Toxin Database: This database is maintained by the National Center for Biotechnology Information (NCBI) and contains information on toxins from a variety of sources, including spider venom. It includes information on the molecular structures of toxins, their biological activities, and their taxonomic affiliations.\n3. The Venomous Animals Database: This database is maintained by the Venomous Animals Toxin Database (VATD) project and contains information on the venoms of a variety of animals, including spiders. It includes information on the toxins found in spider venom, their molecular structures, and their biological activities.\n4. The Spider Venomics Resource: This database is maintained by the University of California, Santa Cruz, and contains information on the transcriptomes of spiders and their venoms. It includes information on the genes and proteins involved in spider venom production, as well as the toxins themselves.\nThese databases are a great resource for researchers and others interested in spider venom toxins, and they provide a wealth of information on these fascinating molecules.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Spider Venom Database is maintained by the Australian Venom Research Unit.\n2. The Toxin Database is maintained by the National Center for Biotechnology Information.\n3. The Venomous Animals Database is maintained by the Venomous Animals Toxin Database project.\n4. The Spider Venomics Resource is maintained by the University of California, Santa Cruz.\n5. These databases provide information on toxins in spider venom, their molecular structures, and their biological activities.",
    "vicuna-13b_fact": [
      "The Spider Venom Database is maintained by the Australian Venom Research Unit.",
      "The Toxin Database is maintained by the National Center for Biotechnology Information.",
      "The Venomous Animals Database is maintained by the Venomous Animals Toxin Database project.",
      "The Spider Venomics Resource is maintained by the University of California, Santa Cruz.",
      "These databases provide information on toxins in spider venom, their molecular structures, and their biological activities."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "vicuna-13b_response": "Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied in the treatment of various types of cancer, including pancreatic cancer. While Axitinib has shown some promise in the treatment of pancreatic cancer, its effectiveness in prolonging survival in patients with this disease has been mixed.\nA number of clinical trials have been conducted to evaluate the safety and efficacy of Axitinib in the treatment of pancreatic cancer. One of the most significant studies was a phase III clinical trial known as the \"AGILE\" trial, which involved over 800 patients with advanced pancreatic cancer. The results of this trial showed that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.\nHowever, some smaller studies have suggested that Axitinib may benefit certain subgroups of pancreatic cancer patients. For example, a 2017 study published in the journal Cancer Research found that Axitinib may benefit patients with pancreatic cancer that has a specific genetic mutation known as CDH1. Additionally, a 2019 study published in the Journal of Clinical Oncology found that Axitinib may benefit patients with pancreatic cancer that has a high level of a protein called \"PD-L1\".\nIt is important to note that the use of Axitinib in the treatment of pancreatic cancer is still being studied, and more research is needed to fully understand its effectiveness in this context. Currently, Axitinib is not approved by the FDA for the treatment of pancreatic cancer.\nIn conclusion, while Axitinib has shown some promise in the treatment of pancreatic cancer, its effectiveness in prolonging survival in patients with this disease has been mixed. Further research is needed to fully understand the potential benefits and risks of Axitinib in the treatment of pancreatic cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied in the treatment of various types of cancer, including pancreatic cancer. \n2. The results of the AGILE trial showed that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.\n3. A 2017 study suggested that Axitinib may benefit patients with pancreatic cancer that has a specific genetic mutation known as CDH1.\n4. A 2019 study suggested that Axitinib may benefit patients with pancreatic cancer that has a high level of a protein called \"PD-L1\".\n5. Axitinib is not approved by the FDA for the treatment of pancreatic cancer.",
    "vicuna-13b_fact": [
      "Axitinib is a tyrosine kinase inhibitor (TKI) that has been studied in the treatment of various types of cancer, including pancreatic cancer.",
      "The results of the AGILE trial showed that Axitinib did not significantly improve overall survival compared to standard chemotherapy in patients with advanced pancreatic cancer.",
      "A 2017 study suggested that Axitinib may benefit patients with pancreatic cancer that has a specific genetic mutation known as CDH1.",
      "A 2019 study suggested that Axitinib may benefit patients with pancreatic cancer that has a high level of a protein called \"PD-L1\".",
      "Axitinib is not approved by the FDA for the treatment of pancreatic cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "vicuna-13b_response": "MLP (myosin regulatory light chain) is a protein that plays a key role in regulating the dynamics of F-actin, a key component of the cytoskeleton. MLP regulates the interaction between myosin motor proteins and actin filaments, allowing for the controlled contraction and relaxation of muscle cells.\nMLP regulates the interaction between myosin motor proteins and actin filaments by binding to the regulatory light chain of myosin. This binding causes a conformational change in the myosin protein, which allows it to bind to actin filaments and generate force. MLP also helps to regulate the activity of myosin motor proteins by inhibiting their activity when they are not needed, and activating them when they are needed to generate force.\nIn addition to regulating the interaction between myosin and actin, MLP also interacts with other proteins that are involved in cytoskeletal dynamics, such as tropomyosin and actinin. These interactions help to stabilize the actin filament network and regulate its dynamics.\nOverall, the regulation of F-actin dynamics by MLP is a complex process that involves multiple protein interactions and conformational changes. Understanding the details of these interactions is important for understanding the mechanisms that underlie muscle contraction and other cytoskeletal functions.",
    "vicuna-13b_fact_raw": "1. MLP (myosin regulatory light chain) regulates the dynamics of F-actin.\n2. MLP regulates the interaction between myosin motor proteins and actin filaments, allowing for the controlled contraction and relaxation of muscle cells.\n3. This interaction is regulated by MLP binding to the regulatory light chain of myosin, causing a conformational change in the myosin protein, which allows it to bind to actin filaments and generate force.\n4. MLP also interacts with other proteins involved in cytoskeletal dynamics, such as tropomyosin and actinin.\n5. Regulation of F-actin dynamics by MLP involves multiple protein interactions and conformational changes.",
    "vicuna-13b_fact": [
      "MLP (myosin regulatory light chain) regulates the dynamics of F-actin.",
      "MLP regulates the interaction between myosin motor proteins and actin filaments, allowing for the controlled contraction and relaxation of muscle cells.",
      "This interaction is regulated by MLP binding to the regulatory light chain of myosin, causing a conformational change in the myosin protein, which allows it to bind to actin filaments and generate force.",
      "MLP also interacts with other proteins involved in cytoskeletal dynamics, such as tropomyosin and actinin.",
      "Regulation of F-actin dynamics by MLP involves multiple protein interactions and conformational changes."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: MLP (myosin light chain phosphatase) does not regulate the dynamics of F-actin directly; it is involved in the dephosphorylation of the regulatory light chain of myosin.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "vicuna-13b_response": "A pseudokinase is a protein that has some of the structural features of a kinase, but does not have the enzymatic activity of a kinase. In the human kinome, there are several hundred pseudokinases. The exact number can vary depending on the source and the specific definition of a pseudokinase used. However, it is estimated that there are around 300-500 pseudokinases in the human genome.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. A pseudokinase is a protein that has some of the structural features of a kinase, but does not display the enzymatic activity of a kinase.\n2. There are several hundred pseudokinases in the human kinome. \n3. The exact count of pseudokinases can vary depending on the source and the specific definition used.\n4. It is estimated that there are around 300-500 pseudokinases in the human genome.",
    "vicuna-13b_fact": [
      "A pseudokinase is a protein that has some of the structural features of a kinase, but does not display the enzymatic activity of a kinase.",
      "There are several hundred pseudokinases in the human kinome.",
      "The exact count of pseudokinases can vary depending on the source and the specific definition used.",
      "It is estimated that there are around 300-500 pseudokinases in the human genome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "vicuna-13b_response": "ApoE mimetics are molecules that mimic the activity of apolipoprotein E (ApoE), a protein that plays a critical role in lipid metabolism and transport. Here are three examples of ApoE mimetics:\n1. Mimetic peptides: Short peptides that mimic the structural and functional properties of ApoE have been developed. These peptides can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream, reducing the risk of cardiovascular disease.\n2. Antibodies: Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed. These antibodies can reduce the levels of ApoE in the bloodstream, leading to a decrease in the concentration of lipids and a lower risk of cardiovascular disease.\n3. Small molecules: Small molecules that mimic the activity of ApoE have been developed. These molecules can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream, reducing the risk of cardiovascular disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Apolipoprotein E (ApoE) is a protein that plays a critical role in lipid metabolism and transport.\n2. Mimetic peptides that mimic ApoE's structural and functional properties have been developed.\n3. These mimetic peptides can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream.\n4. Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed.\n5. Small molecules that mimic the activity of ApoE have also been developed.",
    "vicuna-13b_fact": [
      "Apolipoprotein E (ApoE) is a protein that plays a critical role in lipid metabolism and transport.",
      "Mimetic peptides that mimic ApoE's structural and functional properties have been developed.",
      "These mimetic peptides can bind to ApoE receptors and enhance the clearance of lipids from the bloodstream.",
      "Monoclonal antibodies that bind to ApoE and inhibit its activity have been developed.",
      "Small molecules that mimic the activity of ApoE have also been developed."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "vicuna-13b_response": "SAMHD1 (Sterile alpha motif and HD-domain containing 1) is an enzyme that plays a role in regulating the replication of HIV and other viruses. There is evidence to suggest that there are sex differences in SAMHD1 activity.\nStudies have shown that SAMHD1 activity is higher in females compared to males. This suggests that females may be more resistant to HIV infection due to higher SAMHD1 activity. Additionally, some studies have found that SAMHD1 activity is higher in the female genital tract compared to the male genital tract, which may also contribute to the higher resistance to HIV infection in females.\nIt is important to note that these findings are not universal and more research is needed to fully understand the role of SAMHD1 in HIV infection and the potential sex differences in SAMHD1 activity.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SAMHD1 is an enzyme that regulates the replication of HIV and other viruses.\n2. There is evidence suggesting that there are sex differences in SAMHD1 activity.\n3. Studies have shown SAMHD1 activity to be higher in females than in males.\n4. Higher SAMHD1 activity is believed to make females more resistant to HIV infection.\n5. SAMHD1 activity has been found to be higher in the female genital tract compared to the male genital tract.",
    "vicuna-13b_fact": [
      "SAMHD1 is an enzyme that regulates the replication of HIV and other viruses.",
      "There is evidence suggesting that there are sex differences in SAMHD1 activity.",
      "Studies have shown SAMHD1 activity to be higher in females than in males.",
      "Higher SAMHD1 activity is believed to make females more resistant to HIV infection.",
      "SAMHD1 activity has been found to be higher in the female genital tract compared to the male genital tract."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "vicuna-13b_response": "RUNX2 is a transcription factor that plays a critical role in regulating the differentiation and development of various cell types, including astrocytes. While some studies have suggested that RUNX2 may inhibit astrocyte differentiation, other studies have shown that RUNX2 can promote astrocyte differentiation.\nOne study published in the journal \"Neurochemistry International\" in 2011 found that RUNX2 inhibited the differentiation of astrocytes in vitro by suppressing the expression of genes involved in the astrocyte phenotype. However, other studies have shown that RUNX2 can promote astrocyte differentiation by activating the expression of genes involved in astrocyte development.\nFor example, a study published in the journal \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain. The study showed that RUNX2 activated the expression of genes involved in the astrocyte phenotype and that this process was necessary for the proper development of astrocytes in the brain.\nOverall, the available evidence suggests that the effect of RUNX2 on astrocyte differentiation is complex and may depend on the specific context and developmental stage being studied. Further research is needed to fully understand the role of RUNX2 in regulating astrocyte differentiation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements: \n1. RUNX2 is a transcription factor that plays a critical role in the differentiation and development of various cell types, including astrocytes.\n2. A study in Neurochemistry International in 2011 suggested that RUNX2 inhibited the differentiation of astrocytes.\n3. Some studies have indicated that RUNX2 can promote astrocyte differentiation.\n4. A study published in the journal \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain.\n5. The effect of RUNX2 on astrocyte differentiation may depend on the specific context and developmental stage being studied.",
    "vicuna-13b_fact": [
      "RUNX2 is a transcription factor that plays a critical role in the differentiation and development of various cell types, including astrocytes.",
      "A study in Neurochemistry International in 2011 suggested that RUNX2 inhibited the differentiation of astrocytes.",
      "Some studies have indicated that RUNX2 can promote astrocyte differentiation.",
      "A study published in the journal \"Gene Expression Patterns\" in 2010 found that RUNX2 was required for the differentiation of astrocytes in the developing brain.",
      "The effect of RUNX2 on astrocyte differentiation may depend on the specific context and developmental stage being studied."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "vicuna-13b_response": "The Cobb-Stainsby excision arthroplasty is a surgical procedure performed to treat osteoarthritis of the hip. During the procedure, the surgeon will make an incision over the hip joint and remove the damaged cartilage and bone. The damaged joint is then replaced with an artificial joint made of metal, plastic, or ceramic materials.\nThe specific location where the Cobb-Stainsby excision arthroplasty is performed will depend on the specific needs of the patient and the location of the damaged joint. The incision will typically be made over the hip joint, which is located in the upper part of the leg, just below the gluteal muscles. The surgeon will carefully dissect the tissue and muscles to access the hip joint and perform the procedure.\nAfter the procedure, the patient will typically spend several days in the hospital recovering and undergoing physical therapy. The recovery process can take several months, during which time the patient will need to follow specific instructions to ensure proper healing and prevent complications.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Cobb-Stainsby excision arthroplasty is performed to treat osteoarthritis of the hip.\n2. During the Cobb-Stainsby excision arthroplasty, the damaged cartilage and bone are removed.\n3. The incision for the Cobb-Stainsby excision arthroplasty is typically made over the hip joint.\n4. The hip joint is located in the upper part of the leg, just below the gluteal muscles.\n5. The recovery process after the Cobb-Stainsby excision arthroplasty can take several months.",
    "vicuna-13b_fact": [
      "The Cobb-Stainsby excision arthroplasty is performed to treat osteoarthritis of the hip.",
      "During the Cobb-Stainsby excision arthroplasty, the damaged cartilage and bone are removed.",
      "The incision for the Cobb-Stainsby excision arthroplasty is typically made over the hip joint.",
      "The hip joint is located in the upper part of the leg, just below the gluteal muscles.",
      "The recovery process after the Cobb-Stainsby excision arthroplasty can take several months."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "vicuna-13b_response": "Yes, over-expression of the Growth Regulation by Heterologous Ligand 2 (GRHL2) gene has been shown to lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types. EMT is a process by which epithelial cells, which typically form tight junctions and cover the surface of organs and glands, transform into mesenchymal cells, which are more mobile and have a more fibroblast-like appearance.\nGRHL2 is a transcription factor that plays a role in regulating the expression of genes involved in cell growth and differentiation. Over-expression of GRHL2 has been shown to promote the proliferation and survival of cells, and to inhibit their differentiation. In some cases, this can lead to the development of a more mesenchymal phenotype, including the loss of epithelial cell characteristics and the acquisition of mesenchymal cell characteristics.\nOver-expression of GRHL2 has been observed in a variety of cancer types, including breast cancer, gastric cancer, and lung cancer, and has been associated with poor prognosis and increased risk of metastasis. In addition, over-expression of GRHL2 has been shown to promote the development of resistance to chemotherapy in cancer cells.\nOverall, while the exact mechanisms by which GRHL2 over-expression leads to EMT are not fully understood, it is clear that this process plays a role in the development of certain cancer types and may contribute to the progression of cancer and the acquisition of drug resistance.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Growth Regulation by Heterologous Ligand 2 (GRHL2) over-expression can lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types.\n2. EMT is a process by which epithelial cells transform into mesenchymal cells.\n3. GRHL2 is a transcription factor that affects the expression of genes related to cell growth and differentiation.\n4. Over-expression of GRHL2 has been observed in various types of cancer, including breast, gastric, and lung cancer.\n5. Over-expression of GRHL2 can promote the development of resistance to chemotherapy in cancer cells.",
    "vicuna-13b_fact": [
      "Growth Regulation by Heterologous Ligand 2 (GRHL2) over-expression can lead to the development of an epithelial-to-mesenchymal transition (EMT) phenotype in certain cell types.",
      "EMT is a process by which epithelial cells transform into mesenchymal cells.",
      "GRHL2 is a transcription factor that affects the expression of genes related to cell growth and differentiation.",
      "Over-expression of GRHL2 has been observed in various types of cancer, including breast, gastric, and lung cancer.",
      "Over-expression of GRHL2 can promote the development of resistance to chemotherapy in cancer cells."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "vicuna-13b_response": "T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are upregulated (i.e., expressed at higher levels) in cancer cells compared to normal cells. Several T-UCRs have been implicated in the development and progression of lung cancer.\nOne example is the T-UCR known as TWIST1. TWIST1 is a transcription factor that has been shown to play a role in the development and progression of several types of cancer, including lung cancer. In lung cancer, TWIST1 is often upregulated and has been shown to promote the growth and survival of cancer cells.\nAnother example is the T-UCR known as FOXM1. FOXM1 is a transcription factor that has been shown to be involved in the regulation of cell proliferation and differentiation. In lung cancer, FOXM1 is often upregulated and has been shown to promote the growth and survival of cancer cells.\nIt is important to note that while T-UCRs have been implicated in the development and progression of lung cancer, they are not the only genes that are involved in this process. There are many other genes and pathways that are involved in the development and progression of lung cancer, and a better understanding of these pathways is needed in order to develop effective treatments for this disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are upregulated in cancer cells in comparison to normal cells. \n2. Several T-UCRs have been implicated in the development and progression of lung cancer.\n3. TWIST1 and FOXM1 are Tumor-Upregulated Conserved Regulators known to be implicated in lung cancer. \n4. TWIST1 is a transcription factor that plays a role in the development and progression of several types of cancer, including lung cancer.\n5. FOXM1 is a transcription factor involved in the regulation of cell proliferation and differentiation and is often upregulated in lung cancer.",
    "vicuna-13b_fact": [
      "T-UCRs, or Tumor-Upregulated Conserved Regulators, are genes that are upregulated in cancer cells in comparison to normal cells.",
      "Several T-UCRs have been implicated in the development and progression of lung cancer.",
      "TWIST1 and FOXM1 are Tumor-Upregulated Conserved Regulators known to be implicated in lung cancer.",
      "TWIST1 is a transcription factor that plays a role in the development and progression of several types of cancer, including lung cancer.",
      "FOXM1 is a transcription factor involved in the regulation of cell proliferation and differentiation and is often upregulated in lung cancer."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TWIST1 and FOXM1 are not Tumor-Upregulated Conserved Regulators; they are transcription factors.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "vicuna-13b_response": "GPR151 (also known as G protein-coupled receptor 151) is a member of the G protein-coupled receptor (GPCR) family of membrane receptors. It is a seven transmembrane domain receptor and is thought to play a role in regulating various physiological processes, including glucose metabolism and inflammation.\nGPR151 has been found to be expressed in various tissues, including the pancreas, intestine, and adipose tissue. It has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells and to play a role in regulating glucose uptake in adipose tissue.\nStudies have also suggested that GPR151 may be involved in the regulation of inflammation. For example, GPR151 has been shown to regulate the production of inflammatory cytokines in macrophages and to play a role in the regulation of the immune response.\nOverall, while much is still unknown about the function and regulation of GPR151, it is thought to play an important role in various physiological processes and may be a potential target for the development of new therapies for diseases such as diabetes and inflammation.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GPR151, also known as G protein-coupled receptor 151, is a member of the G protein-coupled receptor family of membrane receptors.\n2. GPR151 is a seven transmembrane domain receptor.\n3. GPR151 has been found to be expressed in various tissues, including the pancreas, intestine, and adipose tissue.\n4. Studies have suggested that GPR151 may be involved in the regulation of inflammation.\n5. GPR151 has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells.",
    "vicuna-13b_fact": [
      "GPR151, also known as G protein-coupled receptor 151, is a member of the G protein-coupled receptor family of membrane receptors.",
      "GPR151 is a seven transmembrane domain receptor.",
      "GPR151 has been found to be expressed in various tissues, including the pancreas, intestine, and adipose tissue.",
      "Studies have suggested that GPR151 may be involved in the regulation of inflammation.",
      "GPR151 has been shown to regulate glucose-stimulated insulin secretion in pancreatic beta cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "vicuna-13b_response": "The Fluzone intradermal quadrivalent vaccine is a vaccine that is used to protect against four different strains of the influenza virus. It contains attenuated live viruses, which means that the viruses have been weakened in order to stimulate an immune response without causing serious illness.\nThe four strains of the influenza virus that are included in the Fluzone intradermal quadrivalent vaccine are:\n* A/Brisbane/10/2019 (H1N1)\n* A/Kansas/14/2019 (H3N2)\n* B/Colorado/06/2017\n* B/Phuket/3073/2018\nIt is important to note that the viruses in the vaccine are attenuated, which means they are weakened and cannot cause serious illness. However, it is possible to experience side effects from the vaccine, such as pain, redness, or swelling at the injection site. It is also possible to experience mild symptoms, such as fever or fatigue, after receiving the vaccine. These side effects are generally mild and short-lived.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Fluzone intradermal quadrivalent vaccine is used to protect against four different strains of the influenza virus.\n2. The Fluzone vaccine contains attenuated live viruses, meaning the viruses are weakened to stimulate an immune response without causing serious illness.\n3. The four strains of the influenza virus included in the Fluzone intradermal quadrivalent vaccine are A/Brisbane/10/2019 (H1N1), A/Kansas/14/2019 (H3N2), B/Colorado/06/2017, and B/Phuket/3073/2018.\n4. It is possible to experience side effects from the Fluzone vaccine like pain, redness, or swelling at the injection site.\n5. Mild symptoms such as fever or fatigue can also be experienced after receiving the Fluzone vaccine.",
    "vicuna-13b_fact": [
      "The Fluzone intradermal quadrivalent vaccine is used to protect against four different strains of the influenza virus.",
      "The Fluzone vaccine contains attenuated live viruses, meaning the viruses are weakened to stimulate an immune response without causing serious illness.",
      "The four strains of the influenza virus included in the Fluzone intradermal quadrivalent vaccine are A/Brisbane/10/2019 (H1N1), A/Kansas/14/2019 (H3N2), B/Colorado/06/2017, and B/Phuket/3073/2018.",
      "It is possible to experience side effects from the Fluzone vaccine like pain, redness, or swelling at the injection site.",
      "Mild symptoms such as fever or fatigue can also be experienced after receiving the Fluzone vaccine."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Fluzone vaccine contains inactivated viruses, not attenuated live viruses.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "vicuna-13b_response": "Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs and systems in the body. There are several genetic factors that have been identified as contributing to the development of SLE, including variations in the TNFR2 gene.\nThe TNFR2 gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2), which is involved in the immune response and inflammation. Variations in the TNFR2 gene have been associated with an increased risk of developing SLE.\nSpecifically, a variation in the TNFR2 gene called the 196G>C polymorphism has been identified as a genetic risk factor for SLE. This variation is located in the promoter region of the TNFR2 gene and has been shown to affect the expression of the TNFRSF2 protein.\nIt is important to note that genetic variations are only one of many factors that can contribute to the development of SLE, and that other environmental and lifestyle factors are also thought to play a role in the disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs and systems in the body.\n2. The TNFR2 gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2).\n3. Variations in the TNFR2 gene have been associated with an increased risk of developing SLE.\n4. A specific variation in the TNFR2 gene, called the 196G>C polymorphism, is located in the promoter region of the gene.\n5. This 196G>C polymorphism in the TNFR2 gene has been shown to affect the expression of the TNFRSF2 protein.",
    "vicuna-13b_fact": [
      "Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs and systems in the body.",
      "The TNFR2 gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 2 (TNFRSF2).",
      "Variations in the TNFR2 gene have been associated with an increased risk of developing SLE.",
      "A specific variation in the TNFR2 gene, called the 196G>C polymorphism, is located in the promoter region of the gene.",
      "This 196G>C polymorphism in the TNFR2 gene has been shown to affect the expression of the TNFRSF2 protein."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "vicuna-13b_response": "Yes, there is a vaccine for peanut allergy, but it is not yet widely available. The vaccine is called Palforzia and was approved by the U.S. Food and Drug Administration (FDA) in December 2020. It is given as an injection and is intended for use in people aged 4 to 17 years old who have a peanut allergy.\nPalforzia works by gradually exposing the body to small amounts of peanut protein over a period of several months. This helps the immune system to become less sensitive to peanuts and reduce the risk of a severe allergic reaction.\nIt is important to note that Palforzia is not a cure for peanut allergy and it does not guarantee protection against allergic reactions. It is also important to continue to follow a peanut-free diet and carry epinephrine injectors (such as EpiPens) in case of a severe allergic reaction.\nIt is also important to note that the vaccine is not yet available in all countries and it is important to check with your doctor or local health authority for availability and the latest information.",
    "vicuna-13b_fact_raw": "1. There is a vaccine for peanut allergy called Palforzia.\n2. The U.S. Food and Drug Administration (FDA) approved Palforzia in December 2020.\n3. The vaccine is given as an injection for people aged 4 to 17 years old who have a peanut allergy.\n4. Palforzia is not a cure for peanut allergy and does not guarantee protection against allergic reactions.\n5. The vaccine is not yet available in all countries.",
    "vicuna-13b_fact": [
      "There is a vaccine for peanut allergy called Palforzia.",
      "The U.S. Food and Drug Administration (FDA) approved Palforzia in December 2020.",
      "The vaccine is given as an injection for people aged 4 to 17 years old who have a peanut allergy.",
      "Palforzia is not a cure for peanut allergy and does not guarantee protection against allergic reactions.",
      "The vaccine is not yet available in all countries."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The U.S. Food and Drug Administration (FDA) approved Palforzia in January 2020.\n3. FALSE [correction]: Palforzia is not a vaccine and is not given as an injection. It is an oral immunotherapy given to people aged 4 to 17 who have a confirmed peanut allergy.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "vicuna-13b_response": "The Fxy gene is a gene that is responsible for the development of the mouse coat color. The Fxy gene is located on the X chromosome of the mouse, which is one of the two sex chromosomes in mice. The X chromosome is the larger of the two sex chromosomes and contains a large number of genes that are involved in various biological processes, including development, growth, and reproduction.\nThe Fxy gene is specifically located on the distal end of the X chromosome, which is the part of the chromosome that is closest to the centromere. The centromere is the point on the chromosome where the two arms of the chromosome are joined. The distal end of the X chromosome is also known as the Xp region.\nThe chromosomal position of a gene is important because it determines the location of the gene on the chromosome and can affect the expression of the gene. The Fxy gene is expressed in the coat cells of the mouse, and its expression is regulated by the surrounding environment and other genetic factors. The chromosomal position of the Fxy gene can affect its expression and can also affect the inheritance of the coat color trait in mice.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Fxy gene is responsible for the development of the mouse coat color.\n2. The Fxy gene is located on the X chromosome of the mouse.\n3. The X chromosome is one of the two sex chromosomes in mice and is the larger of the two.\n4. The Fxy gene is specifically located on the distal end of the X chromosome.\n5. The chromosomal position of a gene can affect its expression and can also affect the inheritance of traits in mice.",
    "vicuna-13b_fact": [
      "The Fxy gene is responsible for the development of the mouse coat color.",
      "The Fxy gene is located on the X chromosome of the mouse.",
      "The X chromosome is one of the two sex chromosomes in mice and is the larger of the two.",
      "The Fxy gene is specifically located on the distal end of the X chromosome.",
      "The chromosomal position of a gene can affect its expression and can also affect the inheritance of traits in mice."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "vicuna-13b_response": "Methyl-propyl-EDTA (MPE) sequencing is a method used to analyze the methylation status of DNA. The method is based on the ability of MPE to selectively bind to methylated DNA, allowing for the separation of methylated and unmethylated DNA.\nThe MPE-seq method involves treating DNA with MPE, which binds to methylated DNA, and then isolating the bound DNA. The bound DNA is then sequenced using next-generation sequencing technologies, allowing for the identification of methylated and unmethylated regions of the genome.\nThe basis of the MPE-seq method is the specific binding of MPE to methylated DNA, which is due to the presence of a methyl group on the cytosine residue in the DNA. MPE has a higher affinity for methylated DNA than for unmethylated DNA, allowing for the selective isolation of methylated DNA.\nOnce the methylated DNA is isolated, it can be sequenced using next-generation sequencing technologies, such as Illumina or PacBio, to identify the methylation status of each base in the genome. The resulting data can be used to generate methylation maps, which can be used to study the role of DNA methylation in various biological processes, such as gene regulation and disease.\nOverall, the MPE-seq method is a powerful tool for studying DNA methylation, and its basis lies in the specific binding of MPE to methylated DNA, which allows for the selective isolation and sequencing of methylated DNA.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Methyl-propyl-EDTA (MPE) sequencing is a technique used to analyze the methylation status of DNA.\n2. The MPE-seq method involves treating DNA with MPE which binds to methylated DNA and then isolating the bound DNA.\n3. The method is dependent on MPE's ability to selectively bind to methylated DNA due to the presence of a methyl group on the cytosine residue in the DNA.\n4. After isolation, the methylated DNA is sequenced using next-generation sequencing technologies, such as Illumina or PacBio.\n5. The data resulting from MPE-seq can be used to generate methylation maps, providing insights into processes such as gene regulation and disease.",
    "vicuna-13b_fact": [
      "Methyl-propyl-EDTA (MPE) sequencing is a technique used to analyze the methylation status of DNA.",
      "The MPE-seq method involves treating DNA with MPE which binds to methylated DNA and then isolating the bound DNA.",
      "The method is dependent on MPE's ability to selectively bind to methylated DNA due to the presence of a methyl group on the cytosine residue in the DNA.",
      "After isolation, the methylated DNA is sequenced using next-generation sequencing technologies, such as Illumina or PacBio.",
      "The data resulting from MPE-seq can be used to generate methylation maps, providing insights into processes such as gene regulation and disease."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "vicuna-13b_response": "GWAR (GNU Wget for Autonomous Robots) is a software system used for controlling and coordinating a swarm of robots. The programming language used for implementing GWAR can vary depending on the specific implementation and the preferences of the developers.\nHowever, in the case of the original GWAR implementation developed by the Robotics Institute at Carnegie Mellon University, the programming language used was Python. Python is a popular, high-level programming language that is well-suited for tasks such as coordinating complex systems and working with large amounts of data. Its ease of use and flexibility make it a popular choice for many applications, including robotics and machine learning.\nIn summary, the programming language used for implementing GWAR can vary, but in the case of the original implementation, Python was used.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. GWAR stands for GNU Wget for Autonomous Robots.\n2. GWAR is a software system used for controlling and coordinating a swarm of robots.\n3. Python was used in the original implementation of GWAR by the Robotics Institute at Carnegie Mellon University.\n4. Python is a high-level programming language.\n5. Python is well-suited for tasks such as coordinating complex systems and working with large amounts of data.",
    "vicuna-13b_fact": [
      "GWAR stands for GNU Wget for Autonomous Robots.",
      "GWAR is a software system used for controlling and coordinating a swarm of robots.",
      "Python was used in the original implementation of GWAR by the Robotics Institute at Carnegie Mellon University.",
      "Python is a high-level programming language.",
      "Python is well-suited for tasks such as coordinating complex systems and working with large amounts of data."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "vicuna-13b_response": "Xaliproden (also known as riluzole) is a medication that is commonly used to treat amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord. The main cause of ALS is not well understood, but it is thought to involve a combination of genetic and environmental factors.\nThere is some evidence to suggest that xaliproden may improve the prognosis of ALS. In clinical trials, xaliproden has been shown to slow the progression of ALS and improve survival in patients with the disease. However, the extent to which xaliproden improves prognosis in ALS is still being studied, and more research is needed to fully understand its effects.\nIt is important to note that the use of xaliproden in ALS is still considered experimental, and it is not yet approved by the FDA for the treatment of ALS. Additionally, the benefits of xaliproden in ALS may vary from person to person, and it is important to discuss the potential benefits and risks of this medication with a healthcare provider before starting treatment.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Xaliproden, also known as riluzole, is a medication used to treat amyotrophic lateral sclerosis (ALS).\n2. ALS is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord.\n3. Clinical trials have shown xaliproden to slow the progression of ALS and improve survival in patients with the disease.\n4. Xaliproden is currently not approved by the FDA for the treatment of ALS.\n5. The use of xaliproden in ALS is still considered experimental.",
    "vicuna-13b_fact": [
      "Xaliproden, also known as riluzole, is a medication used to treat amyotrophic lateral sclerosis (ALS).",
      "ALS is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord.",
      "Clinical trials have shown xaliproden to slow the progression of ALS and improve survival in patients with the disease.",
      "Xaliproden is currently not approved by the FDA for the treatment of ALS.",
      "The use of xaliproden in ALS is still considered experimental."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Xaliproden and riluzole are two different medications. Riluzole is an approved medication for ALS, not xaliproden.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "vicuna-13b_response": "The LiPS-A3S line is a transgenic line of plants that has been engineered to express a bacterial gene called nopaline synthase (NOS) under the control of a plant promoter. The NOS gene is inserted into the chloroplast genome of the plant, specifically into the large inverted repeat (LIT) region of chromosome 1.\nThe LiPS-A3S line was created by Agrobacterium-mediated transformation, which involves the introduction of a DNA construct into plant cells using the Agrobacterium tumefaciens bacterium as a vector. The DNA construct contains the NOS gene, which is driven by a plant promoter called the 35S promoter, and a selection marker gene called the bar gene, which confers resistance to the herbicide bialaphos.\nThe LiPS-A3S line is a useful tool for studying plant metabolism and for developing new strategies for crop improvement. It has been used to study the biosynthesis of secondary metabolites, such as flavonoids and alkaloids, and to develop new methods for the production of valuable compounds in plants.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The LiPS-A3S line is a transgenic line of plants.\n2. In the LiPS-A3S line, the NOS gene is inserted into the large inverted repeat (LIT) region of chromosome 1.\n3. The LiPS-A3S line was created by Agrobacterium-mediated transformation.\n4. The NOS gene in the LiPS-A3S line is driven by a plant promoter called the 35S promoter.\n5. The LiPS-A3S line contains a selection marker gene called the bar gene, which confers resistance to the herbicide bialaphos.",
    "vicuna-13b_fact": [
      "The LiPS-A3S line is a transgenic line of plants.",
      "In the LiPS-A3S line, the NOS gene is inserted into the large inverted repeat (LIT) region of chromosome 1.",
      "The LiPS-A3S line was created by Agrobacterium-mediated transformation.",
      "The NOS gene in the LiPS-A3S line is driven by a plant promoter called the 35S promoter.",
      "The LiPS-A3S line contains a selection marker gene called the bar gene, which confers resistance to the herbicide bialaphos."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "vicuna-13b_response": "There are several tools that use deep learning to predict drug synergy. One example is the DeepSynergy tool, which was developed by researchers at the University of California, San Francisco. This tool uses a deep neural network to predict the synergistic interactions between drugs based on their molecular properties.\nAnother example is the DeepDrug tool, which was developed by researchers at the Massachusetts Institute of Technology. This tool uses a deep convolutional neural network to analyze images of cells and predict the synergistic interactions between drugs based on their effects on cellular processes.\nThere are also several commercial tools that use deep learning for drug discovery, such as the Paige.AI platform and the DrugSpace platform from IBM. These platforms use machine learning algorithms, including deep learning, to analyze large datasets of drug and disease information and identify potential drug candidates and drug combinations.\nIt's important to note that while deep learning has shown promise in predicting drug synergy, it is still a developing field and these tools are not yet widely adopted in the pharmaceutical industry. Additionally, these tools require large amounts of data and computational resources to train and run, and may not be accessible to all researchers.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. DeepSynergy, a tool that uses a deep neural network to predict drug synergy, was developed by researchers at the University of California, San Francisco.\n2. DeepDrug uses a deep convolutional neural network to analyze images of cells and predict drug interactions; it was developed by the Massachusetts Institute of Technology.\n3. Commercial platforms, like Paige.AI and DrugSpace from IBM, use machine learning algorithms, including deep learning, for drug discovery.\n4. Predicting drug synergy with deep learning requires large amounts of data and computational resources to train and run the tools.\n5. Deep learning for predicting drug synergy is a developing field and not yet widely adopted in the pharmaceutical industry.",
    "vicuna-13b_fact": [
      "DeepSynergy, a tool that uses a deep neural network to predict drug synergy, was developed by researchers at the University of California, San Francisco.",
      "DeepDrug uses a deep convolutional neural network to analyze images of cells and predict drug interactions; it was developed by the Massachusetts Institute of Technology.",
      "Commercial platforms, like Paige.AI and DrugSpace from IBM, use machine learning algorithms, including deep learning, for drug discovery.",
      "Predicting drug synergy with deep learning requires large amounts of data and computational resources to train and run the tools.",
      "Deep learning for predicting drug synergy is a developing field and not yet widely adopted in the pharmaceutical industry."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "vicuna-13b_response": "There are several cloud-based platforms that have been developed for comparing GWAS (Genome-Wide Association Studies). Some of the popular ones are:\n1. Amazon Web Services (AWS): AWS offers a variety of cloud-based services, including Amazon Elastic Compute Cloud (EC2) and Amazon S3, which can be used for storing and analyzing large-scale GWAS data.\n2. Google Cloud Platform (GCP): GCP provides a variety of cloud-based services, including Google BigQuery and Google Cloud Storage, which can be used for managing and analyzing large-scale GWAS data.\n3. Microsoft Azure: Azure provides a variety of cloud-based services, including Azure Blob Storage and Azure Machine Learning, which can be used for storing and analyzing large-scale GWAS data.\n4. IBM Cloud: IBM Cloud provides a variety of cloud-based services, including IBM Cloud Object Storage and IBM Watson Studio, which can be used for managing and analyzing large-scale GWAS data.\nThese cloud-based platforms offer a range of tools and services that can be used for comparing GWAS, including data storage, data processing, data analysis, and data visualization. They also provide scalable infrastructure that can handle large-scale GWAS data, making it easier to compare GWAS across different populations and identify genetic variants that are associated with disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Amazon Web Services (AWS) offers Amazon Elastic Compute Cloud (EC2) and Amazon S3 for storing and analyzing large-scale GWAS data.\n2. Google Cloud Platform (GCP) provides services such as Google BigQuery and Google Cloud Storage for managing and analyzing large-scale GWAS data.\n3. Microsoft Azure provides Azure Blob Storage and Azure Machine Learning for storing and analyzing large-scale GWAS data.\n4. IBM Cloud provides IBM Cloud Object Storage and IBM Watson Studio for managing and analyzing large-scale GWAS data.\n5. Cloud-based platforms offer tools and services that can be used for comparing Genome-Wide Association Studies (GWAS), including data storage, data processing, data analysis, and data visualization.",
    "vicuna-13b_fact": [
      "Amazon Web Services (AWS) offers Amazon Elastic Compute Cloud (EC2) and Amazon S3 for storing and analyzing large-scale GWAS data.",
      "Google Cloud Platform (GCP) provides services such as Google BigQuery and Google Cloud Storage for managing and analyzing large-scale GWAS data.",
      "Microsoft Azure provides Azure Blob Storage and Azure Machine Learning for storing and analyzing large-scale GWAS data.",
      "IBM Cloud provides IBM Cloud Object Storage and IBM Watson Studio for managing and analyzing large-scale GWAS data.",
      "Cloud-based platforms offer tools and services that can be used for comparing Genome-Wide Association Studies (GWAS), including data storage, data processing, data analysis, and data visualization."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "vicuna-13b_response": "CMB305 is a monoclonal antibody drug that is currently being investigated for its potential to treat various types of cancer. While it has shown promise in early clinical trials for the treatment of some types of cancer, it has not yet been approved by regulatory authorities for use against sarcomas specifically.\nSarcomas are a rare type of cancer that can arise from various types of cells in the body, including bone, muscle, and connective tissue. They are relatively uncommon, accounting for less than 1% of all cancer cases.\nCMB305 is a bispecific antibody that targets the CD19 and CD3 molecules on the surface of cancer cells. It has been studied primarily in clinical trials for the treatment of B-cell malignancies, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. While early results from these trials have been promising, more research is needed to determine the safety and efficacy of CMB305 for the treatment of sarcomas.\nIt is important to note that the development of new treatments for cancer is a complex and lengthy process that involves extensive research and clinical testing. While CMB305 has shown promise in early trials, it may not ultimately be effective or safe for the treatment of sarcomas. Further research is needed to determine the potential of CMB305 for the treatment of this rare and complex type of cancer.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. CMB305 is a monoclonal antibody drug currently being investigated for its potential against various types of cancer.\n2. CMB305 has not yet been approved by regulatory authorities for use against sarcomas.\n3. Sarcomas are a rare type of cancer accounting for less than 1% of all cancer cases.\n4. CMB305 targets the CD19 and CD3 molecules on the surface of cancer cells.\n5. CMB305 has been studied primarily in clinical trials for the treatment of B-cell malignancies, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.",
    "vicuna-13b_fact": [
      "CMB305 is a monoclonal antibody drug currently being investigated for its potential against various types of cancer.",
      "CMB305 has not yet been approved by regulatory authorities for use against sarcomas.",
      "Sarcomas are a rare type of cancer accounting for less than 1% of all cancer cases.",
      "CMB305 targets the CD19 and CD3 molecules on the surface of cancer cells.",
      "CMB305 has been studied primarily in clinical trials for the treatment of B-cell malignancies, including non-Hodgkin lymphoma and chronic lymphocytic leukemia."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "vicuna-13b_response": "The Saint's Triad is a concept in Christian theology that describes the threefold office of Christ: prophet, priest, and king. These three roles are seen as being united in one person, Jesus Christ. The manifestations of the Saint's Triad can be seen in various aspects of Christ's life and ministry, including his teachings, his sacrificial death, and his reign as King of kings and Lord of lords.\n1. Prophet: As a prophet, Christ is seen as the ultimate revealer of God's truth and will. He taught with authority and power, and his teachings continue to be a source of guidance and inspiration for Christians today.\n2. Priest: As a priest, Christ is seen as the mediator between God and humanity. He offered himself as a sacrifice for the sins of the world, and through his death and resurrection, he made it possible for people to be reconciled to God.\n3. King: As a king, Christ is seen as the ruler and sovereign over all creation. He reigns in glory and power, and one day he will return to establish his kingdom in its fullness.\nThe manifestations of the Saint's Triad can also be seen in the lives of the saints, who are seen as living examples of the Christian life. They embody the virtues and values of the Christian faith, and they serve as inspiration for others to follow in their footsteps.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Saint's Triad in Christian theology refers to the threefold office of Christ as a prophet, priest, and king.\n2. The three roles of the Saint's Triad are seen as being united in one person, Jesus Christ.\n3. Christ, as a prophet in the Saint's Triad, is seen as the ultimate revealer of God's truth and his teachings continue to guide Christians.\n4. Christ, as a priest in the Saint's Triad, is seen as the mediator between God and humanity and offered himself as a sacrifice for the sins of the world.\n5. Christ, as a king in the Saint's Triad, is considered the ruler and sovereign over all creation and will return to establish his kingdom in its fullness.",
    "vicuna-13b_fact": [
      "The Saint's Triad in Christian theology refers to the threefold office of Christ as a prophet, priest, and king.",
      "The three roles of the Saint's Triad are seen as being united in one person, Jesus Christ.",
      "Christ, as a prophet in the Saint's Triad, is seen as the ultimate revealer of God's truth and his teachings continue to guide Christians.",
      "Christ, as a priest in the Saint's Triad, is seen as the mediator between God and humanity and offered himself as a sacrifice for the sins of the world.",
      "Christ, as a king in the Saint's Triad, is considered the ruler and sovereign over all creation and will return to establish his kingdom in its fullness."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The term used in Christian theology is the \"Munus triplex,\" not the \"Saint's Triad,\" which refers to the threefold office of Christ as a prophet, priest, and king.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "vicuna-13b_response": "Overexpression of LY6K, also known as LY6K/KLH, is a protein that has been identified as a potential biomarker for non-small cell lung cancer (NSCLC). However, the relationship between LY6K overexpression and patient prognosis is not straightforward and may depend on various factors.\nSome studies have suggested that LY6K overexpression may be associated with a better prognosis for NSCLC patients. For example, a study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC. Another study published in the journal Cancer Research in 2018 also found that LY6K overexpression was associated with better prognosis in patients with NSCLC, particularly in those with squamous cell carcinoma subtype.\nHowever, other studies have reported conflicting results or have found no association between LY6K overexpression and patient prognosis. For example, a study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.\nIt is important to note that the relationship between LY6K overexpression and patient prognosis may be influenced by various factors, such as the stage and histology of the cancer, the patient's age and smoking history, and the presence of other biomarkers. Therefore, further research is needed to fully understand the role of LY6K in NSCLC and its potential as a biomarker for prognosis.\nIn conclusion, while some studies have suggested that overexpression of LY6K may be associated with a better prognosis for NSCLC patients, the relationship between LY6K and patient prognosis is not well established and may depend on various factors. Further research is needed to fully understand the role of LY6K in NSCLC and its potential as a biomarker for prognosis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. LY6K, also known as LY6K/KLH, is a protein that has been identified as a potential biomarker for non-small cell lung cancer.\n2. A study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.\n3. Another study published in the journal Cancer Research in 2018 also found that LY6K overexpression was associated with better prognosis in patients with NSCLC, particularly in those with squamous cell carcinoma subtype.\n4. A study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.\n5. The relationship between LY6K overexpression and patient prognosis may be influenced by various factors such as stage and histology of the cancer, patient's age and smoking history, and the presence of other biomarkers.",
    "vicuna-13b_fact": [
      "LY6K, also known as LY6K/KLH, is a protein that has been identified as a potential biomarker for non-small cell lung cancer.",
      "A study published in the journal Clinical Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.",
      "Another study published in the journal Cancer Research in 2018 also found that LY6K overexpression was associated with better prognosis in patients with NSCLC, particularly in those with squamous cell carcinoma subtype.",
      "A study published in the journal Lung Cancer in 2019 found that high levels of LY6K expression were not significantly associated with overall survival in NSCLC patients.",
      "The relationship between LY6K overexpression and patient prognosis may be influenced by various factors such as stage and histology of the cancer, patient's age and smoking history, and the presence of other biomarkers."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "vicuna-13b_response": "Cytokinesis is the final stage of cell division, where the cell physically splits into two daughter cells. During cytokinesis, several CDK (cyclin-dependent kinase) targets are dephosphorylated to facilitate the process of cell division. These targets include:\n1. Cdc28 - a CDK that is involved in the progression of the cell cycle in yeast. Cdc28 is dephosphorylated during cytokinesis, which allows it to enter a new cell cycle.\n2. Polo - a CDK that is involved in the regulation of mitosis in animals. Polo is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\n3. Aurora B - a CDK that is involved in the regulation of mitosis in animals. Aurora B is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\n4. Myt1 - a CDK that is involved in the regulation of mitosis in plants. Myt1 is dephosphorylated during cytokinesis, which allows it to activate the spindle assembly checkpoint and ensure that the cell has properly divided.\nOverall, the dephosphorylation of these CDK targets during cytokinesis plays a crucial role in the proper division of cells.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Cdk targets are dephosphorylated during cytokinesis.\n2. Cdc28, a CDK target, is dephosphorylated during cytokinesis to facilitate the cell cycle progression in yeast.\n3. Polo, a CDK target, is dephosphorylated during cytokinesis which allows it to activate the spindle assembly checkpoint in animal mitosis.\n4. Aurora B, a CDK target, is dephosphorylated during cytokinesis, facilitating activation of the spindle assembly checkpoint in animal mitosis.\n5. Myt1, a CDK involved in plant mitosis, is dephosphorylated during cytokinesis to activate the spindle assembly checkpoint.",
    "vicuna-13b_fact": [
      "Cdk targets are dephosphorylated during cytokinesis.",
      "Cdc28, a CDK target, is dephosphorylated during cytokinesis to facilitate the cell cycle progression in yeast.",
      "Polo, a CDK target, is dephosphorylated during cytokinesis which allows it to activate the spindle assembly checkpoint in animal mitosis.",
      "Aurora B, a CDK target, is dephosphorylated during cytokinesis, facilitating activation of the spindle assembly checkpoint in animal mitosis.",
      "Myt1, a CDK involved in plant mitosis, is dephosphorylated during cytokinesis to activate the spindle assembly checkpoint."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "vicuna-13b_response": "Xanamem is a drug that is used to treat acid reflux, also known as gastroesophageal reflux disease (GERD). It is a type of medication called a proton pump inhibitor (PPI), which works by reducing the amount of acid produced by the stomach. Xanamem is available in tablet form and is taken orally. It is usually taken once a day, with or without food. Xanamem is used to treat symptoms of acid reflux such as heartburn, regurgitation, and difficulty swallowing. It is also used to prevent acid reflux from occurring in the first place. Xanamem is available by prescription only and should only be taken under the guidance of a healthcare professional.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Xanamem is a drug that is used to treat acid reflux, also known as gastroesophageal reflux disease (GERD).\n2. Xanamem is a type of medication called a proton pump inhibitor (PPI).\n3. This drug works by reducing the amount of acid produced by the stomach.\n4. Xanamem is available in tablet form and is taken orally.\n5. Xanamem is available by prescription only and should be taken under the guidance of a healthcare professional.",
    "vicuna-13b_fact": [
      "Xanamem is a drug that is used to treat acid reflux, also known as gastroesophageal reflux disease (GERD).",
      "Xanamem is a type of medication called a proton pump inhibitor (PPI).",
      "This drug works by reducing the amount of acid produced by the stomach.",
      "Xanamem is available in tablet form and is taken orally.",
      "Xanamem is available by prescription only and should be taken under the guidance of a healthcare professional."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Xanamem is a drug originally developed for the treatment of Alzheimer's disease not gastroesophageal reflux disease (GERD).\n2. FALSE [correction]: Xanamem is not a proton pump inhibitor (PPI); it is designed to inhibit the production of cortisol in the brain. \n3. FALSE [correction]: Xanamem does not reduce the amount of acid produced by the stomach. It is meant to work by blocking the excess production of the stress hormone cortisol.\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "vicuna-13b_response": "The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae. Hof1 is a transcription factor that regulates the expression of genes involved in stress response and metabolism, while Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases.\nThe Hof1-Cyk3 interaction plays a crucial role in regulating the stress response in yeast. When the cell is exposed to stress, Hof1 is activated and interacts with Cyk3 to inhibit the activity of cyclin-dependent kinases. This inhibition leads to the accumulation of the transcription factor Skn7, which then activates the expression of genes involved in the stress response.\nThe Hof1-Cyk3 interaction also plays a role in regulating metabolism in yeast. When the cell is exposed to nutrient limitation, Hof1-Cyk3 complex formation is induced, which leads to the activation of genes involved in glycolysis and other metabolic pathways.\nOverall, the Hof1-Cyk3 interaction is a critical regulatory mechanism in yeast that helps the cell respond to environmental stress and maintain metabolic homeostasis.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae.\n2. Hof1 is a transcription factor that regulates the expression of genes associated with stress response and metabolism.\n3. Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases.\n4. The Hof1-Cyk3 interaction is involved in regulating stress response and metabolism in Saccharomyces cerevisiae.\n5. When the yeast cell is exposed to nutrient limitation, the Hof1-Cyk3 interaction can trigger the activation of genes involved in glycolysis and other metabolic pathways.",
    "vicuna-13b_fact": [
      "The Hof1-Cyk3 interaction is a protein-protein interaction that occurs in the yeast Saccharomyces cerevisiae.",
      "Hof1 is a transcription factor that regulates the expression of genes associated with stress response and metabolism.",
      "Cyk3 is a cyclin-dependent kinase inhibitor that regulates the activity of cyclin-dependent kinases.",
      "The Hof1-Cyk3 interaction is involved in regulating stress response and metabolism in Saccharomyces cerevisiae.",
      "When the yeast cell is exposed to nutrient limitation, the Hof1-Cyk3 interaction can trigger the activation of genes involved in glycolysis and other metabolic pathways."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "vicuna-13b_response": "T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions that are commonly altered in cancer cells. Several T-UCRs have been implicated in the development and progression of gastric cancer, a type of cancer that affects the stomach.\nOne of the most well-known T-UCRs in gastric cancer is the CDH1 gene, which codes for the E-cadherin protein. Loss of CDH1 expression has been shown to be a common event in gastric cancer and is associated with poor prognosis.\nAnother T-UCR that has been implicated in gastric cancer is the TP53 gene, which is a tumor suppressor gene that plays a crucial role in maintaining genomic stability. Mutations in TP53 have been identified in a significant percentage of gastric cancer cases and are associated with poor prognosis.\nAdditionally, the PIK3CA gene, which codes for a protein that regulates cell growth and survival, has also been implicated in gastric cancer. Mutations in PIK3CA have been identified in a subset of gastric cancer cases and are associated with poor prognosis.\nOverall, these T-UCRs are among the most commonly implicated in gastric cancer, and their alteration has been shown to play a role in the development and progression of this disease.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions commonly altered in cancer cells.\n2. Several T-UCRs have been implicated in the development and progression of gastric cancer.\n3. The CDH1 gene, another T-UCR, codes for the E-cadherin protein and its loss of expression has been shown to be a common event in gastric cancer.\n4. Mutations in the TP53 gene, a known T-UCR and tumor suppressor gene, have been identified in a significant percentage of gastric cancer cases.\n5. The PIK3CA gene codes for a protein that regulates cell growth and survival, and mutations in this gene have also been identified in a subset of gastric cancer cases.",
    "vicuna-13b_fact": [
      "T-UCRs, or Tumor-Upregulated Conserved Regions, are genomic regions commonly altered in cancer cells.",
      "Several T-UCRs have been implicated in the development and progression of gastric cancer.",
      "The CDH1 gene, another T-UCR, codes for the E-cadherin protein and its loss of expression has been shown to be a common event in gastric cancer.",
      "Mutations in the TP53 gene, a known T-UCR and tumor suppressor gene, have been identified in a significant percentage of gastric cancer cases.",
      "The PIK3CA gene codes for a protein that regulates cell growth and survival, and mutations in this gene have also been identified in a subset of gastric cancer cases."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [Correction]: The CDH1 gene is not a T-UCR, but it does code for the E-cadherin protein and its loss of expression has been shown to be a common event in gastric cancer.\n4. FALSE [Correction]: The TP53 gene is not a T-UCR, but it is a tumor suppressor gene and mutations in it have been identified in a significant percentage of gastric cancer cases.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "vicuna-13b_response": "The Lupus Severity Index (LSI) is a scoring system that is used to assess the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease that can affect many parts of the body, including the skin, joints, and organs such as the kidneys, heart, and lungs. The LSI is based on the presence of certain clinical features and laboratory abnormalities that are commonly seen in SLE.\nThe LSI is a simple, easy-to-use tool that can be used by healthcare providers to quickly assess the severity of lupus in a patient. It is based on a total score of 100 points, which can be divided into three categories:\n1. Organ involvement: This category includes points for the presence of active disease in any organ system, such as the skin, joints, kidneys, heart, lungs, and central nervous system.\n2. Activity: This category includes points for the level of activity of the disease, such as whether it is quiescent (inactive), mildly active, moderately active, or severely active.\n3. Chronicity: This category includes points for the duration of disease, such as whether it is new (less than 1 year), established (1-5 years), or long-standing (more than 5 years).\nThe LSI can be used to assess the severity of lupus at a single point in time, or it can be used to track changes in severity over time. It is important to note that the LSI is not specific to lupus and may not accurately reflect the severity of the disease in all patients. It should be used in conjunction with other clinical assessments and laboratory tests to determine the best course of treatment for each individual patient.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Lupus Severity Index (LSI) is a scoring system that is used to assess the severity of systemic lupus erythematosus (SLE).\n2. The LSI is based on the presence of certain clinical features and laboratory abnormalities.\n3. The LSI is a tool used by healthcare providers to quickly assess the severity of lupus in a patient and is based on a total score of 100 points. \n4. Three categories that the LSI score can be divided into are: organ involvement, activity of the disease, and the duration of the disease.\n5. The Lupus Severity Index can be used to track changes in lupus severity over time.",
    "vicuna-13b_fact": [
      "The Lupus Severity Index (LSI) is a scoring system that is used to assess the severity of systemic lupus erythematosus (SLE).",
      "The LSI is based on the presence of certain clinical features and laboratory abnormalities.",
      "The LSI is a tool used by healthcare providers to quickly assess the severity of lupus in a patient and is based on a total score of 100 points.",
      "Three categories that the LSI score can be divided into are: organ involvement, activity of the disease, and the duration of the disease.",
      "The Lupus Severity Index can be used to track changes in lupus severity over time."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "vicuna-13b_response": "ZSWIM6 is a gene that plays a role in the development and function of the brain, and mutations in this gene have been associated with several neurodevelopmental disorders.\nOne disorder that is caused by de novo mutations in ZSWIM6 is schizophrenia. Studies have found that individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6 than individuals without the disorder.\nAnother disorder that may be caused by de novo mutations in ZSWIM6 is autism spectrum disorder (ASD). While the evidence is still inconclusive, some studies have suggested that de novo mutations in ZSWIM6 may contribute to the development of ASD in some individuals.\nIt is important to note that while mutations in ZSWIM6 have been associated with these disorders, the relationship between the gene and the disorders is complex and not fully understood. Further research is needed to determine the exact role of ZSWIM6 in the development and function of the brain, and to better understand the relationship between ZSWIM6 mutations and these disorders.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. ZSWIM6 is a gene that plays a role in brain development and function.\n2. Schizophrenia is a disorder known to be caused by de novo mutations in ZSWIM6.\n3. Individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6.\n4. Autism spectrum disorder (ASD) may also be associated with de novo mutations in ZSWIM6. \n5. The relationship between ZSWIM6 mutations and related disorders such as schizophrenia and autism is not fully understood.",
    "vicuna-13b_fact": [
      "ZSWIM6 is a gene that plays a role in brain development and function.",
      "Schizophrenia is a disorder known to be caused by de novo mutations in ZSWIM6.",
      "Individuals with schizophrenia are more likely to have de novo mutations in ZSWIM6.",
      "Autism spectrum disorder (ASD) may also be associated with de novo mutations in ZSWIM6.",
      "The relationship between ZSWIM6 mutations and related disorders such as schizophrenia and autism is not fully understood."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "vicuna-13b_response": "The Koos Classification is a system for classifying bacteria based on their cell wall composition. It is used primarily for the identification of bacteria in the laboratory. The classification system is based on the composition of the bacterial cell wall and divides bacteria into four main groups: A, B, C, and D.\nGroup A bacteria have a cell wall containing peptidoglycan and muramic acid. Group B bacteria have a cell wall containing peptidoglycan and lipids. Group C bacteria have a cell wall containing peptidoglycan and glycans. Group D bacteria have a cell wall containing only lipids.\nThe Koos Classification is useful for identifying bacteria, but it is not used to classify diseases. Diseases are classified based on the symptoms they cause and the underlying medical conditions that lead to those symptoms. For example, a disease like pneumonia can be classified based on the cause, such as bacterial, viral, or fungal, and the severity of the disease.\nIn summary, the Koos Classification is a system for classifying bacteria based on their cell wall composition, but it is not used to classify diseases. Diseases are classified based on the symptoms they cause and the underlying medical conditions that lead to those symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Koos Classification is a system for classifying bacteria based on their cell wall composition.\n2. The Koos Classification system divides bacteria into four main groups: A, B, C, and D.\n3. Group A bacteria in Koos Classification have a cell wall containing peptidoglycan and muramic acid.\n4. Group B bacteria in Koos Classification have a cell wall containing peptidoglycan and lipids.\n5. The Koos Classification system is not used to classify diseases.",
    "vicuna-13b_fact": [
      "The Koos Classification is a system for classifying bacteria based on their cell wall composition.",
      "The Koos Classification system divides bacteria into four main groups: A, B, C, and D.",
      "Group A bacteria in Koos Classification have a cell wall containing peptidoglycan and muramic acid.",
      "Group B bacteria in Koos Classification have a cell wall containing peptidoglycan and lipids.",
      "The Koos Classification system is not used to classify diseases."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Koos Classification is a system for classifying pituitary adenomas based on their size and supra and parasellar extension.\n2. FALSE [correction]: The Koos Classification system divides pituitary adenomas into four stages: I, II, III, and IV.\n3. FALSE [correction]: The Koos Classification does not classify bacteria and has no information about Group A and its cell wall composition.\n4. FALSE [correction]: The Koos Classification does not classify bacteria and has no information about Group B and its cell wall composition.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "vicuna-13b_response": "AZD8601 is a drug that is being developed for the treatment of various diseases, including cancer. The in vivo effects of AZD8601 refer to its effects on living organisms, as opposed to in vitro effects, which are observed in laboratory conditions.\nThe in vivo effects of AZD8601 have been studied in various preclinical models, and some promising results have been observed. For example, AZD8601 has been shown to have anti-tumor effects in models of cancer, by inhibiting the activity of a protein called CDK12. In addition, AZD8601 has been shown to have immunomodulatory effects, which may help to enhance the effects of cancer immunotherapy.\nIt is important to note that the in vivo effects of AZD8601 may vary depending on the disease being targeted, the dose and schedule of administration, and other factors. Further research is needed to fully understand the in vivo effects of AZD8601 and to determine its potential as a treatment for various diseases.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. AZD8601 is a drug that is being developed for the treatment of various diseases, including cancer.\n2. The in vivo effects of AZD8601 have been studied in various preclinical models.\n3. AZD8601 has shown to have anti-tumor effects in models of cancer.\n4. The drug, AZD8601, operates by inhibiting the activity of a protein called CDK12.\n5. AZD8601 has been shown to have immunomodulatory effects.",
    "vicuna-13b_fact": [
      "AZD8601 is a drug that is being developed for the treatment of various diseases, including cancer.",
      "The in vivo effects of AZD8601 have been studied in various preclinical models.",
      "AZD8601 has shown to have anti-tumor effects in models of cancer.",
      "The drug, AZD8601, operates by inhibiting the activity of a protein called CDK12.",
      "AZD8601 has been shown to have immunomodulatory effects."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "vicuna-13b_response": "SAHFS stands for Secure Hash Functions (SHA) with a Hash Value of 160 bits. These hash functions are used to create a unique fixed-length output, known as a hash value or digest, from an input of any size. The input can be any type of data, such as a message, file, or password.\nThere are several ways to create a SAHFS, but the most commonly used method is through the use of a cryptographic algorithm. This algorithm takes the input data and performs a series of mathematical operations on it, which results in the creation of the hash value. The specific algorithm used to create a SAHFS is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.\nThe process of creating a SAHFS is generally considered to be one-way, meaning that it is computationally infeasible to recreate the original input data from the hash value. This makes SAHFS useful for a variety of purposes, such as verifying the integrity of data, authenticating the identity of a sender, and storing passwords securely.\nIn summary, SAHFS are created through the use of a cryptographic algorithm that takes an input of any size and produces a fixed-length output, known as a hash value or digest. This process is defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. SAHFS stands for Secure Hash Functions (SHA) with a Hash Value of 160 bits.\n2. SAHFS produce a unique fixed-length output from an input of any size, known as a hash value or digest.\n3. SAHFS uses a cryptographic algorithm defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.\n4. The process of creating a SAHFS is generally considered to be one-way, making it computationally infeasible to recreate the original input from the hash value.\n5. SAHFS can be used for verifying data integrity, authenticating the identity of a sender, and storing passwords securely.",
    "vicuna-13b_fact": [
      "SAHFS stands for Secure Hash Functions (SHA) with a Hash Value of 160 bits.",
      "SAHFS produce a unique fixed-length output from an input of any size, known as a hash value or digest.",
      "SAHFS uses a cryptographic algorithm defined by the National Institute of Standards and Technology (NIST) in their Federal Information Processing Standards (FIPS) publication 180-4.",
      "The process of creating a SAHFS is generally considered to be one-way, making it computationally infeasible to recreate the original input from the hash value.",
      "SAHFS can be used for verifying data integrity, authenticating the identity of a sender, and storing passwords securely."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: SHA stands for Secure Hash Algorithm with a Hash Value of 160 bits.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "vicuna-13b_response": "The PDZ domain is a protein domain found in the SATB1 (Special AT-rich binding protein 1) protein. The PDZ domain is a common protein interaction domain that is involved in the regulation of various cellular processes, including cell signaling, trafficking, and development.\nThe PDZ domain of SATB1 is involved in protein-protein interactions with other proteins, including receptors, ion channels, and scaffolding proteins. These interactions play a role in the regulation of cellular responses to various stimuli, including hormones, neurotransmitters, and growth factors.\nSATB1 is expressed in various tissues, including the brain, heart, and pancreas, and is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival. The PDZ domain of SATB1 is thought to play a role in these processes by mediating interactions with other proteins that regulate cellular signaling pathways.\nOverall, the function of the PDZ domain in SATB1 is to mediate protein-protein interactions that regulate cellular processes, including cell signaling, trafficking, and development.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The PDZ domain is a protein domain found in the SATB1 protein.\n2. The PDZ domain is involved in regulating various cellular processes such as cell signaling, trafficking, and development.\n3. The PDZ domain in SATB1 mediates protein-protein interactions with other proteins, including receptors, ion channels, and scaffolding proteins.\n4. SATB1 is expressed in various tissues, such as the brain, heart, and pancreas.\n5. SATB1 is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival.",
    "vicuna-13b_fact": [
      "The PDZ domain is a protein domain found in the SATB1 protein.",
      "The PDZ domain is involved in regulating various cellular processes such as cell signaling, trafficking, and development.",
      "The PDZ domain in SATB1 mediates protein-protein interactions with other proteins, including receptors, ion channels, and scaffolding proteins.",
      "SATB1 is expressed in various tissues, such as the brain, heart, and pancreas.",
      "SATB1 is involved in the regulation of cellular processes such as cell proliferation, differentiation, and survival."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "vicuna-13b_response": "The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms. It is an acronym that stands for:\nB - Bedtime routine: Establishing a consistent bedtime routine can help regulate the sleep-wake cycle and promote better sleep.\nL - Light exposure: Exposure to natural light during the day and dim red light in the evening can help regulate the sleep-wake cycle and improve sleep quality.\nI - Insomnia-specific exercises: Cognitive-behavioral therapy for insomnia (CBT-I) is a type of therapy that can help people with insomnia improve their sleep by changing negative thoughts and behaviors related to sleep.\nS - Sleep hygiene: Practicing good sleep hygiene, such as maintaining a dark, cool, and quiet sleep environment, can improve sleep quality.\nS - Sleep restriction: Limiting time in bed to the amount of time spent asleep can help increase the sleep drive and improve sleep quality.\nOverall, the BLISS technique is based on the principles of cognitive-behavioral therapy for insomnia (CBT-I) and emphasizes the importance of establishing a consistent bedtime routine, regulating light exposure, and practicing good sleep hygiene to improve sleep quality and reduce insomnia symptoms.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms.\n2. BLISS is an acronym that stands for Bedtime routine, Light exposure, Insomnia-specific exercises, Sleep hygiene, and Sleep restriction.\n3. Cognitive-behavioral therapy for insomnia (CBT-I) is a component of the BLISS technique.\n4. The BLISS technique emphasizes the importance of establishing a consistent bedtime routine, regulating light exposure, and practicing good sleep hygiene.\n5. One of the principles of the BLISS technique is limiting time in bed to the amount of time spent asleep.",
    "vicuna-13b_fact": [
      "The BLISS technique is a method for improving sleep quality and reducing insomnia symptoms.",
      "BLISS is an acronym that stands for Bedtime routine, Light exposure, Insomnia-specific exercises, Sleep hygiene, and Sleep restriction.",
      "Cognitive-behavioral therapy for insomnia (CBT-I) is a component of the BLISS technique.",
      "The BLISS technique emphasizes the importance of establishing a consistent bedtime routine, regulating light exposure, and practicing good sleep hygiene.",
      "One of the principles of the BLISS technique is limiting time in bed to the amount of time spent asleep."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: BLISS is an acronym that stands for Bedtime routine, Limiting behavior, Internal distractions, Sleep hygiene, and Stimulus control.\n3. FALSE [correction]: Cognitive-behavioral therapy for insomnia (CBT-I) is a separate method for managing insomnia, it is not a component of the BLISS technique.\n4. TRUE\n5. FALSE [correction]: One of the principles of the BLISS technique is controlling stimulus that can interfere with sleep, not limiting time in bed to the amount of time asleep.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "vicuna-13b_response": "NK3R (Neurokinin-3 receptor) is a G protein-coupled receptor that is involved in various physiological processes, including pain, inflammation, and gastrointestinal motility. Antagonists of NK3R can bind to the receptor and block its activation, leading to various therapeutic effects. Here are three examples of NK3R antagonists:\n1. Aprepitant: Aprepitant is a synthetic analogue of the natural neurotransmitter substance P, which is a potent antagonist of NK3R. Aprepitant is used as an antiemetic drug to prevent nausea and vomiting associated with chemotherapy. It is also being investigated for its potential use in treating other conditions, such as pain and inflammation.\n2. Emend: Emend (fosaprepitant) is a prodrug of aprepitant and is used to prevent nausea and vomiting associated with chemotherapy. It is a long-acting form of aprepitant and is administered as a single dose on the day of chemotherapy. Emend has been shown to have anti-inflammatory and analgesic effects in addition to its antiemetic effects.\n3. MK-8628: MK-8628 is a potent and selective NK3R antagonist that has been shown to have anti-inflammatory and analgesic effects in animal models. It has been proposed as a potential treatment for chronic pain conditions, such as fibromyalgia and neuropathic pain. MK-8628 is currently in preclinical development and has not yet been approved for use in humans.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Neurokinin-3 receptor (NK3R) is a G protein-coupled receptor involved in physiological processes such as pain, inflammation, and gastrointestinal motility.\n2. Aprepitant is a synthetic analogue of the natural neurotransmitter substance P and an antagonist of NK3R, used as an antiemetic drug to prevent feelings of sickness and vomiting associated with chemotherapy.\n3. Emend (fosaprepitant) is a prodrug of aprepitant used to prevent nausea and vomiting related to chemotherapy.\n4. Emend (fosaprepitant) has displayed anti-inflammatory and analgesic effects alongside its antiemetic qualities.\n5. MK-8628 is a potent and selective NK3R antagonist being developed to potentially treat chronic pain conditions like fibromyalgia and neuropathic pain, currently in preclinical development.",
    "vicuna-13b_fact": [
      "Neurokinin-3 receptor (NK3R) is a G protein-coupled receptor involved in physiological processes such as pain, inflammation, and gastrointestinal motility.",
      "Aprepitant is a synthetic analogue of the natural neurotransmitter substance P and an antagonist of NK3R, used as an antiemetic drug to prevent feelings of sickness and vomiting associated with chemotherapy.",
      "Emend (fosaprepitant) is a prodrug of aprepitant used to prevent nausea and vomiting related to chemotherapy.",
      "Emend (fosaprepitant) has displayed anti-inflammatory and analgesic effects alongside its antiemetic qualities.",
      "MK-8628 is a potent and selective NK3R antagonist being developed to potentially treat chronic pain conditions like fibromyalgia and neuropathic pain, currently in preclinical development."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Aprepitant is a synthetic substance, and it is an antagonist of the neurokinin-1 receptor (NK1R), not NK3R. It is used as an antiemetic drug to prevent feelings of sickness and vomiting associated with chemotherapy.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "vicuna-13b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called \"drug X\". Unfortunately, I do not have any further information about this drug as my training data only goes up until 2021 and I don't have access to any confidential or proprietary information. However, I can tell you that ghrelin is a hormone that plays a role in regulating appetite and energy homeostasis in the body. Inverse agonists are a type of drug that bind to a receptor but do not activate it, instead they block the activation of the receptor.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Drug X is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. Ghrelin is a hormone that regulates appetite and energy homeostasis in the body.\n3. Inverse agonists are a type of drug that bind to a receptor but do not activate it, instead they block the activation of the receptor.",
    "vicuna-13b_fact": [
      "Drug X is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "Ghrelin is a hormone that regulates appetite and energy homeostasis in the body.",
      "Inverse agonists are a type of drug that bind to a receptor but do not activate it, instead they block the activation of the receptor."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "vicuna-13b_response": "Vaxchora is a cholera vaccine that is given as a single dose and is approved for the prevention of moderate to severe cholera in adults and children six years of age and older. The protective efficacy of Vaxchora against moderate to severe cholera has been demonstrated in clinical trials.\nIn a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older. In another study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.\nIt is important to note that the protective efficacy of a vaccine can vary depending on a number of factors, including the population being vaccinated, the strain of cholera being targeted, and the timing of vaccination relative to exposure to cholera.\nIt is also important to follow the vaccination schedule and advice of your healthcare professional for the best protection.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. Vaxchora is a cholera vaccine that is given as a single dose.\n2. Vaxchora is approved for the prevention of moderate to severe cholera in adults and children six years of age and older.\n3. In a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older.\n4. In a study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.\n5. The protective efficacy of a vaccine can vary depending on a number of factors, including the population being vaccinated, the strain of cholera being targeted, and the timing of vaccination relative to exposure to cholera.",
    "vicuna-13b_fact": [
      "Vaxchora is a cholera vaccine that is given as a single dose.",
      "Vaxchora is approved for the prevention of moderate to severe cholera in adults and children six years of age and older.",
      "In a study conducted in Bangladesh, Vaxchora was found to be 85% effective in preventing moderate to severe cholera in adults and children six years of age and older.",
      "In a study conducted in Haiti, Vaxchora was found to be 90% effective in preventing moderate to severe cholera in adults and children six years of age and older.",
      "The protective efficacy of a vaccine can vary depending on a number of factors, including the population being vaccinated, the strain of cholera being targeted, and the timing of vaccination relative to exposure to cholera."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Vaxchora is approved for the prevention of cholera in adults 18 through 64 years of age.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "vicuna-13b_response": "The first cholera vaccine approved in the United States was the Vaxchora vaccine, which was approved by the Food and Drug Administration (FDA) in 2016. Vaxchora is a single-dose, oral cholera vaccine that is administered in a single dose and is designed to provide protection against cholera for up to six months. The Vaxchora vaccine was developed by PaxVax, a biotechnology company based in California.\nCholera is an acute diarrheal disease that is caused by infection with the bacterium Vibrio cholerae. It is spread through contaminated food or water and can cause severe dehydration and even death if left untreated. Cholera vaccines are an important tool in preventing the spread of cholera in endemic areas and in travelers to areas where cholera is common. The Vaxchora vaccine is the first cholera vaccine to be approved in the United States and it is an important step in the prevention and control of cholera.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The Vaxchora vaccine was the first cholera vaccine approved in the United States.\n2. The Food and Drug Administration (FDA) approved the Vaxchora vaccine in 2016.\n3. Vaxchora is a single-dose, oral cholera vaccine designed to provide protection against cholera for up to six months.\n4. PaxVax, a biotechnology company based in California, developed the Vaxchora vaccine.\n5. Cholera, an acute diarrheal disease caused by infection with the bacterium Vibrio cholerae, can be prevented with vaccines like Vaxchora.",
    "vicuna-13b_fact": [
      "The Vaxchora vaccine was the first cholera vaccine approved in the United States.",
      "The Food and Drug Administration (FDA) approved the Vaxchora vaccine in 2016.",
      "Vaxchora is a single-dose, oral cholera vaccine designed to provide protection against cholera for up to six months.",
      "PaxVax, a biotechnology company based in California, developed the Vaxchora vaccine.",
      "Cholera, an acute diarrheal disease caused by infection with the bacterium Vibrio cholerae, can be prevented with vaccines like Vaxchora."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "vicuna-13b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene. This gene provides instructions for making a protein called Bruton's tyrosine kinase, which plays a key role in the development and function of immune cells. Mutations in the BTK gene can lead to a reduction in the number of immune cells and an increased susceptibility to infections, which are characteristic of CVID. Other genetic causes of CVID include mutations in the IL-21R, CD40, and STAT3 genes.",
    "vicuna-13b_fact_raw": "Here are all the factual statements:\n1. The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene.\n2. The BTK gene provides instructions for making a protein called Bruton's tyrosine kinase.\n3. Bruton's tyrosine kinase plays a key role in the development and function of immune cells.\n4. Mutations in the BTK gene can lead to a reduction in the number of immune cells and an increased susceptibility to infections.\n5. Other genetic causes of CVID include mutations in the IL-21R, CD40, and STAT3 genes.",
    "vicuna-13b_fact": [
      "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is a mutation in the BTK gene.",
      "The BTK gene provides instructions for making a protein called Bruton's tyrosine kinase.",
      "Bruton's tyrosine kinase plays a key role in the development and function of immune cells.",
      "Mutations in the BTK gene can lead to a reduction in the number of immune cells and an increased susceptibility to infections.",
      "Other genetic causes of CVID include mutations in the IL-21R, CD40, and STAT3 genes."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The most common genetic cause of common variable immunodeficiency (CVID) in Europeans is not a mutation in the BTK gene, but mutations in the TNFSF12-TNFSF13 and ICOS genes have been implicated.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "vicuna-13b_response": "The IFIT1 gene is a key regulator of the antiviral response and has been implicated in the pathogenesis of systemic lupus erythematosus (SLE), an autoimmune disease characterized by chronic inflammation and the production of autoantibodies.\nStudies have shown that IFIT1 plays a critical role in the regulation of the immune response and the prevention of autoimmunity. Mutations in the IFIT1 gene have been associated with an increased risk of developing SLE, and individuals with SLE often have lower levels of IFIT1 expression in their cells.\nThe IFIT1 protein has been shown to interact with the signaling lymphocytic activation molecule (SLAM) family of receptors, which are involved in the activation and regulation of immune cells. In the context of SLE, IFIT1 may regulate the activation and function of immune cells, such as T cells and B cells, and prevent the development of autoantibodies.\nOverall, the IFIT1 gene plays a critical role in regulating the immune response and preventing autoimmunity, and its dysregulation has been implicated in the pathogenesis of SLE. Further research is needed to fully understand the role of IFIT1 in SLE and to develop new treatments for this debilitating autoimmune disease.",
    "vicuna-13b_fact_raw": "1. The IFIT1 gene is a key regulator of the antiviral response and has been implicated in the pathogenesis of systemic lupus erythematosus (SLE).\n2. Mutations in the IFIT1 gene have been associated with an increased risk of developing SLE.\n3. Individuals with SLE often have lower levels of IFIT1 expression in their cells.\n4. The IFIT1 protein interacts with the signaling lymphocytic activation molecule (SLAM) family of receptors, which are involved in the activation and regulation of immune cells.\n5. The IFIT1 gene plays a crucial role in regulating the immune response, preventing autoimmunity, and its dysregulation has been implicated in the pathogenesis of SLE.",
    "vicuna-13b_fact": [
      "The IFIT1 gene is a key regulator of the antiviral response and has been implicated in the pathogenesis of systemic lupus erythematosus (SLE).",
      "Mutations in the IFIT1 gene have been associated with an increased risk of developing SLE.",
      "Individuals with SLE often have lower levels of IFIT1 expression in their cells.",
      "The IFIT1 protein interacts with the signaling lymphocytic activation molecule (SLAM) family of receptors, which are involved in the activation and regulation of immune cells.",
      "The IFIT1 gene plays a crucial role in regulating the immune response, preventing autoimmunity, and its dysregulation has been implicated in the pathogenesis of SLE."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: The IFIT1 protein does not interact with the SLAM family of receptors; it is involved in recognizing viral RNA and mediating an antiviral response.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "unknown",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "vicuna-13b_response": "The Liverpool Elbow Score is a tool used to assess the severity of elbow injuries in children. It was developed by the Liverpool Elbow Score Group, which was a collaboration between several hospitals in the United Kingdom. The score is used to evaluate the degree of elbow fractures, dislocations, and other injuries in children. It helps healthcare providers to determine the best course of treatment for a child's elbow injury based on the severity of the injury. The Liverpool Elbow Score is used in conjunction with other factors, such as the child's age, overall health, and activity level, to determine the best treatment approach. The score is typically calculated based on the results of an X-ray or other imaging test, and it ranges from 0 to 100, with higher scores indicating more severe injuries.",
    "vicuna-13b_fact_raw": "1. The Liverpool Elbow Score is used to assess the severity of elbow injuries in children.\n2. The Liverpool Elbow Score was developed by a collaboration between several hospitals in the United Kingdom known as the Liverpool Elbow Score Group.\n3. The score helps healthcare providers determine the best treatment for a child's elbow injury based on the severity of the injury.\n4. The Liverpool Elbow Score is calculated based on the results of an X-ray or other imaging test.\n5. The score ranges from 0 to 100, with higher scores indicating more severe injuries.",
    "vicuna-13b_fact": [
      "The Liverpool Elbow Score is used to assess the severity of elbow injuries in children.",
      "The Liverpool Elbow Score was developed by a collaboration between several hospitals in the United Kingdom known as the Liverpool Elbow Score Group.",
      "The score helps healthcare providers determine the best treatment for a child's elbow injury based on the severity of the injury.",
      "The Liverpool Elbow Score is calculated based on the results of an X-ray or other imaging test.",
      "The score ranges from 0 to 100, with higher scores indicating more severe injuries."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Liverpool Elbow Score was developed by a team at the Alder Hey Children's Hospital in Liverpool, not by a collaboration between several hospitals.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "vicuna-13b_response": "The 100,000 Genomes Project is a large-scale genomics project that was launched in the UK in 2012 with the goal of sequencing the genomes of 100,000 participants in order to advance our understanding of genetics and genomics and to improve the diagnosis and treatment of genetic diseases.\nIn terms of sarcoma, the 100,000 Genomes Project has made significant efforts to understand the genetic basis of this disease. Sarcoma is a rare type of cancer that affects connective tissue, such as bone, muscle, and cartilage. It is estimated that around 3,000 people in the UK are diagnosed with sarcoma each year.\nThe project has collected and analyzed whole-genome sequences of sarcoma patients, as well as healthy individuals, to identify genetic variations that may be associated with the development and progression of sarcoma. The project has also analyzed RNA sequencing data to identify changes in gene expression that may be associated with the disease.\nIn addition, the project has also established a network of sarcoma clinical trials that aim to test new treatments for sarcoma patients based on the genetic changes identified through the project.\nOverall, the efforts of the 100,000 Genomes Project on sarcoma have led to a better understanding of the genetic basis of this disease, and have paved the way for the development of new, more effective treatments for sarcoma patients.",
    "vicuna-13b_fact_raw": "1. The 100,000 Genomes Project was launched in the UK in 2012 with the goal of sequencing the genomes of 100,000 participants.\n2. The 100,000 Genomes Project aims to improve the diagnosis and treatment of genetic diseases.\n3. Sarcoma affects connective tissue, such as bone, muscle, and cartilage, with around 3,000 people diagnosed in the UK each year.\n4. The 100,000 Genomes Project has collected and analyzed whole-genome sequences of sarcoma patients and healthy individuals.\n5. The project has also established a network of sarcoma clinical trials to test new treatments for sarcoma patients based on genetic changes identified through the project.",
    "vicuna-13b_fact": [
      "The 100,000 Genomes Project was launched in the UK in 2012 with the goal of sequencing the genomes of 100,000 participants.",
      "The 100,000 Genomes Project aims to improve the diagnosis and treatment of genetic diseases.",
      "Sarcoma affects connective tissue, such as bone, muscle, and cartilage, with around 3,000 people diagnosed in the UK each year.",
      "The 100,000 Genomes Project has collected and analyzed whole-genome sequences of sarcoma patients and healthy individuals.",
      "The project has also established a network of sarcoma clinical trials to test new treatments for sarcoma patients based on genetic changes identified through the project."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The 100,000 Genomes Project was launched in the UK in 2013 with the goal of sequencing the genomes of 100,000 participants.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "vicuna-13b_response": "I'm sorry, but I couldn't find any information about a protein called ALEX1 that contains armadillo repeats. Armadillo repeats are a type of protein motif that are found in many proteins and are characterized by a repeated sequence of 34-37 amino acids. They are often found in proteins that are involved in cell adhesion and signaling.\nIt's possible that ALEX1 is a newly discovered protein or that it doesn't contain armadillo repeats. Without more information, it's difficult to say for sure. If you have any additional information about ALEX1 or why you are interested in its potential armadillo repeat content, I may be able to provide more specific information.",
    "vicuna-13b_fact_raw": "1. Armadillo repeats are a type of protein motif characterized by a repeated sequence of 34-37 amino acids.\n2. Proteins with armadillo repeats are often involved in cell adhesion and signaling.\n3. The query's specific protein, ALEX1, may or may not contain armadillo repeats.\n4. There is no readily available information about the protein ALEX1 containing armadillo repeats.\n5. The protein ALEX1 might be newly discovered.",
    "vicuna-13b_fact": [
      "Armadillo repeats are a type of protein motif characterized by a repeated sequence of 34-37 amino acids.",
      "Proteins with armadillo repeats are often involved in cell adhesion and signaling.",
      "The query's specific protein, ALEX1, may or may not contain armadillo repeats.",
      "There is no readily available information about the protein ALEX1 containing armadillo repeats.",
      "The protein ALEX1 might be newly discovered."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "vicuna-13b_response": "Enzymes that remove histone modifications include:\n1. Histone demethylases: These enzymes remove methyl groups from histone tails, such as Lysine-specific demethylase 1 (LSD1) and Lysine-specific demethylase 2 (LSD2).\n2. Histone acetyltransferases (HATs): These enzymes add acetyl groups to histone tails, such as GCN5 and CBP.\n3. Histone deacetylases (HDACs): These enzymes remove acetyl groups from histone tails.\n4. Histone phosphatases: These enzymes remove phosphate groups from histone tails, such as PP2A and PP1.\n5. Histone ubiquitin ligases: These enzymes add ubiquitin molecules to histone tails, leading to their degradation by the proteasome.\nThese enzymes play a crucial role in regulating gene expression by controlling the accessibility of chromatin to transcription factors and the compaction of chromatin.",
    "vicuna-13b_fact_raw": "1. Histone demethylases, including Lysine-specific demethylase 1 (LSD1) and Lysine-specific demethylase 2 (LSD2), remove methyl groups from histone tails.\n2. Histone acetyltransferases (HATs), like GCN5 and CBP, add acetyl groups to histone tails.\n3. Histone deacetylases (HDACs) are enzymes that remove acetyl groups from histone tails.\n4. Histone phosphatases, such as PP2A and PP1, remove phosphate groups from histone tails.\n5. Histone ubiquitin ligases add ubiquitin molecules to histone tails, leading to their degradation by the proteasome.",
    "vicuna-13b_fact": [
      "Histone demethylases, including Lysine-specific demethylase 1 (LSD1) and Lysine-specific demethylase 2 (LSD2), remove methyl groups from histone tails.",
      "Histone acetyltransferases (HATs), like GCN5 and CBP, add acetyl groups to histone tails.",
      "Histone deacetylases (HDACs) are enzymes that remove acetyl groups from histone tails.",
      "Histone phosphatases, such as PP2A and PP1, remove phosphate groups from histone tails.",
      "Histone ubiquitin ligases add ubiquitin molecules to histone tails, leading to their degradation by the proteasome."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Histone ubiquitin ligases add ubiquitin molecules to histone tails, but this does not always lead to their degradation by the proteasome. Ubiquitination can also lead to changes in chromatin structure and gene regulation.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "vicuna-13b_response": "There is some evidence to suggest that head CT scans may increase the risk of brain tumors, although the absolute risk is small. CT scans use ionizing radiation, which can cause DNA damage and increase the risk of cancer. However, the risk of brain tumors from a single CT scan is generally considered to be low, and the benefits of the scan in diagnosing and treating medical conditions usually outweigh the risks.\nThat being said, it's important to minimize radiation exposure whenever possible, especially in children and young adults who are more sensitive to the effects of radiation. If you need a CT scan, it's important to discuss the risks and benefits with your doctor and to choose the most appropriate imaging test for your medical condition.\nIt's also worth noting that advances in CT technology have led to significant reductions in radiation dose over the years, and some scans may use lower doses of radiation than others. Your doctor can help determine which type of scan is best for you based on your individual medical needs.",
    "vicuna-13b_fact_raw": "1. Head CT scans use ionizing radiation, which can cause DNA damage and increase the risk of cancer.\n2. The absolute risk of getting brain tumors from CT Scans is small.\n3. The risk of brain tumors from a single CT scan is generally considered to be low.\n4. Children and young adults are more sensitive to the effects of radiation.\n5. Advances in CT technology have led to significant reductions in radiation dose over the years.",
    "vicuna-13b_fact": [
      "Head CT scans use ionizing radiation, which can cause DNA damage and increase the risk of cancer.",
      "The absolute risk of getting brain tumors from CT Scans is small.",
      "The risk of brain tumors from a single CT scan is generally considered to be low.",
      "Children and young adults are more sensitive to the effects of radiation.",
      "Advances in CT technology have led to significant reductions in radiation dose over the years."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "vicuna-13b_response": "Otx2 is a transcription factor that is involved in the regulation of embryonic development in many organisms, including mammals. Otx2 is known to be involved in the maintenance of embryonic stem cell (ESC) pluripotency, which is a type of pluripotency that allows ESCs to differentiate into any cell type in the body.\nOtx2 is a key transcription factor in the maintenance of ESC pluripotency in mice, and it is believed to play a similar role in other mammals. Otx2 is required for the self-renewal of ESCs and for the maintenance of their pluripotent state. Loss of Otx2 function in ESCs leads to a loss of pluripotency and differentiation of the cells.\nIn summary, Otx2 is associated with the maintenance of ESC pluripotency, which is a type of pluripotency that allows ESCs to differentiate into any cell type in the body.",
    "vicuna-13b_fact_raw": "1. Otx2 is a transcription factor involved in the regulation of embryonic development in many organisms, including mammals.\n2. Otx2 is involved in the maintenance of embryonic stem cell (ESC) pluripotency.\n3. The type of pluripotency that allows ESCs to differentiate into any cell type in the body is called embryonic stem cell pluripotency.\n4. Otx2 is required for the self-renewal of ESCs and for the maintenance of their pluripotent state.\n5. Loss of Otx2 function in ESCs leads to a loss of pluripotency and differentiation of the cells.",
    "vicuna-13b_fact": [
      "Otx2 is a transcription factor involved in the regulation of embryonic development in many organisms, including mammals.",
      "Otx2 is involved in the maintenance of embryonic stem cell (ESC) pluripotency.",
      "The type of pluripotency that allows ESCs to differentiate into any cell type in the body is called embryonic stem cell pluripotency.",
      "Otx2 is required for the self-renewal of ESCs and for the maintenance of their pluripotent state.",
      "Loss of Otx2 function in ESCs leads to a loss of pluripotency and differentiation of the cells."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The type of pluripotency that allows ESCs to differentiate into any cell type in the body is called totipotency.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "vicuna-13b_response": "The number of DNaseI hypersensitive sites (DHS) marking the murine beta globin locus region can vary depending on the specific strain of mouse and the conditions used for the experiment. However, in general, the beta globin locus region is known to contain several DHS sites that are recognized by the DNaseI enzyme.\nThe beta globin locus region is a complex genomic region that contains several genes, including the beta globin genes, which encode the beta chains of hemoglobin. The DNaseI hypersensitive sites in this region are typically associated with active transcription, as the region is highly transcribed. The number and distribution of DHS sites in the beta globin locus region can vary depending on the stage of development, cell type, and other factors.\nIn general, the number of DHS sites in the murine beta globin locus region is estimated to be around 20 to 30. However, the exact number of DHS sites in this region can vary depending on the specific strain of mouse and the experimental conditions used.",
    "vicuna-13b_fact_raw": "1. The number of DNaseI hypersensitive sites (DHS) marking the murine beta globin locus region can vary depending on the specific strain of mouse and the conditions used for the experiment.\n2. The beta globin locus region contains several genes, including the beta globin genes, which encode the beta chains of hemoglobin.\n3. The DNaseI hypersensitive sites in the beta globin locus region are typically associated with active transcription.\n4. The number and distribution of DHS sites in the beta globin locus region can vary depending on the stage of development, cell type, and other factors.\n5. The general estimate of DHS sites in the murine beta globin locus region is around 20 to 30.",
    "vicuna-13b_fact": [
      "The number of DNaseI hypersensitive sites (DHS) marking the murine beta globin locus region can vary depending on the specific strain of mouse and the conditions used for the experiment.",
      "The beta globin locus region contains several genes, including the beta globin genes, which encode the beta chains of hemoglobin.",
      "The DNaseI hypersensitive sites in the beta globin locus region are typically associated with active transcription.",
      "The number and distribution of DHS sites in the beta globin locus region can vary depending on the stage of development, cell type, and other factors.",
      "The general estimate of DHS sites in the murine beta globin locus region is around 20 to 30."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "vicuna-13b_response": "Here is a list of some European influenza vaccines:\n1. Fluarix - manufactured by GlaxoSmithKline\n2. Influvac - manufactured by Sanofi Pasteur\n3. Afluria - manufactured by Seqirus\n4. FluLaval - manufactured by Bio-Rad Laboratories\n5. FluMist - manufactured by AstraZeneca\n6. FluNase - manufactured by Sanofi Pasteur\n7. Fluarix Tetra - manufactured by GlaxoSmithKline\n8. Influvac Tetra - manufactured by Sanofi Pasteur\n9. Afluria Tetra - manufactured by Seqirus\n10. FluLaval Tetra - manufactured by Bio-Rad Laboratories\nIt's important to note that the availability of these vaccines may vary by country and by year, as well as the specific strains included in the vaccine. Additionally, new vaccines may be developed and approved in the future.",
    "vicuna-13b_fact_raw": "1. Fluarix is a European influenza vaccine manufactured by GlaxoSmithKline.\n2. Influvac, a European influenza vaccine, is manufactured by Sanofi Pasteur.\n3. Afluria is an influenza vaccine produced by Seqirus in Europe.\n4. FluLaval is a European influenza vaccine made by Bio-Rad Laboratories.\n5. FluMist is a flu vaccine manufactured by AstraZeneca in Europe.",
    "vicuna-13b_fact": [
      "Fluarix is a European influenza vaccine manufactured by GlaxoSmithKline.",
      "Influvac, a European influenza vaccine, is manufactured by Sanofi Pasteur.",
      "Afluria is an influenza vaccine produced by Seqirus in Europe.",
      "FluLaval is a European influenza vaccine made by Bio-Rad Laboratories.",
      "FluMist is a flu vaccine manufactured by AstraZeneca in Europe."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Influvac, a European influenza vaccine, is manufactured by Abbott.\n3. FALSE [correction]: Afluria is produced by Seqirus but it is manufactured in the United States, not Europe.\n4. FALSE [correction]: FluLaval is a European influenza vaccine made by GlaxoSmithKline, not Bio-Rad Laboratories.\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "vicuna-13b_response": "Yes, the Paramyxovirus genome is segmented, negative-sense RNA. The Paramyxovirus genus is a group of viruses that cause a range of diseases in humans and animals, including measles, mumps, and respiratory syncytial virus. The genome of Paramyxoviruses is segmented, meaning that it is divided into multiple segments of negative-sense RNA.\nNegative-sense RNA refers to the way in which the genetic information is stored in the RNA molecule. In negative-sense RNA, the genetic information is stored in a complementary strand to the messenger RNA (mRNA) that is used for protein translation. This means that the genetic information in negative-sense RNA is complementary to the amino acid sequence of the proteins that are produced from it.\nThe segmented nature of the Paramyxovirus genome is important for the replication and transcription of the virus. Each segment of the genome is replicated and transcribed independently, allowing the virus to produce multiple copies of its genome during infection. This also allows the virus to evolve rapidly, as mutations in one segment of the genome may not affect the function of the other segments.\nOverall, the segmented, negative-sense RNA genome of the Paramyxovirus is a key feature of these viruses and is important for their replication and evolution.",
    "vicuna-13b_fact_raw": "1. The Paramyxovirus genome is segmented, negative-sense RNA.\n2. The Paramyxovirus genus is a group of viruses that cause a range of diseases in humans and animals, including measles, mumps, and respiratory syncytial virus.\n3. In negative-sense RNA, the genetic information is stored in a complementary strand to the messenger RNA (mRNA) that is used for protein translation.\n4. Each segment of the Paramyxovirus genome is replicated and transcribed independently.\n5. The segmented nature of the Paramyxovirus genome allows the virus to evolve rapidly, as mutations in one segment of the genome may not affect the function of the other segments.",
    "vicuna-13b_fact": [
      "The Paramyxovirus genome is segmented, negative-sense RNA.",
      "The Paramyxovirus genus is a group of viruses that cause a range of diseases in humans and animals, including measles, mumps, and respiratory syncytial virus.",
      "In negative-sense RNA, the genetic information is stored in a complementary strand to the messenger RNA (mRNA) that is used for protein translation.",
      "Each segment of the Paramyxovirus genome is replicated and transcribed independently.",
      "The segmented nature of the Paramyxovirus genome allows the virus to evolve rapidly, as mutations in one segment of the genome may not affect the function of the other segments."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: The Paramyxovirus genome is non-segmented, negative-sense RNA.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The Paramyxovirus genome is non-segmented, so it does not have individual segments that are replicated and transcribed independently.\n5. FALSE [correction]: The Paramyxovirus genome is non-segmented, so the statement about segmented nature does not apply. However, non-segmented viruses can still evolve rapidly due to other mechanisms such as high mutation rates during replication.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "vicuna-13b_response": "Roflumilast Cream is a medication used to treat the symptoms of eczema, a chronic skin condition that causes red, itchy, and inflamed patches on the skin. It is a topical cream that is applied directly to the affected areas of the skin. Roflumilast Cream works by inhibiting the action of certain enzymes that contribute to the inflammation and itching associated with eczema. It is intended for use in adults and children aged 2 years and older.",
    "vicuna-13b_fact_raw": "1. Roflumilast Cream is used to treat the symptoms of eczema.\n2. Eczema is a chronic skin condition causing red, itchy, and inflamed patches on the skin.\n3. Roflumilast Cream is a topical cream that is applied directly to affected areas of the skin.\n4. Roflumilast Cream inhibits certain enzymes that contribute to inflammation and itching.\n5. Roflumilast Cream is for use in adults and children aged 2 years and older.",
    "vicuna-13b_fact": [
      "Roflumilast Cream is used to treat the symptoms of eczema.",
      "Eczema is a chronic skin condition causing red, itchy, and inflamed patches on the skin.",
      "Roflumilast Cream is a topical cream that is applied directly to affected areas of the skin.",
      "Roflumilast Cream inhibits certain enzymes that contribute to inflammation and itching.",
      "Roflumilast Cream is for use in adults and children aged 2 years and older."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "vicuna-13b_response": "There are several tools that have been developed for identifying and visualizing ncRNA promoters. Some of these tools include:\n1. HOTSPOTTER: This tool is a web-based software that uses a combination of statistical and bioinformatic approaches to identify potential ncRNA promoters in genomic regions. It can also visualize the predicted promoters in the context of the genomic sequence.\n2. RNAmap: This tool is a command-line program that can be used to identify and visualize the distribution of ncRNAs in the genome. It can also identify potential ncRNA promoters and track the expression of ncRNAs in different cell types.\n3. ncRNA Promoter Finder: This tool is a web-based software that uses a combination of machine learning and bioinformatic approaches to identify potential ncRNA promoters in the genome. It can also visualize the predicted promoters in the context of the genomic sequence.\n4. RNAhybrid: This tool is a command-line program that can be used to identify and analyze ncRNA-protein interactions in the genome. It can also identify potential ncRNA promoters and track the expression of ncRNAs in different cell types.\n5. ncRNA-Promoter Finder: This tool is a web-based software that uses a combination of machine learning and bioinformatic approaches to identify potential ncRNA promoters in the genome. It can also visualize the predicted promoters in the context of the genomic sequence.\nThese are some of the tools that have been developed for identifying and visualizing ncRNA promoters, and they can be used to help researchers better understand the role of ncRNAs in gene regulation.",
    "vicuna-13b_fact_raw": "1. HOTSPOTTER is a web-based software developed for identifying and visualizing ncRNA promoters.\n2. RNAmap is a command-line program used to identify and visualize the distribution of ncRNAs in the genome and potential ncRNA promoters.\n3. ncRNA Promoter Finder is a web-based software that uses machine learning and bioinformatic approaches to identify potential ncRNA promoters in the genome.\n4. RNAhybrid is a command-line program developed to identify and analyze ncRNA-protein interactions in the genome and potential ncRNA promoters.\n5. ncRNA-Promoter Finder is a tool that uses machine learning and bioinformatic approaches to identify potential ncRNA promoters in the genome.",
    "vicuna-13b_fact": [
      "HOTSPOTTER is a web-based software developed for identifying and visualizing ncRNA promoters.",
      "RNAmap is a command-line program used to identify and visualize the distribution of ncRNAs in the genome and potential ncRNA promoters.",
      "ncRNA Promoter Finder is a web-based software that uses machine learning and bioinformatic approaches to identify potential ncRNA promoters in the genome.",
      "RNAhybrid is a command-line program developed to identify and analyze ncRNA-protein interactions in the genome and potential ncRNA promoters.",
      "ncRNA-Promoter Finder is a tool that uses machine learning and bioinformatic approaches to identify potential ncRNA promoters in the genome."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: HOTSPOTTER is not developed specifically for ncRNA promoters, it's a generic tool for hotspot analysis in genomics.\n2. FALSE [correction]: RNAmap is not specifically for identifying ncRNA promoters; it's used for visualizing RNA secondary structure, accessibility, and interaction with other molecules.\n3. TRUE\n4. FALSE [correction]: RNAhybrid is a tool for predicting microRNA target sites, not for identifying ncRNA-protein interactions or ncRNA promoters.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "vicuna-13b_response": "The SWIM (Sparse Weighted Integrated Matrix) tool is a bioinformatics tool that can be used to identify genes that are differentially expressed in a given dataset, such as a set of glioblastoma samples. Glioblastoma is a type of brain cancer that is highly aggressive and difficult to treat.\nThere are several ways to identify genes that are down-regulated in glioblastoma using the SWIM tool. One approach is to compare the expression levels of genes in a set of glioblastoma samples to the expression levels of the same genes in a control sample, such as normal brain tissue. The SWIM tool can then identify genes that have lower expression levels in the glioblastoma samples compared to the control samples.\nHere are a few examples of genes that have been identified as being down-regulated in glioblastoma using the SWIM tool:\n1. PTEN (Phosphatase and Tensin Homolog): PTEN is a tumor suppressor gene that plays a role in regulating cell growth and survival. Loss of PTEN function has been associated with the development and progression of glioblastoma.\n2. CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A): CDKN2A is a tumor suppressor gene that encodes a protein that inhibits cyclin-dependent kinase activity. Loss of CDKN2A function has been associated with the development and progression of glioblastoma.\n3. PTK2 (Protein Tyrosine Kinase 2): PTK2 is a gene that encodes a protein that plays a role in cell growth and differentiation. Loss of PTK2 function has been associated with the development and progression of glioblastoma.\n4. TP53 (Tumor Protein 53): TP53 is a tumor suppressor gene that plays a role in regulating cell growth and apoptosis (programmed cell death). Mutations in TP53 have been associated with the development and progression of glioblastoma.\nIt's important to note that these are just a few examples of genes that have been identified as being down-regulated in glioblastoma using the SWIM tool, and",
    "vicuna-13b_fact_raw": "1. The SWIM tool is a bioinformatics tool used to identify differentially expressed genes in specific datasets.\n2. The SWIM tool can identify genes that have lower expression levels in certain samples when compared to control samples. \n3. PTEN, a tumor suppressor gene, has been identified by the SWIM tool as being down-regulated in glioblastoma.\n4. CDKN2A, another tumor suppressor gene, has also been identified as being down-regulated in glioblastoma using the SWIM tool. \n5. The SWIM tool has identified TP53, another tumor suppressor gene, as being down-regulated in glioblastoma.",
    "vicuna-13b_fact": [
      "The SWIM tool is a bioinformatics tool used to identify differentially expressed genes in specific datasets.",
      "The SWIM tool can identify genes that have lower expression levels in certain samples when compared to control samples.",
      "PTEN, a tumor suppressor gene, has been identified by the SWIM tool as being down-regulated in glioblastoma.",
      "CDKN2A, another tumor suppressor gene, has also been identified as being down-regulated in glioblastoma using the SWIM tool.",
      "The SWIM tool has identified TP53, another tumor suppressor gene, as being down-regulated in glioblastoma."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "vicuna-13b_response": "TADs, or Topologically Associated Domains, are regions of the genome that are associated with specific chromatin structures and are thought to play important roles in regulating gene expression. There are several R packages that have been developed for studying TADs, including:\n1. TAD-seq: This package provides functions for analyzing TAD-seq data, which is a technique used to identify and characterize TADs in the genome.\n2. TADtools: This package provides a suite of tools for analyzing TADs, including functions for identifying TAD boundaries, visualizing TADs, and comparing TADs between samples.\n3. TADgraph: This package provides a graph-based representation of TADs that can be used to analyze the interactions between TADs and other genomic features.\n4. TADb: This package provides a database of TADs for a variety of organisms, including humans, mice, and yeast.\n5. TAD-seqR: This package provides functions for analyzing TAD-seq data and visualizing TADs, as well as tools for comparing TADs between samples.\n6. TAD-enrichment: This package provides functions for identifying enriched TADs in a given sample, such as enriched TADs in a specific cell type or developmental stage.\n7. TAD-discover: This package provides functions for discovering new TADs in a genome, such as identifying TADs that are not present in a reference genome.\n8. TAD-regions: This package provides functions for identifying TAD regions that are associated with specific gene expression patterns or other genomic features.\nThese packages can be used to analyze TADs in a variety of organisms and for a variety of research questions related to TADs and their role in regulating gene expression.",
    "vicuna-13b_fact_raw": "1. Topologically Associated Domains (TADs) are regions of the genome associated with specific chromatin structures and play roles in regulating gene expression.\n2. The TAD-seq R package provides functions for analyzing TAD-seq data, a technique for identifying and characterizing TADs.\n3. TADtools is an R package offering tools for analyzing TADs, including functions for identification, visualization, and comparison.\n4. TADgraph is an R package that represents TADs in a graph-based format for analyzing interactions.\n5. The TADb R package provides a TADs database for organisms such as humans, mice, and yeast.",
    "vicuna-13b_fact": [
      "Topologically Associated Domains (TADs) are regions of the genome associated with specific chromatin structures and play roles in regulating gene expression.",
      "The TAD-seq R package provides functions for analyzing TAD-seq data, a technique for identifying and characterizing TADs.",
      "TADtools is an R package offering tools for analyzing TADs, including functions for identification, visualization, and comparison.",
      "TADgraph is an R package that represents TADs in a graph-based format for analyzing interactions.",
      "The TADb R package provides a TADs database for organisms such as humans, mice, and yeast."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no known R package specifically called \"TAD-seq\" for analyzing TAD-seq data. However, there are other bioinformatics tools such as HiCExplorer and TADbit available for such analysis.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "vicuna-13b_response": "Bioconductor is a widely used open-source software package for computational molecular biology. There are several Bioconductor tools that can be used to access bacterial regulatory networks, including:\n1. Bacillus Regulon DB (BacillusReg): Bacillus Regulon DB is a database of gene regulatory interactions in Bacillus subtilis. It provides a comprehensive and curated collection of regulatory interactions, including information on transcriptional and post-transcriptional regulation.\n2. RegulonBuilder: RegulonBuilder is a tool for constructing gene regulatory networks from microarray data. It can be used to identify transcriptional regulators and predict regulatory interactions based on gene expression data.\n3. PromoterVista: PromoterVista is a tool for analyzing gene promoter sequences and identifying potential regulatory elements. It can be used to identify transcription factor binding sites and predict the regulatory effects of mutations or polymorphisms in promoter regions.\n4. Genetic Regulatory Elements (GREs): Genetic Regulatory Elements (GREs) is a collection of regulatory sequence motifs that are recognized by transcription factors in Bacillus subtilis. It provides a comprehensive and curated collection of regulatory elements, including information on the binding sites and regulatory effects of transcription factors.\nOverall, these Bioconductor tools can be used to access and analyze bacterial regulatory networks, providing valuable insights into the complex regulatory mechanisms that control gene expression in bacteria.",
    "vicuna-13b_fact_raw": "1. Bioconductor is an open-source software package for computational molecular biology.\n2. Bacillus Regulon DB (BacillusReg) is a Bioconductor tool that provides a database of gene regulatory interactions in Bacillus subtilis.\n3. RegulonBuilder is a Bioconductor tool designed to construct gene regulatory networks from microarray data.\n4. PromoterVista is a Bioconductor tool used in analyzing gene promoter sequences and identifying potential regulatory elements.\n5. Genetic Regulatory Elements (GREs) is a Bioconductor tool that provides a collection of regulatory sequence motifs recognized by transcription factors in Bacillus subtilis.",
    "vicuna-13b_fact": [
      "Bioconductor is an open-source software package for computational molecular biology.",
      "Bacillus Regulon DB (BacillusReg) is a Bioconductor tool that provides a database of gene regulatory interactions in Bacillus subtilis.",
      "RegulonBuilder is a Bioconductor tool designed to construct gene regulatory networks from microarray data.",
      "PromoterVista is a Bioconductor tool used in analyzing gene promoter sequences and identifying potential regulatory elements.",
      "Genetic Regulatory Elements (GREs) is a Bioconductor tool that provides a collection of regulatory sequence motifs recognized by transcription factors in Bacillus subtilis."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Bacillus Regulon DB (BacillusReg) is not a Bioconductor tool, but a standalone database for Bacillus subtilis gene regulatory interactions.\n3. TRUE\n4. FALSE [correction]: PromoterVista is not a Bioconductor tool. The actual Bioconductor tool for analyzing gene promoters is called 'PWMEnrich'.\n5. FALSE [correction]: Genetic Regulatory Elements (GREs) is not a specific Bioconductor tool. Bioconductor provides various tools for analyzing regulatory sequence motifs, such as 'TFBSTools'.",
    "vicuna-13b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "vicuna-13b_response": "The shikimate pathway is a metabolic pathway that occurs in plants, fungi, and bacteria. It is involved in the biosynthesis of aromatic amino acids, such as phenylalanine, tyrosine, and tryptophan, as well as the precursor for the production of the aromatic compound, anthocyanins, which are responsible for the red, purple, and blue colors in fruits and flowers. The end products of the shikimate pathway are aromatic amino acids, anthocyanins, and other aromatic compounds.",
    "vicuna-13b_fact_raw": "1. The shikimate pathway occurs in plants, fungi, and bacteria.\n2. The shikimate pathway is involved in the biosynthesis of aromatic amino acids.\n3. Phenylalanine, tyrosine, and tryptophan are some of the aromatic amino acids produced by the shikimate pathway.\n4. The shikimate pathway is responsible for the production of anthocyanins, which are responsible for the red, purple, and blue colors in fruits and flowers. \n5. The end products of the shikimate pathway are aromatic amino acids, anthocyanins, and other aromatic compounds.",
    "vicuna-13b_fact": [
      "The shikimate pathway occurs in plants, fungi, and bacteria.",
      "The shikimate pathway is involved in the biosynthesis of aromatic amino acids.",
      "Phenylalanine, tyrosine, and tryptophan are some of the aromatic amino acids produced by the shikimate pathway.",
      "The shikimate pathway is responsible for the production of anthocyanins, which are responsible for the red, purple, and blue colors in fruits and flowers.",
      "The end products of the shikimate pathway are aromatic amino acids, anthocyanins, and other aromatic compounds."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The shikimate pathway is not responsible for the production of anthocyanins, which are synthesized through the phenylpropanoid pathway.\n5. FALSE [correction]: The end products of the shikimate pathway are primarily aromatic amino acids; other aromatic compounds may be produced, but anthocyanins are not among them.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "vicuna-13b_response": "Nelson's syndrome is a rare condition characterized by the growth of a pheochromocytoma, a type of adrenal gland tumor, in association with a hyperparathyroidism, a condition in which the parathyroid gland becomes overactive and produces too much parathyroid hormone. Cabergoline is a medication that is used to treat hyperprolactinemia, a condition in which the pituitary gland produces too much prolactin, a hormone that stimulates milk production in women. Cabergoline works by decreasing the amount of prolactin produced by the pituitary gland.\nThere is no evidence to suggest that cabergoline is used for the treatment of Nelson's syndrome. The treatment of Nelson's syndrome typically involves surgery to remove the pheochromocytoma and parathyroid gland, as well as medications to manage the symptoms of the condition. If you have been diagnosed with Nelson's syndrome, it is important to work closely with your healthcare team to develop a treatment plan that is appropriate for your specific needs.",
    "vicuna-13b_fact_raw": "1. Nelson's syndrome is a rare condition characterized by the growth of a pheochromocytoma and hyperparathyroidism.\n2. Cabergoline is a medication used to treat hyperprolactinemia.\n3. Hyperprolactinemia is a condition in which the pituitary gland produces too much prolactin.\n4. There is no evidence to suggest that cabergoline is used for the treatment of Nelson's syndrome.\n5. The treatment of Nelson's syndrome typically involves surgery to remove the pheochromocytoma and parathyroid gland, as well as medications to manage the symptoms of the condition.",
    "vicuna-13b_fact": [
      "Nelson's syndrome is a rare condition characterized by the growth of a pheochromocytoma and hyperparathyroidism.",
      "Cabergoline is a medication used to treat hyperprolactinemia.",
      "Hyperprolactinemia is a condition in which the pituitary gland produces too much prolactin.",
      "There is no evidence to suggest that cabergoline is used for the treatment of Nelson's syndrome.",
      "The treatment of Nelson's syndrome typically involves surgery to remove the pheochromocytoma and parathyroid gland, as well as medications to manage the symptoms of the condition."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Nelson's syndrome is a rare condition characterized by the growth of an adenoma in the pituitary gland after the removal of the adrenal glands.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The treatment of Nelson's syndrome typically involves surgery to remove the adenoma from the pituitary gland, not the pheochromocytoma and parathyroid gland. Medications may also be used to manage the symptoms of the condition.",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "vicuna-13b_response": "Liebenberg syndrome is a rare genetic disorder that is characterized by the presence of multiple café-au-lait spots, which are light-brown pigmented skin lesions, and other symptoms. The main manifestation of Liebenberg syndrome is the presence of multiple café-au-lait spots, which are typically found on the trunk of the body, but can also be found on the limbs and face. These spots are usually symmetrically distributed and are usually benign, meaning they do not pose any medical risk.\nIn addition to the café-au-lait spots, people with Liebenberg syndrome may also have other symptoms, such as nevi (moles), freckles, or other pigmented skin lesions. They may also have a higher risk of developing other pigmented skin conditions, such as melanoma, a type of skin cancer.\nIt is important to note that the presence of café-au-lait spots does not necessarily mean that a person has Liebenberg syndrome. The diagnosis of Liebenberg syndrome is made based on the presence of multiple café-au-lait spots and other symptoms, such as nevi or freckles, and a thorough examination by a dermatologist or other healthcare provider.",
    "vicuna-13b_fact_raw": "1. Liebenberg syndrome is a rare genetic disorder.\n2. The main manifestation of Liebenberg syndrome is the presence of multiple café-au-lait spots.\n3. The café-au-lait spots associated with Liebenberg syndrome are often found on the trunk of the body, limbs, and face.\n4. People with Liebenberg syndrome may also have symptoms like moles, freckles, or other pigmented skin lesions.\n5. Individuals with Liebenberg syndrome may be at a higher risk of developing other pigmented skin conditions, like melanoma.",
    "vicuna-13b_fact": [
      "Liebenberg syndrome is a rare genetic disorder.",
      "The main manifestation of Liebenberg syndrome is the presence of multiple café-au-lait spots.",
      "The café-au-lait spots associated with Liebenberg syndrome are often found on the trunk of the body, limbs, and face.",
      "People with Liebenberg syndrome may also have symptoms like moles, freckles, or other pigmented skin lesions.",
      "Individuals with Liebenberg syndrome may be at a higher risk of developing other pigmented skin conditions, like melanoma."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Liebenberg syndrome's main manifestation is not the presence of multiple café-au-lait spots but rather the abnormal development of the arms and hands, resembling the forelimbs of an ape.\n3. FALSE [correction]: Café-au-lait spots are not typically associated with Liebenberg syndrome, so their location on the body is not relevant.\n4. FALSE [correction]: Liebenberg syndrome is characterized by limb abnormalities, not primarily by moles, freckles, or other pigmented skin lesions.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "vicuna-13b_response": "MPS1 (mono-ADP-ribosylation factor 1) is a protein that plays a role in cellular metabolism and is involved in the regulation of cell growth and division. Inhibition of MPS1 kinase has been shown to have potential therapeutic effects in various diseases, including cancer. Here are some orally bioavailable MPS1 kinase inhibitors:\n1. S61045: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\n2. AZD1284: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\n3. MK-8628: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\n4. S63845: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\n5. MK-5686: This is a potent and selective MPS1 kinase inhibitor that has been shown to inhibit the growth of cancer cells in vitro and in vivo.\nIt is important to note that these are just a few examples of MPS1 kinase inhibitors and that there may be others that are orally bioavailable. Additionally, the effectiveness and safety of these inhibitors may vary depending on the specific disease being targeted and the individual patient. Therefore, it is important to consult with a healthcare professional for proper evaluation and treatment.",
    "vicuna-13b_fact_raw": "1. MPS1 is a protein that plays a role in cellular metabolism and is involved in the regulation of cell growth and division.\n2. Inhibition of MPS1 kinase has potential therapeutic effects in various diseases, including cancer.\n3. S61045, AZD1284, MK-8628, S63845, and MK-5686 are examples of orally bioavailable MPS1 kinase inhibitors.\n4. These MPS1 kinase inhibitors have been shown to inhibit the growth of cancer cells in vitro and in vivo.\n5. The effectiveness and safety of these inhibitors can vary depending on the specific disease being targeted and the individual patient.",
    "vicuna-13b_fact": [
      "MPS1 is a protein that plays a role in cellular metabolism and is involved in the regulation of cell growth and division.",
      "Inhibition of MPS1 kinase has potential therapeutic effects in various diseases, including cancer.",
      "S61045, AZD1284, MK-8628, S63845, and MK-5686 are examples of orally bioavailable MPS1 kinase inhibitors.",
      "These MPS1 kinase inhibitors have been shown to inhibit the growth of cancer cells in vitro and in vivo.",
      "The effectiveness and safety of these inhibitors can vary depending on the specific disease being targeted and the individual patient."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: S61045 and S63845 are examples of orally bioavailable MPS1 kinase inhibitors, while AZD1284, MK-8628, and MK-5686 are not specifically mentioned as such.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "vicuna-13b_response": "Golimumab is a monoclonal antibody drug that is approved for the treatment of various autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is not specifically approved for the treatment of diabetes.\nThere have been some studies that have explored the potential of golimumab in treating diabetes-related complications, such as diabetic nephropathy (kidney disease) and diabetic retinopathy (eye disease). However, these studies have been limited and have not yet resulted in the approval of golimumab for the treatment of diabetes or its complications.\nIt is important to note that golimumab is a potent immunosuppressive drug that can affect the immune system's response to various diseases, including diabetes. Therefore, it is crucial to closely monitor patients with diabetes who are receiving golimumab therapy and to consult with a healthcare provider regarding any changes in diabetes management that may be necessary.",
    "vicuna-13b_fact_raw": "1. Golimumab is a monoclonal antibody drug approved for the treatment of various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.\n2. Golimumab is not specifically approved for the treatment of diabetes.\n3. Some studies have explored the potential of golimumab in treating diabetes-related complications, such as diabetic nephropathy and diabetic retinopathy.\n4. The studies exploring golimumab's potential in treating diabetes-related complications have not led to the approval of golimumab for diabetes or its complications treatment.\n5. Golimumab is a potent immunosuppressive drug that impacts the immune system's response to various diseases, including diabetes.",
    "vicuna-13b_fact": [
      "Golimumab is a monoclonal antibody drug approved for the treatment of various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.",
      "Golimumab is not specifically approved for the treatment of diabetes.",
      "Some studies have explored the potential of golimumab in treating diabetes-related complications, such as diabetic nephropathy and diabetic retinopathy.",
      "The studies exploring golimumab's potential in treating diabetes-related complications have not led to the approval of golimumab for diabetes or its complications treatment.",
      "Golimumab is a potent immunosuppressive drug that impacts the immune system's response to various diseases, including diabetes."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: While golimumab is an immunosuppressive drug that impacts the immune system's response to various diseases, it is not specifically indicated or approved for the treatment of diabetes itself.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "vicuna-13b_response": "Progeria is a rare, progressive, and fatal genetic disorder that affects children. It is characterized by an appearance that is older than their chronological age, including wrinkled skin, a thin and fragile body, and a small stature. The disorder is caused by a mutation in the LMNA gene, which is located on chromosome 1.\nThe LMNA gene provides instructions for making a protein called lamin A, which is a key component of the cell's inner membrane. The mutation in the LMNA gene that causes progeria leads to the production of an abnormal form of lamin A, which disrupts the structure and function of the cell's inner membrane. This disruption can cause a range of problems, including premature aging and a variety of health issues.\nProgeria is inherited in an autosomal recessive pattern, which means that a person must inherit two copies of the mutated gene (one from each parent) to develop the disorder. If a person has only one copy of the mutated gene, they are a carrier of the disorder and are not likely to be affected. However, if a carrier has a child with a partner who is also a carrier, there is a 25% chance that their child will inherit both copies of the mutated gene and develop progeria.",
    "vicuna-13b_fact_raw": "1. Progeria is a rare, progressive, and fatal genetic disorder that affects children.\n2. The disorder is caused by a mutation in the LMNA gene located on chromosome 1.\n3. The LMNA gene mutation leads to the production of an abnormal form of lamin A.\n4. The abnormal lamin A disrupts the structure and function of the cell's inner membrane.\n5. Progeria is inherited in an autosomal recessive pattern, requiring a person to inherit two copies of the mutated gene to develop the disorder.",
    "vicuna-13b_fact": [
      "Progeria is a rare, progressive, and fatal genetic disorder that affects children.",
      "The disorder is caused by a mutation in the LMNA gene located on chromosome 1.",
      "The LMNA gene mutation leads to the production of an abnormal form of lamin A.",
      "The abnormal lamin A disrupts the structure and function of the cell's inner membrane.",
      "Progeria is inherited in an autosomal recessive pattern, requiring a person to inherit two copies of the mutated gene to develop the disorder."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Progeria is not inherited in an autosomal recessive pattern; it usually occurs due to a spontaneous genetic mutation and is not typically passed down from parents to their children.",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "vicuna-13b_response": "12q14 and 12q24 are two regions on chromosome 12 that have been associated with various diseases and traits.\n12q14 is commonly associated with cancer, particularly with the development and progression of breast, ovarian, and prostate cancers. It is also associated with schizophrenia, a mental disorder characterized by symptoms such as delusions, hallucinations, and disorganized thinking.\n12q24 is associated with several diseases and traits, including cancer, particularly with the development of leukemia and lymphoma. It is also associated with autoimmune disorders, such as rheumatoid arthritis, and with cardiovascular disease, particularly with the risk of myocardial infarction. Additionally, 12q24 has been associated with type 2 diabetes, as well as with certain traits such as height and body mass index (BMI).\nIt is important to note that the association between these regions and the diseases/traits they are associated with is complex and multifactorial, and further research is needed to fully understand the underlying mechanisms.",
    "vicuna-13b_fact_raw": "1. 12q14 is a region on chromosome 12 associated with various diseases and traits, including cancer and schizophrenia.\n2. The region 12q14 is commonly associated with the development and progression of breast, ovarian, and prostate cancers.\n3. 12q24 is a region on chromosome 12 associated with several diseases and traits, including cancer, autoimmune disorders, cardiovascular disease, as well as type 2 diabetes, height, and body mass index (BMI).\n4. The region 12q24 is associated with the development of leukemia and lymphoma, rheumatoid arthritis, and the risk of myocardial infarction.\n5. The association between regions 12q14 and 12q24 and the diseases and traits they are associated with is complex and multifactorial.",
    "vicuna-13b_fact": [
      "12q14 is a region on chromosome 12 associated with various diseases and traits, including cancer and schizophrenia.",
      "The region 12q14 is commonly associated with the development and progression of breast, ovarian, and prostate cancers.",
      "12q24 is a region on chromosome 12 associated with several diseases and traits, including cancer, autoimmune disorders, cardiovascular disease, as well as type 2 diabetes, height, and body mass index (BMI).",
      "The region 12q24 is associated with the development of leukemia and lymphoma, rheumatoid arthritis, and the risk of myocardial infarction.",
      "The association between regions 12q14 and 12q24 and the diseases and traits they are associated with is complex and multifactorial."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "vicuna-13b_response": "Roundabout (Robo) receptors are a family of G protein-coupled receptors that play important roles in various biological processes, including cell migration, cell adhesion, and axon guidance. The ligands of Roundabout (Robo) receptors include:\n1. Slit: Slit is a protein that is found in the extracellular matrix and is expressed in a variety of tissues. It is a ligand for Robo1, Robo2, and Robo3 receptors and plays a role in the regulation of cell migration and axon guidance.\n2. Netrin: Netrin is a protein that is found in the extracellular matrix and is expressed in a variety of tissues. It is a ligand for Robo1, Robo2, and Robo3 receptors and plays a role in the regulation of cell migration and axon guidance.\n3. Cone-rod dystrophy protein: Cone-rod dystrophy protein is a protein that is found in the extracellular matrix and is expressed in a variety of tissues. It is a ligand for Robo1, Robo2, and Robo3 receptors and plays a role in the regulation of cell migration and axon guidance.\n4. Thrombospondin: Thrombospondin is a protein that is found in the extracellular matrix and is expressed in a variety of tissues. It is a ligand for Robo1, Robo2, and Robo3 receptors and plays a role in the regulation of cell migration and axon guidance.\nOverall, Roundabout (Robo) receptors are G protein-coupled receptors that play important roles in various biological processes, including cell migration, cell adhesion, and axon guidance. The ligands of Roundabout (Robo) receptors include Slit, Netrin, Cone-rod dystrophy protein, and Thrombospondin.",
    "vicuna-13b_fact_raw": "1. Roundabout (Robo) receptors are a family of G protein-coupled receptors.\n2. Robo receptors play roles in biological processes such as cell migration, cell adhesion, and axon guidance.\n3. Slit is a ligand for Robo1, Robo2, and Robo3 receptors.\n4. Netrin is a ligand for Robo1, Robo2, and Robo3 receptors.\n5. Cone-rod dystrophy protein and Thrombospondin are ligands for Robo1, Robo2, and Robo3 receptors.",
    "vicuna-13b_fact": [
      "Roundabout (Robo) receptors are a family of G protein-coupled receptors.",
      "Robo receptors play roles in biological processes such as cell migration, cell adhesion, and axon guidance.",
      "Slit is a ligand for Robo1, Robo2, and Robo3 receptors.",
      "Netrin is a ligand for Robo1, Robo2, and Robo3 receptors.",
      "Cone-rod dystrophy protein and Thrombospondin are ligands for Robo1, Robo2, and Robo3 receptors."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Roundabout (Robo) receptors are a family of single-pass transmembrane receptors, not G protein-coupled receptors.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Netrin is not a ligand for Robo receptors; it is a ligand for UNC5 Netrin receptors.\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "vicuna-13b_response": "TFII-I, also known as transcription factor II-I, is a protein that plays a role in the regulation of gene expression during cellular differentiation and development. While TFII-I has been shown to play a role in the differentiation of several cell types, its role in megakaryopoiesis, the process by which megakaryocytes develop from hematopoietic stem cells, is not well understood.\nSome studies have suggested that TFII-I may be involved in the regulation of genes that are important for megakaryopoiesis, such as the thrombopoietin receptor (MPO) and the platelet-derived growth factor receptor (PDGFR-β). Other studies have found that TFII-I is expressed in megakaryocytes and that its depletion can lead to a decrease in the number of megakaryocytes in the bone marrow.\nOverall, while there is evidence to suggest that TFII-I may play a role in megakaryopoiesis, the exact nature of its involvement in this process is not yet fully understood. Further research is needed to determine the specific mechanisms by which TFII-I regulates megakaryopoiesis and the role it plays in the development of megakaryocytes.",
    "vicuna-13b_fact_raw": "1. TFII-I, also known as transcription factor II-I, is a protein that plays a role in the regulation of gene expression during cellular differentiation and development.\n2. TFII-I has been shown to play a role in the differentiation of several cell types.\n3. The role of TFII-I in megakaryopoiesis, the development of megakaryocytes from hematopoietic stem cells, is not well understood.\n4. Some studies suggest that TFII-I may be involved in the regulation of genes important for megakaryopoiesis, such as the thrombopoietin receptor (MPO) and the platelet-derived growth factor receptor (PDGFR-β).\n5. Certain studies have found that depletion of TFII-I can lead to a decrease in the number of megakaryocytes in the bone marrow.",
    "vicuna-13b_fact": [
      "TFII-I, also known as transcription factor II-I, is a protein that plays a role in the regulation of gene expression during cellular differentiation and development.",
      "TFII-I has been shown to play a role in the differentiation of several cell types.",
      "The role of TFII-I in megakaryopoiesis, the development of megakaryocytes from hematopoietic stem cells, is not well understood.",
      "Some studies suggest that TFII-I may be involved in the regulation of genes important for megakaryopoiesis, such as the thrombopoietin receptor (MPO) and the platelet-derived growth factor receptor (PDGFR-β).",
      "Certain studies have found that depletion of TFII-I can lead to a decrease in the number of megakaryocytes in the bone marrow."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Some studies suggest that TFII-I may be involved in the regulation of genes important for megakaryopoiesis, such as the thrombopoietin receptor (c-MPL) and the platelet-derived growth factor receptor (PDGFR-β).\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "vicuna-13b_response": "Atenolol is a beta-blocker medication that is commonly used to treat hypertension, angina, and certain types of heart arrhythmias. It is metabolized by several enzymes, including CYP2D6, which is a member of the cytochrome P450 family of enzymes.\nCYP2D6 is responsible for converting atenolol to its active metabolite, which is then further metabolized by other enzymes. The conversion of atenolol to its active metabolite is an important step in the elimination of the drug from the body.\nIt is important to note that the metabolism of atenolol, including its conversion to its active metabolite, can be affected by various factors, such as genetic differences in the CYP2D6 enzyme, other medications that a person is taking, and other health conditions. Therefore, the metabolism of atenolol can vary from person to person, and the effectiveness and safety of the drug may be influenced by these factors.\nIn conclusion, while CYP2D6 is one of the enzymes involved in the metabolism of atenolol, it is not the only enzyme responsible for this process. The metabolism of atenolol can be influenced by various factors, and the effectiveness and safety of the drug may be influenced by these factors.",
    "vicuna-13b_fact_raw": "1. Atenolol is a beta-blocker medication used to treat hypertension, angina, and certain types of heart arrhythmias.\n2. Atenolol is metabolized by several enzymes, including CYP2D6.\n3. CYP2D6 is responsible for converting atenolol to its active metabolite.\n4. The metabolism of atenolol can be affected by various factors such as genetic differences in the CYP2D6 enzyme, other medications that a person is taking, and other health conditions.\n5. The effectiveness and safety of atenolol may be influenced by the individual's metabolism of the drug.",
    "vicuna-13b_fact": [
      "Atenolol is a beta-blocker medication used to treat hypertension, angina, and certain types of heart arrhythmias.",
      "Atenolol is metabolized by several enzymes, including CYP2D6.",
      "CYP2D6 is responsible for converting atenolol to its active metabolite.",
      "The metabolism of atenolol can be affected by various factors such as genetic differences in the CYP2D6 enzyme, other medications that a person is taking, and other health conditions.",
      "The effectiveness and safety of atenolol may be influenced by the individual's metabolism of the drug."
    ],
    "vicuna-13b_judge_raw": "1. TRUE\n2. FALSE [correction]: Atenolol is not significantly metabolized by the liver and does not involve CYP2D6.\n3. FALSE [correction]: Atenolol does not have an active metabolite; it is excreted unchanged in the urine.\n4. TRUE\n5. TRUE",
    "vicuna-13b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "vicuna-13b_response": "ExpansionHunter is a software tool that is used to detect and remove unwanted software from a computer system. It is developed by Emsisoft, a German software company.\nHere are the versions of ExpansionHunter that are currently available:\n1. ExpansionHunter 2.31.0.35\n2. ExpansionHunter 2.31.0.34\n3. ExpansionHunter 2.31.0.33\n4. ExpansionHunter 2.31.0.32\n5. ExpansionHunter 2.31.0.31\n6. ExpansionHunter 2.31.0.30\n7. ExpansionHunter 2.31.0.29\n8. ExpansionHunter 2.31.0.28\n9. ExpansionHunter 2.31.0.27\n10. ExpansionHunter 2.31.0.26\nNote: The version numbers may change as new versions of the software are released.",
    "vicuna-13b_fact_raw": "1. ExpansionHunter is a software tool used to detect and remove unwanted software from a computer system.\n2. ExpansionHunter is developed by Emsisoft, a German software company.\n3. One version of ExpansionHunter that is available is 2.31.0.35.\n4. Another version of ExpansionHunter that is available is 2.31.0.34.\n5. The version numbers of ExpansionHunter may change as new versions of the software are released.",
    "vicuna-13b_fact": [
      "ExpansionHunter is a software tool used to detect and remove unwanted software from a computer system.",
      "ExpansionHunter is developed by Emsisoft, a German software company.",
      "One version of ExpansionHunter that is available is 2.31.0.35.",
      "Another version of ExpansionHunter that is available is 2.31.0.34.",
      "The version numbers of ExpansionHunter may change as new versions of the software are released."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: ExpansionHunter is a software tool used for detecting repeat expansions within genomic data, not for removing unwanted software.\n2. FALSE [correction]: ExpansionHunter is developed by Illumina, a company that specializes in genetic variation analysis, not Emsisoft.\n3. FALSE [correction]: The version numbers provided do not correspond to known versions of ExpansionHunter, which typically follow a different format (e.g., v3.2.2).\n4. FALSE [correction]: The version numbers provided do not correspond to known versions of ExpansionHunter, which typically follow a different format (e.g., v3.2.2).\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "vicuna-13b_response": "Adamts18 (A Disintegrin and Metalloprotease with Thrombospondin Type 1 Motifs 18) is a protein that plays a role in regulating hormone receptor signaling. It is a member of the ADAMTS (A Disintegrin And Metalloprotease With Thrombospondin Motifs) family of proteins, which are known to be involved in the regulation of various cellular processes, including cell adhesion, migration, and differentiation.\nAdamts18 is expressed in various tissues, including the brain, and it is thought to play a role in the regulation of neurotransmitter release and neuronal plasticity. In the context of hormone receptor signaling, Adamts18 has been shown to regulate the activity of the estrogen receptor (ER), a hormone receptor that plays a critical role in the regulation of various physiological processes, including reproduction and bone health.\nStudies have shown that Adamts18 can interact with the ER and modulate its activity by regulating the proteolytic processing of the ER. Specifically, Adamts18 can cleave the ER protein, leading to its degradation and decreased activity. In this way, Adamts18 acts as a negative regulator of ER signaling, helping to maintain proper levels of ER activity and prevent excessive signaling.\nOverall, the role of Adamts18 in hormone receptor signaling is to regulate the activity of the estrogen receptor and other hormone receptors, thereby helping to maintain proper levels of hormone signaling and prevent excessive signaling that could lead to disease or other adverse effects.",
    "vicuna-13b_fact_raw": "1. Adamts18 is a protein that plays a role in regulating hormone receptor signaling.\n2. Adamts18 is a member of the ADAMTS (A Disintegrin And Metalloprotease With Thrombospondin Motifs) family of proteins.\n3. The protein, Adamts18, is expressed in various tissues including the brain.\n4. Adamts18 has been shown to regulate the activity of the estrogen receptor.\n5. Adamts18 acts as a negative regulator of estrogen receptor signaling by regulating the proteolytic processing of the receptor which leads to degradation and decreased activity.",
    "vicuna-13b_fact": [
      "Adamts18 is a protein that plays a role in regulating hormone receptor signaling.",
      "Adamts18 is a member of the ADAMTS (A Disintegrin And Metalloprotease With Thrombospondin Motifs) family of proteins.",
      "The protein, Adamts18, is expressed in various tissues including the brain.",
      "Adamts18 has been shown to regulate the activity of the estrogen receptor.",
      "Adamts18 acts as a negative regulator of estrogen receptor signaling by regulating the proteolytic processing of the receptor which leads to degradation and decreased activity."
    ],
    "vicuna-13b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-13b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "vicuna-13b_response": "Thiazovivin is an antiviral drug that is used to treat hepatitis B and C. Its mode of action is to inhibit the activity of the hepatitis B virus (HBV) and hepatitis C virus (HCV) by targeting the viral replication complex.\nThiazovivin binds to the HBV and HCV RNA and inhibits viral replication by preventing viral RNA transcription and assembly of viral particles. It also inhibits the activity of the viral reverse transcriptase, which is responsible for the reverse transcription of viral RNA into DNA.\nThiazovivin has a unique mechanism of action compared to other antiviral drugs, as it does not target the viral envelope or the viral protease, which are the common targets of other antiviral drugs.\nIt is important to note that Thiazovivin should only be used under the guidance of a healthcare professional, as it can have side effects and interactions with other medications.",
    "vicuna-13b_fact_raw": "1. Thiazovivin is an antiviral drug used to treat hepatitis B and C.\n2. Thiazovivin inhibits the activity of the hepatitis B virus (HBV) and hepatitis C virus (HCV) by targeting the viral replication complex.\n3. Thiazovivin binds to the HBV and HCV RNA and prevents viral RNA transcription and assembly of viral particles.\n4. Thiazovivin inhibits the activity of the viral reverse transcriptase, which is responsible for the reverse transcription of viral RNA into DNA.\n5. Thiazovivin has a different mechanism of action than other antiviral drugs as it does not target the viral envelope or the viral protease.",
    "vicuna-13b_fact": [
      "Thiazovivin is an antiviral drug used to treat hepatitis B and C.",
      "Thiazovivin inhibits the activity of the hepatitis B virus (HBV) and hepatitis C virus (HCV) by targeting the viral replication complex.",
      "Thiazovivin binds to the HBV and HCV RNA and prevents viral RNA transcription and assembly of viral particles.",
      "Thiazovivin inhibits the activity of the viral reverse transcriptase, which is responsible for the reverse transcription of viral RNA into DNA.",
      "Thiazovivin has a different mechanism of action than other antiviral drugs as it does not target the viral envelope or the viral protease."
    ],
    "vicuna-13b_judge_raw": "1. FALSE [correction]: Thiazovivin is not an antiviral drug, it is a small molecule used to enhance the survival and reprogramming of somatic cells to induced pluripotent stem cells.\n2. FALSE [correction]: Thiazovivin does not inhibit the activity of HBV or HCV as it is not an antiviral drug.\n3. FALSE [correction]: Thiazovivin does not bind to HBV or HCV RNA as it is not an antiviral drug.\n4. FALSE [correction]: Thiazovivin does not inhibit the activity of viral reverse transcriptase as it is not an antiviral drug.\n5. TRUE",
    "vicuna-13b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  }
]